"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOUSSN_GMARTINO",2000,3,6,1,1,0,1,1,1,0,1,0,0,0,0,0,3,0,0,0,1,1,0.0220599698591696,NA,0,0.333333333333333,0.089,0.133,0,0.133,"M BASILE;A DATTOLA;P MACCARONE;DE SALVO S;ALESSANDRO PARISI;SCIPIONE CARERJ;GIULIANA GIANNETTO;S CELI;CONCETTA ZITO;TRIFIRO MP;F CONSOLO;A PARISI;SIMONA CELI;ANTONIO ALBERTI;ANTONINO ALBERTI","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","M BASILE;A DATTOLA;P MACCARONE;DE SALVO S;SCIPIONE CARERJ;CONCETTA ZITO;TRIFIRO MP;F CONSOLO;ALESSANDRO PARISI;SIMONA CELI;ANTONIO ALBERTI;GIULIANA GIANNETTO;S CELI;A PARISI;ANTONINO ALBERTI","0.31;0.31;0.31;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.14;0.14;0.14;0.14","M BASILE;A DATTOLA;SCIPIONE CARERJ","2;2;1","M BASILE;A DATTOLA;SCIPIONE CARERJ","0.31;0.31;0.2","A DATTOLA;ALESSANDRO PARISI;ANTONIO ALBERTI;M BASILE;P MACCARONE;SIMONA CELI;CONCETTA ZITO;DE SALVO S;F CONSOLO;SCIPIONE CARERJ;TRIFIRO MP;A PARISI;ANTONINO ALBERTI;GIULIANA GIANNETTO;S CELI","2;2;2;2;2;2;1;1;1;1;1;0;0;0;0","A DATTOLA;SCIPIONE CARERJ;M BASILE","2;1;0","A DATTOLA;SCIPIONE CARERJ;M BASILE","1;1;0","MEDICINE;PHYSICS","3;1","INTERNAL MEDICINE;RADIOLOGY;SURGERY;CARDIOLOGY;ENVIRONMENTAL HEALTH;NURSING;OPTICS","3;2;2;1;1;1;1","BILE DUCT;CANCER;CARCINOMA;HEMODYNAMICS;HYPOKINESIA;INCIDENCE (GEOMETRY);INFERIOR VENA CAVA;MORTALITY RATE;PALLIATIVE CARE;PALLIATIVE TREATMENT;PERCUTANEOUS;POPULATION;PREOPERATIVE CARE;PULMONARY ARTERY;PULMONARY EMBOLISM;RECTUM;THROMBOSIS;TRICUSPID VALVE;ULTRASONOGRAPHY;ULTRASOUND;VENTRICLE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMPULLA OF VATER;COLORECTAL CANCER;LIFE EXPECTANCY;PROSTATE CANCER;TRICUSPID INSUFFICIENCY","1;1;1;1;1","TRANSRECTAL ULTRASONOGRAPHY","1","PULMONARY EMBOLISM;RECTAL NEOPLASMS;HUMANS;HYPERTENSION, PULMONARY;TRICUSPID VALVE INSUFFICIENCY;VENOUS THROMBOSIS;VENTRICULAR DYSFUNCTION, RIGHT;ANTICOAGULANTS;BILIARY TRACT NEOPLASMS;FEMALE;FIBRINOLYTIC AGENTS;FOLLOW-UP STUDIES;HEPARIN;MALE;MIDDLE AGED;PANCREATIC NEOPLASMS;TIME FACTORS;AGED;ECHOCARDIOGRAPHY;ENDOSCOPY","5;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1","COLORECTAL CANCER RESEARCH AND TREATMENT;PANCREATIC CANCER RESEARCH AND TREATMENT;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM","1;1;1","AMPULLA OF VATER;CANCER IMAGING;ECHOCARDIOGRAPHY;HYPOKINESIA;NEUROENDOCRINE TUMORS;PALLIATIVE TREATMENT;PANCREATIC NEUROENDOCRINE TUMORS;PREOPERATIVE CARE;PULMONARY EMBOLISM;TRANSRECTAL ULTRASONOGRAPHY;TRICUSPID INSUFFICIENCY;TUMOR CLASSIFICATION","1;1;1;1;1;1;1;1;1;1;1;1","CARDIOLOGIC DIAGNOSIS;DIVERSION TREATMENT;EMBOLISM ECHOCARDIOGRAPHY;ENDOSCOPIC-PERCUTANEOUS APPROACH;NEOPLASMS EXPERIENCE;PALLIATIVE TREATMENT;POSTOPERATIVE FOLLOW-UP;PREOPERATIVE STAGING;PULMONARY EMBOLISM;RECTAL NEOPLASMS;SURGICAL DIVERSION;TRANSRECTAL ULTRASONOGRAPHY;TREATMENT VERSUS;VERSUS ENDOSCOPIC-PERCUTANEOUS","1;1;1;1;1;1;1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,971,50,0,0,149,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","BRAIN DISORDERS;CHRONIC PAIN;HEADACHES;MIGRAINES;NEUROSCIENCES;PAIN RESEARCH","1;1;1;1;1;1","NEUROLOGICAL","1","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2001,4,6.75,1,0.75,0,0.75,1,0.75,0,0.75,0,0,0,0,1,3,0,0,0.25,0.75,6.5,0.142255514515517,NA,0,0.75,0.204,0.167,0,0.167,"M BASILE;MARCELLO ARAGONA;A DATTOLA;P MACCARONE;P DATTOLA;SIMONA CELI;D ROMEO;M. MESITI;A ALBERTI;FILIPPO LA TORRE;ALESSANDRO PARISI;STEFANO CASCINU;GIUSEPPE PASTURA;LA TORRE;A PARISI;ANTONIO PONTORIERO;ANTONIO ALBERTI;ANNA MARIA SILIPIGNI;S PANETTA;STEFANIA PANETTA","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MARCELLO ARAGONA;M BASILE;A DATTOLA;P MACCARONE;P DATTOLA;SIMONA CELI;LA TORRE;ANTONIO PONTORIERO;S PANETTA;LA TORRE F;A ALBERTI;ALESSANDRO PARISI;A PARISI;ANTONIO ALBERTI;D ROMEO;M. MESITI;FILIPPO LA TORRE;STEFANO CASCINU;GIUSEPPE PASTURA;ANNA MARIA SILIPIGNI","0.32;0.29;0.29;0.29;0.29;0.29;0.2;0.2;0.2;0.2;0.14;0.14;0.14;0.14;0.12;0.12;0.12;0.12;0.12;0.12","MARCELLO ARAGONA;A ALBERTI;GIUSEPPE PASTURA;ANTONIO ALBERTI","2;1;1;1","MARCELLO ARAGONA;A ALBERTI;ANTONIO ALBERTI;GIUSEPPE PASTURA","0.32;0.14;0.14;0.12","MARCELLO ARAGONA;ANNA MARIA SILIPIGNI;D ROMEO;FILIPPO LA TORRE;GIUSEPPE PASTURA;M. MESITI;STEFANIA PANETTA;STEFANO CASCINU;A DATTOLA;ANTONIO PONTORIERO;LA TORRE;LA TORRE F;M BASILE;P DATTOLA;P MACCARONE;S PANETTA;SIMONA CELI;A ALBERTI;A PARISI;ALESSANDRO PARISI","24;22;22;22;22;22;22;22;2;2;2;2;2;2;2;2;2;1;1;1","GIUSEPPE PASTURA;MARCELLO ARAGONA;A ALBERTI;ANTONIO ALBERTI","22;2;1;1","A ALBERTI;ANTONIO ALBERTI;GIUSEPPE PASTURA;MARCELLO ARAGONA","1;1;1;1","MEDICINE;ART;BIOLOGY","3;1;1","INTERNAL MEDICINE;SURGERY;CANCER RESEARCH;CELL BIOLOGY;ENDOCRINOLOGY;GENETICS;LITERATURE;MOLECULAR BIOLOGY;NUCLEAR MEDICINE;ONCOLOGY;RADIOLOGY","3;2;1;1;1;1;1;1;1;1;1","CANCER;CELL;DNA;DOPPLER ULTRASOUND;GENE;PANCREAS;RECEPTOR;RESECTION;SCINTIGRAPHY;SENESCENCE;SENSIBILITY;THROMBOSIS;THYROID;ULTRASONOGRAPHY;ULTRASOUND","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;CARCINOGENESIS;CELL CYCLE;COLOR DOPPLER;NERVE GROWTH FACTOR;TELOMERASE;TELOMERE;THYROIDECTOMY;TRANSCRIPTION FACTOR","1;1;1;1;1;1;1;1;1","DNA-BINDING PROTEIN;OESTROGEN RECEPTOR;TELOMERASE REVERSE TRANSCRIPTASE;TOTAL THYROIDECTOMY","1;1;1;1","COMMON BILE DUCT NEOPLASMS;HUMANS;RECEPTORS, NERVE GROWTH FACTOR;AMPULLA OF VATER;BREAST NEOPLASMS;CELL TRANSFORMATION, NEOPLASTIC;FEMALE;MIDDLE AGED;NEOPLASMS;THYROID DISEASES;ADULT;AGED;BIOMARKERS, TUMOR;DNA-BINDING PROTEINS;MALE;RECEPTORS, ESTROGEN;TELOMERASE;TELOMERE;THYROIDECTOMY;ULTRASONOGRAPHY","4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","COMPLICATIONS AND TECHNIQUES IN THYROID SURGERY;NUTRITIONAL GENOMICS: PERSONALIZED NUTRITION AND HEALTH;PANCREATIC CANCER RESEARCH AND TREATMENT;ROLES OF NEUROTROPHINS IN NERVOUS SYSTEM FUNCTION","1;1;1;1","COLOR DOPPLER;DOPPLER ULTRASOUND;ENDOSCOPIC THYROIDECTOMY;METABOLIC SYNDROME;NERVE REGENERATION;NEURONAL PLASTICITY;OESTROGEN RECEPTOR;SENESCENCE;SHELTERIN;TELOMERE-BINDING PROTEIN;THYROID NODULES;THYROID SURGERY;TUMOR MICROENVIRONMENT","1;1;1;1;1;1;1;1;1;1;1;1;1","PERSONAL EXPERIENCE;BREAST CANCER;CANCER PATIENTS;COLOR-DOPPLER ULTRASONOGRAPHY;FACTOR RECEPTOR;GROWTH FACTOR;HIGH-RESOLUTION ULTRASONOGRAPHY;INTRAOPERATIVE COLOR-DOPPLER;INVASION METHODS;LONG-TERM MONITORING;NERVE GROWTH;PERIAMPULLAR TUMORS;POSTOPERATIVE THYROID;RECEPTOR IMMUNOREACTIVITY;RESIDUE PERSONAL;TELOMERE-BINDING PROTEINS;THYROID RESIDUE;TUMORS ROLE;VASCULAR INVASION","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","","",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2002,11,6.27272727272727,2.27272727272727,0.727272727272727,0.363636363636364,0.727272727272727,1.08695652173913,0.888888888888889,1,0.888888888888889,0.272727272727273,0,4,1,0,6,0.36,0.09,0,0.55,42.73,0.774483802996725,NA,0.0909090909090909,0.454545454545455,0.366,0.097,0.167,0.097,"FRANCESCO CORRADO;GIUSEPPE MAGAZZÙ;CONCETTA SFERLAZZAS;CLAUDIO SCISCA;G GERMANOTTA;FRANCESCO STILO;GIULIANA ANASTASI;A CERTO;MOISÉS CASAL-RIVAS;S PUSTORINO;GIOVANNI PARISI;SAVERIO LODDO;G BERTOLI;R. MAISANO;A CARDITELLO;RINO BELLOCCO;SACCÀ CA;MARIA BUSÁ;MICHELE PAGANO;ESTHER BOULLOSA-SEOANE","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FRANCESCO CORRADO;GIUSEPPE MAGAZZÙ;CONCETTA SFERLAZZAS;CLAUDIO SCISCA;FRANCESCO STILO;GIULIANA ANASTASI;A CERTO;MOISÉS CASAL-RIVAS;GIOVANNI PARISI;A CARDITELLO;ESTHER BOULLOSA-SEOANE;GIUSEPPE BASILE;ANTONIO DAVID;P MACCARONE;ANTONIO BASILE;A PARISI;LUIS DOMÍNGUEZ–VIGUERA;MAURIZIO BASILE;SAVERIO LODDO;G BERTOLI","0.76;0.67;0.67;0.29;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.17","FRANCESCO CORRADO;GIUSEPPE MAGAZZÙ;CONCETTA SFERLAZZAS;CLAUDIO SCISCA;S PUSTORINO;SAVERIO LODDO;A CARDITELLO;SACCÀ CA;MARIA BUSÁ;ISABELLA VENZA;C INFERRERA;LUCIANA RIGOLI;GIOVANNI SQUADRITO;ROSARIO ALBERTO CARUSO;ANTONIO BASILE;MARILENA CRUPI;GIUSEPPE M. CAMPO;A PARISI;ALESSANDRA CRISAFULLI;ROSARIO D’ANNA","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FRANCESCO CORRADO;GIUSEPPE MAGAZZÙ;CONCETTA SFERLAZZAS;CLAUDIO SCISCA;A CARDITELLO;ANTONIO BASILE;A PARISI;SAVERIO LODDO;SACCÀ CA;MARIA BUSÁ;ISABELLA VENZA;C INFERRERA;LUCIANA RIGOLI;ROSARIO ALBERTO CARUSO;MARILENA CRUPI;D. TETI;S PUSTORINO;GIOVANNI SQUADRITO;GIUSEPPE M. CAMPO;ALESSANDRA CRISAFULLI","0.76;0.67;0.67;0.29;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.12;0.09;0.09;0.09","FRANCESCO CORRADO;ACHILLE P. CAPUTI;ALESSANDRA CRISAFULLI;DOMENICA ALTAVILLA;FRANCESCO SQUADRITO;GIOACCHINO CALAPAI;GIOVANNI SQUADRITO;GIUSEPPE M. CAMPO;NUNZIATA MORABITO;PIETRO RUGGERI;ROSARIO D’ANNA;C INFERRERA;G BERTOLI;LUCIANA RIGOLI;MICHELE PAGANO;RINO BELLOCCO;ROSARIO ALBERTO CARUSO;CONCETTA SFERLAZZAS;GIUSEPPE MAGAZZÙ;CLAUDIO SCISCA","253;231;231;231;231;231;231;231;231;231;231;186;186;186;186;186;186;22;22;16","ALESSANDRA CRISAFULLI;FRANCESCO CORRADO;GIOVANNI SQUADRITO;GIUSEPPE M. CAMPO;NUNZIATA MORABITO;PIETRO RUGGERI;ROSARIO D’ANNA;C INFERRERA;LUCIANA RIGOLI;ROSARIO ALBERTO CARUSO;CONCETTA SFERLAZZAS;GIUSEPPE MAGAZZÙ;CLAUDIO SCISCA;D. TETI;ISABELLA VENZA;MARIA BUSÁ;MARILENA CRUPI;SAVERIO LODDO;A PARISI;S PUSTORINO","231;231;231;231;231;231;231;186;186;186;22;22;15;7;7;7;7;7;5;2","CONCETTA SFERLAZZAS;GIUSEPPE MAGAZZÙ;A CARDITELLO;A PARISI;ALESSANDRA CRISAFULLI;ANTONIO BASILE;C INFERRERA;CLAUDIO SCISCA;D. TETI;FRANCESCO CORRADO;GIOVANNI SQUADRITO;GIUSEPPE M. CAMPO;ISABELLA VENZA;LUCIANA RIGOLI;MARIA BUSÁ;MARILENA CRUPI;NUNZIATA MORABITO;PIETRO RUGGERI;ROSARIO ALBERTO CARUSO;ROSARIO D’ANNA","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATERIALS SCIENCE;PHYSICS","10;4;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;RADIOLOGY;GASTROENTEROLOGY;GENETICS;OBSTETRICS;PALEONTOLOGY;ACOUSTICS;BIOCHEMISTRY;CARDIOLOGY;DATABASE;ENDOCRINOLOGY;GENERAL SURGERY;METALLURGY;ONCOLOGY;ORGANIC CHEMISTRY;PSYCHIATRY","9;5;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1","ANEMIA;ARTERY;CANCER;COMPLICATION;DISEASE;PERCUTANEOUS;PREGNANCY;ABLATION;ACCIDENTAL;ALTERNATIVE MEDICINE;ANEURYSM;BIOPSY;BLOOD PRESSURE;BRONCHOSCOPY;CARCINOMA;COMPUTED TOMOGRAPHY;CONCOMITANT;CONFIDENCE INTERVAL;DYSPHAGIA;EMBOLIZATION;ENDOSCOPY;ENDOTHELIAL DYSFUNCTION;ENDOTHELIUM;ESOPHAGUS;FOREIGN BODIES;FOREIGN BODY;GENISTEIN;HEMOGLOBIN;INGESTION;INTERVENTIONAL RADIOLOGY;ION;LAPAROTOMY;LUNG;MAGNESIUM;MALIGNANCY;MULTIVARIATE ANALYSIS;MYOCARDIAL INFARCTION;NEUROLOGY;NITRIC OXIDE;NODULE (GEOLOGY);PATHOGENESIS;PATHOLOGICAL;PERIPHERAL;PERISTALSIS;PNEUMOTHORAX;PROPORTIONAL HAZARDS MODEL;PUNCHING;RECEPTOR;RELATION (DATABASE);STAGE (STRATIGRAPHY);STENOSIS;SURVIVAL ANALYSIS;ULTRASOUND;VASODILATION","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACHALASIA;ACUTE CORONARY SYNDROME;BRACHIAL ARTERY;COLORECTAL CANCER;ENDOTHELIN 1;ENDOTHELIN RECEPTOR;FINE-NEEDLE ASPIRATION;GASTRECTOMY;GASTRODUODENAL ARTERY;HAZARD RATIO;METASTASIS;NEURORADIOLOGY;PERCUTANEOUS CORONARY INTERVENTION;PERFORATION;PLACEBO;POSTPARTUM PERIOD;RADIOFREQUENCY ABLATION;SOLITARY PULMONARY NODULE;THROMBOLYSIS;UNIVARIATE ANALYSIS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ABCIXIMAB;ESOPHAGEAL MOTILITY DISORDER;TIMI","1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;EMBOLIZATION, THERAPEUTIC;STOMACH NEOPLASMS;ANEURYSM, FALSE;CARCINOMA, NON-SMALL-CELL LUNG;FOREIGN BODIES;LIVER NEOPLASMS;AGED;CARCINOMA, HEPATOCELLULAR;CARCINOMA, SMALL CELL;CELIAC DISEASE;COLON;CORONARY DISEASE;DEGLUTITION DISORDERS;ENDOTHELIUM, VASCULAR;ESOPHAGEAL MOTILITY DISORDERS","10;8;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;DIAGNOSIS AND TREATMENT OF LUNG CANCER;HEALTH EFFECTS OF SOY ISOFLAVONES AND PHYTOESTROGENS;HEPATOCELLULAR CARCINOMA;MANAGEMENT OF INGESTED FOREIGN BODIES AND FOOD IMPACTIONS;MANAGEMENT OF MESENTERIC ISCHEMIA AND ANEURYSMS;MECHANOSENSITIVE ION CHANNELS IN PHYSIOLOGY AND DISEASE;METASTATIC CARCINOMAS FROM LUNG AND BREAST","2;1;1;1;1;1;1;1;1;1","CELIAC DISEASE;ABCIXIMAB;ACCIDENTAL;BRACHIAL ARTERY;CARDIAC IMAGING;CONCOMITANT;ECHOCARDIOGRAPHY;ENDOLUMINAL VACUUM THERAPY;ENDOSCOPIC STENTING;ENDOTHELIAL DYSFUNCTION;ESOPHAGEAL FOREIGN BODIES;ESOPHAGEAL MOTILITY DISORDER;ESOPHAGEAL MOTILITY DISORDERS;ESOPHAGEAL PERFORATION;ESTROGEN;FOREIGN BODIES;GASTRIC CANCER;GASTRODUODENAL ARTERY;INGESTION;INTERVENTIONAL RADIOLOGY","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CELIAC DISEASE;ACCIDENTAL INGESTION;ACUTE CORONARY;ADVANCED GASTRIC;ANEURYSM SECONDARY;ANION TRANSPORT;ARTERY ANEURYSM;ASPIRATION BIOPSY;BODIES CLINICAL;CLINICAL CONSIDERATIONS;CONCENTRATIONS ENDOTHELIN-;CORONARY MICROEMBOLIZATION;CORONARY SYNDROME;DEPENDENT VASODILATION;ENDOTHELIN- LEVELS;ENDOTHELIUM DEPENDENT;ERYTHROCYTES SICKLE;ESOPHAGEAL MOTILITY;ESOPHAGEAL TRANSIT;FOREIGN BODIES;GASTRIC CARCINOMA;GASTRODUODENAL ARTERY;INDICATIVE HYPOTHESIS;INTRATUMORAL NEUTROPHILS;LIVER TUMORS;MOTILITY DISORDERS;NITRIC OXIDE;NONTOXIC GOITER;NORMAL ERYTHROCYTES;NORTHERN ITALY","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GASTRIC CARCINOMA;HIGH-POWER FIELDS;ADVANCED GASTRIC;AFFECT MATERNOFETAL;ANDOR PUERPERIUM;CD DIAGNOSED;CELIAC DISEASE;DISEASE CD;EXTENSIVE AMOUNT;GASTROINTESTINAL SYMPTOMS;LATE PREGNANCY;LATENT CD;MATERNOFETAL HEALTH;MILD GASTROINTESTINAL;PREGNANCY ANDOR;PROGNOSTIC FACTORS;ACT NONSPECIFICALLY;ADJUVANT THERAPY;AGE LOCATION;ANALYSES BASED;ANALYSIS SEX;AUTHORS SELECTED;CANCER GROWTH;CARCINOMA GENDER;CLINICAL-PATHOLOGICAL FACTORS;CLINICOPATHOLOGICAL FEATURES;COX PROPORTIONAL;CREMONA HOSPITAL;CRUDE SURVIVAL;DEFENSE MECHANISMS","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2003,15,8.66666666666667,3.53333333333333,0.8,0.333333333333333,0.8,1.26190476190476,1,1.25,1.09090909090909,0.133333333333333,1,4,5,0,5,0.27,0.33,0,0.33,35.87,0.677651399460009,NA,0,0.8,0.357,0.333,0.333,0.33,"FRANCESCO SQUADRITO;HERBERT MARINI;DOMENICA ALTAVILLA;M ROSSITTO;PAOLO SEMINARA;R. MAISANO;FILIPPO LA TORRE;BARBARA DEODATO;A CICCOLO;MAURO GIACCA;MARIA PASSANITI;M T FONTI;N. CARISTI;FRANCESCO S. VENUTI;MARIAROSARIA GALEANO;TOMMASO CENTORRINO;MARGHERITA CALÒ;GIUSEPPE M. CAMPO;D FAMILIANI;SANTO GANGEMI","5;4;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1","FRANCESCO SQUADRITO;M ROSSITTO;A CICCOLO;M T FONTI;TOMMASO CENTORRINO;HERBERT MARINI;DOMENICA ALTAVILLA;R. MAISANO;FILIPPO LA TORRE;N. CARISTI;MARIA PAOLA GERMANÒ;SALVATORE CATANIA;VIRGINIA SILVARI;CHIARA COSTA;MARTINO L BARBARO;BARBARA DEODATO;MAURO GIACCA;MARIAROSARIA GALEANO;F MIRENDA;T MANDOLFINO","1.33;0.33;0.33;0.33;0.33;0.33;0.33;0.27;0.27;0.27;0.2;0.2;0.2;0.2;0.2;0.18;0.18;0.18;0.17;0.17","FRANCESCO SQUADRITO;HERBERT MARINI;DOMENICA ALTAVILLA;PAOLO SEMINARA;R. MAISANO;FILIPPO LA TORRE;BARBARA DEODATO;A CICCOLO;MAURO GIACCA;MARIA PASSANITI;N. CARISTI;FRANCESCO S. VENUTI;MARIAROSARIA GALEANO;MARGHERITA CALÒ;R CARBONI;DONATELLA SANGARI;FRANCESCO STAGNO D’ALCONTRES;LETTERIA MINUTOLI;MICHELE ROSARIO COLONNA;S. GULLI","5;4;4;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","FRANCESCO SQUADRITO;A CICCOLO;HERBERT MARINI;DOMENICA ALTAVILLA;R. MAISANO;FILIPPO LA TORRE;N. CARISTI;CHIARA COSTA;MARTINO L BARBARO;BARBARA DEODATO;MAURO GIACCA;MARIAROSARIA GALEANO;LA SPADA M;MARIA PASSANITI;DONATELLA SANGARI;S. GULLI;LOREDANA BOCCHINO;IRENE CASTAGNA;LUCIA MORGANTE;GIAN FILIPPO BAGNATO","1.33;0.33;0.33;0.33;0.27;0.27;0.27;0.2;0.2;0.18;0.18;0.18;0.17;0.14;0.14;0.14;0.14;0.14;0.14;0.14","FRANCESCO SQUADRITO;DOMENICA ALTAVILLA;HERBERT MARINI;BARBARA DEODATO;MARIAROSARIA GALEANO;MAURO GIACCA;DOMENICO CUCINOTTA;NIKOLA ARSIC;V. TORRE;GIUSEPPE M. CAMPO;MARIA PASSANITI;FRANCESCO S. VENUTI;MARGHERITA CALÒ;PAOLO SEMINARA;AGATINO MANGANARO;ANTONIO EPIFANIO;ANTONIO GRANATA;FORTUNATA TRIPODI;GIUSEPPE GALLITTO;N LEGGIADRO","342;313;313;211;211;211;151;151;151;102;102;96;96;96;67;67;67;67;67;67","DOMENICA ALTAVILLA;FRANCESCO SQUADRITO;HERBERT MARINI;BARBARA DEODATO;AGATINO MANGANARO;ANTONIO GRANATA;SCIPIONE CARERJ;LETTERIA MINUTOLI;MARIA ESPOSITO;MARIA PASSANITI;FRANCESCO S. VENUTI;FRANCESCO STAGNO D’ALCONTRES;GIOVANNI SQUADRITO;MARGHERITA CALÒ;MARIAROSARIA GALEANO;MAURO GIACCA;MICHELE ROSARIO COLONNA;PAOLO SEMINARA;PATRIZIA LO CASCIO;VALERIO TORRE","313;306;277;211;67;67;67;66;66;66;60;60;60;60;60;60;60;60;60;60","DOMENICA ALTAVILLA;FRANCESCO SQUADRITO;HERBERT MARINI;A CICCOLO;BARBARA DEODATO;R. MAISANO;AGATINO MANGANARO;ANTONIO GRANATA;ANTÓNIO TOSCANO;C. ARRIGO;CARMELO RODOLICO;CHIARA COSTA;DONATELLA SANGARI;FILIPPO LA TORRE;FRANCESCO S. VENUTI;FRANCESCO STAGNO D’ALCONTRES;GIAN FILIPPO BAGNATO;GIOVANNI SQUADRITO;GIUSEPPE ALTAVILLA;IRENE CASTAGNA","4;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ENGINEERING","15;4;3;1","INTERNAL MEDICINE;BIOCHEMISTRY;SURGERY;PATHOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;ONCOLOGY;PHARMACOLOGY;ANESTHESIA;CANCER RESEARCH;GENERAL SURGERY;MOLECULAR BIOLOGY;CARDIOLOGY;CELL BIOLOGY;DERMATOLOGY;ENVIRONMENTAL HEALTH;GENETICS;MECHANICAL ENGINEERING;ORGANIC CHEMISTRY;PEDIATRICS;PSYCHIATRY","11;6;5;4;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1","GENE;TOXICITY;ANGIOGENESIS;ATRIAL FIBRILLATION;CHEMOTHERAPY;DISEASE;IMMUNOHISTOCHEMISTRY;OXIDATIVE STRESS;RECEPTOR;VEGF RECEPTORS;WOUND HEALING;ABDOMINAL SURGERY;ANEURYSM;ANTIBODY;ANTIOXIDANT;APOPTOSIS;ARTERY;ASPIRIN;BLOOD LOSS;BLOOD TRANSFUSION;BRAIN DAMAGE;CANCER;CAROTID ARTERIES;COMPLICATION;ENZYME;EPIDEMIOLOGY;EPILEPSY;ETIOLOGY;EXTRACELLULAR MATRIX;HERNIA;HYPERPLASIA;HYSTERECTOMY;INTRAPERITONEAL INJECTION;ISCHEMIA;LIGATION;MEDIAN STERNOTOMY;MIGRAINE;MUSCULAR DYSTROPHY;MYASTHENIA GRAVIS;MYOCARDIAL INFARCTION;MYOPATHY;NECROSIS;NITRIC OXIDE;PANCREATITIS;POPULATION;PROSPECTIVE COHORT STUDY;PROSTHESIS;RHEUMATOLOGY;SMOOTH MUSCLE;SPORTS MEDICINE;STENT;STROKE (ENGINE);STROMAL CELL;TUMOR NECROSIS FACTOR ALPHA;YOUNG ADULT","5;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","LIPID PEROXIDATION;RECOMBINANT DNA;GENETIC ENHANCEMENT;VASCULAR ENDOTHELIAL GROWTH FACTOR;ABDOMINAL AORTIC ANEURYSM;AMIODARONE;BEHCET'S DISEASE;BLOT;BREAST CANCER;CISPLATIN;COMMON CAROTID ARTERY;DOCETAXEL;DYSFERLIN;GENOTYPE;GIST;GLUTAMATE RECEPTOR;GLUTATHIONE;GROWTH FACTOR;INTERNAL HERNIA;INTERSTITIAL CELL OF CAJAL;INTIMAL HYPERPLASIA;ISCHAEMIC STROKE;ISCHEMIC STROKE;MESSENGER RNA;MONOCLONAL ANTIBODY;MUTATION;NEUROTOXICITY;NF-ΚB;NITRIC OXIDE SYNTHASE;PHENOTYPE;RESTENOSIS;SKIN REPAIR;STROMAL TUMOR;THYMECTOMY;TRANSCRIPTION FACTOR;TUMOR NECROSIS FACTOR Α;VALPROIC ACID;WESTERN BLOT","3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","VECTOR (MOLECULAR BIOLOGY);ANTHRACYCLINE;ANTIBODY THERAPY;ENOS;HAPLOTYPE;KAINIC ACID;LIMB-GIRDLE MUSCULAR DYSTROPHY;METASTATIC BREAST CANCER;MISSENSE MUTATION;MODIFIED RANKIN SCALE;MONOCLONAL ANTIBODY THERAPY;NEOINTIMAL HYPERPLASIA;NFKB1;VASCULAR ENDOTHELIAL GROWTH FACTOR A;VINORELBINE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;AGED;ANIMALS;GASTROINTESTINAL NEOPLASMS;MIDDLE AGED;ADULT;ANTINEOPLASTIC AGENTS, PHYTOGENIC;BURNS;LIPID PEROXIDATION;NF-KAPPA B;SKIN;WOUND HEALING;AMINO ACID OXIDOREDUCTASES;BRAIN ISCHEMIA;GLUTATHIONE;HEPATOCYTES;HERNIA;L-LACTATE DEHYDROGENASE","10;9;8;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4","CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;WOUND HEALING AND REGENERATION;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;ETIOLOGY AND MANAGEMENT OF PERITONEAL ADHESIONS;GENOTOXICITY AND CARCINOGENESIS MECHANISMS;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;NF-?B SIGNALING IN INFLAMMATION AND CANCER;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT","2;2;1;1;1;1;1;1;1;1;1;1;1","ADENO-ASSOCIATED VIRUS;NEUROTOXICITY;ANEURYSM RUPTURE;ANEURYSM SCREENING;ANTI-TNF THERAPY;ANTIBODY THERAPY;BRAIN DAMAGE;DYSFERLIN;DYSTROPHIN;ETIOLOGY;FOUNDER EFFECT;GENE THERAPY;GIST CONSENSUS CONFERENCE;HEPATOTOXICITY;HERNIA REPAIR;INFARCTION TREATMENT;INTERNAL HERNIA;INTIMAL HYPERPLASIA;INTRAPERITONEAL INJECTION;ISCHAEMIC STROKE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ENDOTHELIAL GROWTH;FACTOR GENE;GENE TRANSFER;GROWTH FACTOR;VASCULAR ENDOTHELIAL;WOUND HEALING;ABDOMINAL AORTIC;ACID-INDUCED TOXICITY;ADENO-ASSOCIATED VIRAL;ADENO-ASSOCIATED VIRUS;ANTI-TUMOR NECROSIS;ANTIBODY THERAPY;AORTIC ANEURYSM;ATTENUATES CERULEIN-INDUCED;BEHCETS DISEASE;BLOOD FLOW;BREAST CANCER;BURN INJURY;CAROTID ARTERY;CERULEIN-INDUCED PANCREATITIS;CRUCIAL ROLE;CYTOTOXICITY EVALUATION;DAMAGE PREVENTION;DIABETIC MOUSE;DYSF MUTATIONS;FACTOR MONOCLONAL;FOLLOW-UP STUDY;FOUNDER EFFECT;GASTROINTESTINAL STROMAL;GENETICALLY DIABETIC","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","WOUND HEALING;CONVENTIONAL IMMUNOSUPPRESSIVE;BD REFRACTORY;BREAKING STRENGTH;DIABETIC MICE;GENE TRANSFER;IMMUNOSUPPRESSIVE DRUGS;INFLIXIMAB TREATMENT;MATURE PROTEIN;MUCOCUTANEOUS OCULAR;WOUND CONTENT;AAV ENCODING;AAV VECTOR;AAV VECTORS;ACID ISOFORM;ACTIVE BD;ACTIVITY ASSAY;ADENO-ASSOCIATED VIRUS;AMINO ACID;ANGIOGENESIS REEPITHELIZATION;ANGIOGENIC FACTOR;ARTHRITIC SYMPTOMS;ARTICULAR VASCULAR;BD MANIFESTATIONS;BD THERAPEUTIC;BEHCETS DISEASE;BENEFICIAL EFFECT;BETA-GALACTOSIDASE ACTIVITY;CBLKSJ DBDB;CENTRAL NERVOUS","4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2004,12,7.91666666666667,2.16666666666667,0.583333333333333,0.166666666666667,0.583333333333333,1.1304347826087,1,0.666666666666667,1,0.166666666666667,0,2,2,2,4,0.17,0.17,0.17,0.33,18.92,0.402023679778063,NA,0.166666666666667,0.75,0.346,0.241,0,0.241,"SALVATORE BENVENGA;BERNADETTE PAVONE;ADRIANA ARENA;STEFANO ALCARO;R PAVIA;FRANCESCO ORTUSO;VIDYA D. MULE;ROSARIA OTTANÀ;FRANCESCO MONACO;SIMONETTA NERI;MARIA GABRIELLA VIGORITA;FRANCESCO TRIMARCHI;B MONDELLO;M MONACO;GIUSEPPA FERRARO;FRANCESCO STILO;MADDALENA GROSSO;G AGOSTANI;R BRECCIAROLI;P CONGIA","3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","SALVATORE BENVENGA;FRANCESCO TRIMARCHI;BERNADETTE PAVONE;ADRIANA ARENA;STEFANO ALCARO;FRANCESCO ORTUSO;ROSARIA OTTANÀ;SIMONETTA NERI;MARIA GABRIELLA VIGORITA;MARCUS SCHAUB;DONAT R. SPAHN;MICHAEL ZAUGG;MARTIN J. LONDON;FABRIZIO GUARNERI;LIBERO SANTARPIA;MARIO VACCARO;R PAVIA;VIDYA D. MULE;FRANCESCO MONACO;B MONDELLO","0.84;0.7;0.27;0.27;0.27;0.27;0.27;0.27;0.27;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.19;0.19;0.19;0.19","SALVATORE BENVENGA;BERNADETTE PAVONE;ADRIANA ARENA;M MONACO;GIUSEPPA FERRARO;ANTONIO TRAMONTANA;GIUSEPPE VITA;MARCUS SCHAUB;ANTONINO SCIMONE;VINCENZO ADAMO;ELISABETTA ALAFACI;STEFANO PERGOLIZZI;GIANLUCA SPITALERI;MARIA TROVATO;DONAT R. SPAHN;ANNA MAZZEO;C GIORGIANNI;NICOLA SETTINERI;ANTÓNIO TOSCANO;CONCETTA SERGI","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SALVATORE BENVENGA;BERNADETTE PAVONE;ADRIANA ARENA;MARCUS SCHAUB;DONAT R. SPAHN;M MONACO;MARIA TROVATO;ANGELA DE SARRO;GIUSEPPA FERRARO;ANTONINO SCIMONE;VINCENZO ADAMO;ELISABETTA ALAFACI;STEFANO PERGOLIZZI;GIANLUCA SPITALERI;C GIORGIANNI;NICOLA SETTINERI;CONCETTA SERGI;FRANCA SPANO;AGATA LAUDANI;ANTONIO TRAMONTANA","0.84;0.27;0.27;0.25;0.25;0.19;0.14;0.11;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.1;0.09","SALVATORE BENVENGA;FRANCESCO TRIMARCHI;FABRIZIO GUARNERI;LIBERO SANTARPIA;MARIO VACCARO;AGATA LAUDANI;ANTONINO SCIMONE;CONCETTA SERGI;ELISABETTA ALAFACI;FRANCA SPANO;GIANLUCA SPITALERI;GIUSEPPA FERRARO;NICOLA SETTINERI;STEFANO PERGOLIZZI;VINCENZO ADAMO;ADRIANA ARENA;BERNADETTE PAVONE;FRANCESCO ORTUSO;MARIA GABRIELLA VIGORITA;ROSARIA OTTANÀ","84;66;49;49;49;42;42;42;42;42;42;42;42;42;42;38;38;38;38;38","SALVATORE BENVENGA;AGATA LAUDANI;ANTONINO SCIMONE;CONCETTA SERGI;ELISABETTA ALAFACI;FRANCA SPANO;GIANLUCA SPITALERI;GIUSEPPA FERRARO;NICOLA SETTINERI;STEFANO PERGOLIZZI;VINCENZO ADAMO;ADRIANA ARENA;BERNADETTE PAVONE;ANGELA DE SARRO;C GIORGIANNI;MARIA TROVATO;DONAT R. SPAHN;MARCUS SCHAUB;ANTONIO TRAMONTANA;ANNA MAZZEO","66;42;42;42;42;42;42;42;42;42;42;38;38;35;21;18;6;6;1;0","ADRIANA ARENA;BERNADETTE PAVONE;SALVATORE BENVENGA;AGATA LAUDANI;ANGELA DE SARRO;ANTONINO SCIMONE;ANTONIO TRAMONTANA;C GIORGIANNI;CONCETTA SERGI;DONAT R. SPAHN;ELISABETTA ALAFACI;FRANCA SPANO;GIANLUCA SPITALERI;GIUSEPPA FERRARO;MARCUS SCHAUB;MARIA TROVATO;NICOLA SETTINERI;STEFANO PERGOLIZZI;VINCENZO ADAMO;ANNA MAZZEO","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;0","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY","10;7;4;1","INTERNAL MEDICINE;BIOCHEMISTRY;PATHOLOGY;SURGERY;VIROLOGY;COMBINATORIAL CHEMISTRY;ENDOCRINOLOGY;GENETICS;IMMUNOLOGY;INTENSIVE CARE MEDICINE;STEREOCHEMISTRY;ANATOMY;ANESTHESIA;AUDIOLOGY;CANCER RESEARCH;GASTROENTEROLOGY;MICROBIOLOGY;NEUROSCIENCE;ONCOLOGY;ORGANIC CHEMISTRY;PALEONTOLOGY;PHARMACOLOGY;PSYCHIATRY;RADIOLOGY","6;3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","RECEPTOR;ANTIBODY;THYROID;VIRUS;ADENOMA;AMINO ACID;AMYLOIDOSIS;ANTIGEN;CARDIOTHORACIC SURGERY;CENTRAL NERVOUS SYSTEM;CHEMOTHERAPY;CHYLOTHORAX;COGNITION;CYTOPLASM;DNA;EMBOLIZATION;EPILEPSY;GENE;GLYCOSIDE;HEART FAILURE;HIPPOCAMPUS;HORMONE;IMMUNOHISTOCHEMISTRY;INTERCALATION (CHEMISTRY);LYMPHATIC SYSTEM;MEDIASTINUM;PERIOPERATIVE;PLEURAL EFFUSION;POLYNEUROPATHY;RADIATION THERAPY;REGIMEN;RHEUMATOID ARTHRITIS;SIGNAL TRANSDUCTION;STAINING;TEST (BIOLOGY);THORACOTOMY;TOXICITY;TRANSTHYRETIN","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","THYROIDITIS;ALLELE;AUTOANTIBODY;BLOCKADE;BORRELIA BURGDORFERI;BRONCHIAL ARTERY;CARDIOMYOPATHY;CISPLATIN;CODING REGION;EPITOPE;EXON;GENOTYPE;GLUTAMATE RECEPTOR;GLUTAMINE;HEAD AND NECK CANCER;HEPATOCYTE GROWTH FACTOR;HERPES SIMPLEX VIRUS;HSL AND HSV;INTELLIGENCE QUOTIENT;MOLECULAR MIMICRY;MUTATION;NEUROPSYCHOLOGY;NEUROTRANSMITTER;NEUTROPENIA;PHASES OF CLINICAL RESEARCH;PHENOTYPE;PROGRESSIVE DISEASE;RAVEN'S PROGRESSIVE MATRICES;STAT3;TAURINE;WECHSLER ADULT INTELLIGENCE SCALE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLELIC HETEROGENEITY;ANTI-THYROID AUTOANTIBODIES;C-MET;FEBRILE NEUTROPENIA;GENETIC HETEROGENEITY;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;NEUROPSYCHOLOGICAL TEST;WECHSLER INTELLIGENCE SCALE FOR CHILDREN;WECHSLER MEMORY SCALE","1;1;1;1;1;1;1;1;1","HUMANS;ANTINEOPLASTIC AGENTS;;ADENOMA;ADULT;CARCINOMA;CHYLOTHORAX;COLORECTAL NEOPLASMS;MALE;MIDDLE AGED;AGED;AGED, 80 AND OVER;ANTINEOPLASTIC AGENTS, PHYTOGENIC;ANTIVIRAL AGENTS;BRONCHIAL ARTERIES;CISPLATIN;EPILEPSY, REFLEX;FEMALE;HEMOTHORAX;INTERCALATING AGENTS","7;6;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","CHEMICAL GLYCOBIOLOGY AND THERAPEUTIC APPLICATIONS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;DIAGNOSIS AND MANAGEMENT OF CHYLOTHORAX AND CHYLOUS ASCITES;HETEROCYCLIC COMPOUNDS FOR DRUG DISCOVERY;IMMUNOTOXIN THERAPY FOR CANCER TREATMENT;MECHANISMS AND TREATMENT OF LIVER FIBROSIS;MOLECULAR MECHANISMS OF AMYLOIDOSIS;MOLECULAR MECHANISMS OF SYNAPTIC PLASTICITY AND NEUROLOGICAL DISORDERS;NEUROTOXIC EFFECTS OF ANESTHETIC AGENTS ON BRAIN DEVELOPMENT;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT;THYROID DISEASE AND HORMONE REGULATION","1;1;1;1;1;1;1;1;1;1;1;1","ALLELIC HETEROGENEITY;ALUMINUM RESISTANCE;ALUMINUM TOXICITY;ANTI-THYROID AUTOANTIBODIES;AUTOIMMUNE THYROID DISEASE;BRONCHIAL ARTERY;CANCER CELL METABOLISM;CARBOHYDRATE-BASED DRUG DESIGN;CARDIOTHORACIC SURGERY;CHYLOTHORAX;CODING REGION;FAMILIAL AMYLOID POLYNEUROPATHY;HEPATOCYTE GROWTH FACTOR;HETEROCYCLIC COMPOUNDS;HSL AND HSV;HYPERTHYROIDISM;HYPOTHYROIDISM;METALLIC EXPOSURE;METASTATIC BREAST CANCER;MOLECULAR MIMICRY","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SURGICAL APPROACH;ACID LEVELS;AMINO ACID;ANALYSIS ANTI-HSV-;ARTERIES ANATOMICAL;AUDIOGENIC SEIZURE;BRONCHIAL ARTERIES;CELL CARCINOMA;CHYLOTHORAX SURGICAL;CLINICAL SIGNIFICANCE;CLINICAL STUDIES;COGNITIVE DISORDERS;COLORECTAL TUMORS;CONFORMATIONAL ANALYSIS;CYTOSTATIC AGENTS;DNA-INTERCALATING -FLUOREN-Β-O-GLYCOSIDES;EVALUATION NOTE;FACTOR STAT;FLUORENON--CARBOXAMIDES SYNTHESIS;GENE MUTATIONS;HGF C-MET;HORMONE AUTOANTIBODIES;IBORRELIA BURGDORFERII;IL--DEFICIENT MICE;IMMUNOHISTOCHEMICAL EXPRESSION;IMMUNOMODULATORY EVALUATION;INCREASING FREQUENCY;METASTATIC HEAD;NECK SQUAMOUS;NEUROTRANSMITTER AMINO","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","VETERANS AFFAIRS;BETA BLOCKADE;RANDOMIZED CONTROLLED;BETA BLOCKERS;CONTROLLED TRIALS;AFFAIRS COOPERATIVE;BETA BLOCKER;COOPERATIVE STUDIES;MYOCARDIAL INFARCTION;OBSERVATIONAL DATA;PERIOPERATIVE BETA;PERIOPERATIVE CARE;PERIOPERATIVE TREATMENT;POISE STUDY;REDUCE PERIOPERATIVE;RISK FACTORS;SAN FRANCISCO;TREATMENT RECOMMENDATIONS;ACCEPTED GUIDANCE;ACCOMPANYING EDITORIAL;ACCURATE ASSESSMENT;ACTIVE ROLE;ACUTELY BETA;ADEQUATELY DEFINING;ADEQUATELY POWERED;ADVERSE OUTCOMEA;AFFAIRS EFFORT;AFFAIRS SOPHISTICATED;AFFAIRS WASHINGTON;AFFAIRSTHIS TOPIC","7;6;5;4;4;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,6,3552.5,9.09,0,0,202,0,0,1,0,1,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1;1","CLINICAL RESEARCH;PEDIATRIC;CANCER;CHILDHOOD LEUKEMIA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;PEDIATRIC CANCER;RARE DISEASES;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN;TRANSPLANTATION","2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA","1;1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2005,23,7.43478260869565,2.52173913043478,0.739130434782609,0.304347826086957,0.739130434782609,1,0.944444444444444,0.875,0.944444444444444,0.173913043478261,0,7,6,3,7,0.3,0.26,0.13,0.3,31.78,0.600309224810971,NA,0.0434782608695652,0.739130434782609,0.309,0.141,0.107,0.141,"R PAVIA;MARIO BARONE;SALVATORE BENVENGA;B MONDELLO;GIOSAFAT SPITALERI;F. FAVARI;BERNADETTE PAVONE;ERSILIA FISCARELLI;F LEMMA;MARINA BUSETTI;C. MAISANO;A. PRELLE;M ROSSITTO;JAKOB PASSWEG;DOMENICO CUCINOTTA;D MAGLITTO;BÁRBARA ADAMO;ROSSELLA MUSOLINO;R BRECCIAROLI;CARLO SAITTA","4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","R PAVIA;SALVATORE BENVENGA;B MONDELLO;MARIO BARONE;CLAUDIO GUARNERI;FABRIZIO GUARNERI;GIUSEPPE CANNELLA;PAOLO CASSOTTANA;ERNESTO PAOLETTI;R BRECCIAROLI;D D'ARRIGO;CARLO ABBATE;P BARRESI;C GIORGIANNI;F LEMMA;D MAGLITTO;MASSIMO MARULLO;R. DE PASQUALE;MARIO BARBARO;DARIO FAMILIARI","0.78;0.53;0.45;0.42;0.33;0.33;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2","R PAVIA;SALVATORE BENVENGA;BERNADETTE PAVONE;M ROSSITTO;JAKOB PASSWEG;DOMENICO CUCINOTTA;CARLO SAITTA;MICHELE BONAIUTO;MASSIMO MARULLO;SÉBASTIEN MAURY;GÈRARD SOCIÉ;M.A. SARDO;VINCENZO PITINI;ADRIANA ARENA;CLAUDIO GUARNERI;SIMONE CESARO;P. SPADARO;R. MAISANO;M. AGUENNOUZ;FRANCO LOCATELLI","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","R PAVIA;SALVATORE BENVENGA;CLAUDIO GUARNERI;FABRIZIO GUARNERI;GIUSEPPE CANNELLA;PAOLO CASSOTTANA;ERNESTO PAOLETTI;CARLO ABBATE;P BARRESI;MASSIMO MARULLO;MARIO BARBARO;DARIO FAMILIARI;CHIARA COSTA;E. MORINI;STEFANIA CATANIA;M ROSSITTO;VINCENZO PITINI;P. SPADARO;FRANCESCA GRANATA;C MASTROJENI","0.78;0.53;0.33;0.33;0.33;0.33;0.33;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17","ANDREA BACIGALUPO;ANNA LOCASCIULLI;ARCANGELO PRETE;EDOARDO LANINO;FRANCO LOCATELLI;GÈRARD SOCIÉ;JAKOB PASSWEG;JUDITH MARSH;SIMONE CESARO;SÉBASTIEN MAURY;CLAUDIO GUARNERI;FABRIZIO GUARNERI;SALVATORE BENVENGA;A. DI BENEDETTO;DOMENICO CUCINOTTA;E. DI CESARE;EUGENIO ALESSI;F CORRADO;GIACOMO NICOCIA;GIUSEPPINA RUSSO","180;180;180;180;180;180;180;180;180;180;177;177;177;89;89;89;89;89;89;89","ANDREA BACIGALUPO;ANNA LOCASCIULLI;ARCANGELO PRETE;EDOARDO LANINO;FRANCO LOCATELLI;GÈRARD SOCIÉ;JAKOB PASSWEG;JUDITH MARSH;SIMONE CESARO;SÉBASTIEN MAURY;CLAUDIO GUARNERI;FABRIZIO GUARNERI;SALVATORE BENVENGA;A. DI BENEDETTO;DOMENICO CUCINOTTA;E. DI CESARE;EUGENIO ALESSI;GIUSEPPINA RUSSO;ANTONIO TOSCANO;CARMELO RODOLICO","180;180;180;180;180;180;180;180;180;180;177;177;177;89;89;89;89;89;76;76","A. DI BENEDETTO;ADRIANA ARENA;ALESSANDRA BITTO;ANDREA BACIGALUPO;ANNA LOCASCIULLI;ANNA MEO;ANTONINO SAITTA;ANTONIO BONAIUTO;ANTONIO TOSCANO;ARCANGELO PRETE;BERNADETTE PAVONE;C MASTROJENI;CARLO SAITTA;CARMELO RODOLICO;CHIARA COSTA;CLAUDIO GUARNERI;DOMENICO CUCINOTTA;E. DI CESARE;EDOARDO LANINO;EUGENIO ALESSI","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;PHYSICS;PSYCHOLOGY","20;7;2;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;GASTROENTEROLOGY;ONCOLOGY;PHYSICAL THERAPY;PROGRAMMING LANGUAGE;ANESTHESIA;CARDIOLOGY;DERMATOLOGY;ENVIRONMENTAL HEALTH;GENERAL SURGERY;GYNECOLOGY;HUMANITIES;IMMUNOLOGY;INTENSIVE CARE MEDICINE;LIBRARY SCIENCE;MECHANICAL ENGINEERING;MEDICAL EMERGENCY;METALLURGY;MICROBIOLOGY;NEUROSCIENCE;NURSING;OBSTETRICS;OPTICS;PEDAGOGY;PHARMACOLOGY;PSYCHIATRY;STEREOCHEMISTRY;UROLOGY;VIROLOGY","12;9;5;5;4;4;4;4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;CHEMOTHERAPY;CANCER;ENZYME;REGIMEN;ANTIOXIDANT;METHOTREXATE;OXIDATIVE STRESS;RADIATION THERAPY;REHABILITATION;ALTERNATIVE MEDICINE;ANTIBODY;ANTIGEN;ASBESTOS;ATORVASTATIN;BACTERIA;BETA (PROGRAMMING LANGUAGE);BLOOD PRESSURE;BONE MARROW;CARCINOMA;CHOLESTEROL;CITATION;COMPLICATION;COPD;CURRICULUM;DIABETES MELLITUS;DISEASE;GLYCOSYLATION;HELICOBACTER PYLORI;HORMONE;ICON;IN VITRO;INCIDENCE (GEOMETRY);LAPAROSCOPY;LUNG;LUNG CANCER;LYMPHOMA;MECHANICAL VENTILATION;MESOTHELIOMA;MULTIMODAL THERAPY;MUSCLE DISORDER;MUSCLE HYPERTROPHY;MUSCULAR DYSTROPHY;MYOCARDIAL INFARCTION;MYOPATHY;NEUROENDOCRINE TUMORS;OBESITY;OCCUPATIONAL SAFETY AND HEALTH;PANCREATITIS;PATHOLOGICAL;POISON CONTROL;POPULATION;PREDNISONE;PREGNANCY;PROLENE;PULMONARY DISEASE;PULMONARY EMBOLISM;QUALITY OF LIFE (HEALTHCARE);SHOCK (CIRCULATORY);SKELETAL MUSCLE;SOMATOSTATIN;SPINAL CORD;SPLEEN;STAINING;STOMACH;TESTOSTERONE (PATCH);THALASSEMIA;THROMBOSIS;TOXICITY;TRANSPLANTATION;TYPING;VAPOURS;WORK (PHYSICS)","6;5;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENOTYPE;MUTATION;PERFORMANCE STATUS;ANDROGEN;ANNEXIN;ANTI-THYMOCYTE GLOBULIN;APLASTIC ANEMIA;ARCHAEA;AUTOANTIBODY;AUTOIMMUNE DISEASE;AUTOIMMUNE PANCREATITIS;AUTOIMMUNITY;BETA THALASSEMIA;BIOLOGICAL ACTIVITY;BLADDER CANCER;BREAST CANCER;BURKHOLDERIA;CARBONIC ANHYDRASE;CHEMICAL SYNTHESIS;CISPLATIN;CLONE (JAVA METHOD);CYCLOPHOSPHAMIDE;CYTOTOXICITY;DEEP VEIN;DIASTOLE;DOCETAXEL;DYSFERLIN;DYSLIPIDEMIA;DYSTROPHIN;GASTRECTOMY;GASTRITIS;GEMCITABINE;GESTATION;GLUTATHIONE;HEMOGLOBIN A2;HUMAN FACTORS AND ERGONOMICS;HUMAN LEUKOCYTE ANTIGEN;INFARCTION;INJURY PREVENTION;LEFT VENTRICULAR HYPERTROPHY;LIPID PEROXIDATION;LIPOPROTEIN;LUNG VOLUMES;MERKEL CELL CARCINOMA;MOLECULAR MIMICRY;NEUTROPENIA;OCTREOTIDE;PARAOXONASE;PARAPLEGIA;PHASES OF CLINICAL RESEARCH;PHENOTYPE;PLACEBO;PNEUMOPERITONEUM;PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;PULMONARY REHABILITATION;RITUXIMAB;SARCOLEMMA;SEROMA;SPLENIC INFARCTION;SUBJECT MATTER;TEMOZOLOMIDE;TRANSCRIPTION FACTOR;VENOUS THROMBOSIS;VERO CELL;VINBLASTINE;VIRULENCE;VITAMIN E","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALPHA-THALASSEMIA;ANTIANDROGEN;AUTOIMMUNE GASTRITIS;BURKHOLDERIA CENOCEPACIA;BURKHOLDERIA CEPACIA COMPLEX;CAGA;CARBONIC ANHYDRASE I;CARBONIC ANHYDRASE II;COMPOUND HETEROZYGOSITY;CYPROTERONE ACETATE;FLUDARABINE;GESTATIONAL DIABETES;LIMB-GIRDLE MUSCULAR DYSTROPHY;LUNG VOLUME REDUCTION SURGERY;MERKEL CELL;METASTATIC BREAST CANCER;MOLECULAR EPIDEMIOLOGY;MULTILOCUS SEQUENCE TYPING;NUCLEAR PROTEIN;POINT MUTATION;PON1;PULSED-FIELD GEL ELECTROPHORESIS;RESTRICTION FRAGMENT LENGTH POLYMORPHISM;SULFOLOBUS SOLFATARICUS;TRANSITIONAL CELL CARCINOMA;VIRILIZATION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;INFARCTION;ANTINEOPLASTIC AGENTS;SKIN NEOPLASMS;TREATMENT OUTCOME;ADRENAL GLAND NEOPLASMS;ANEMIA, APLASTIC;BREAST NEOPLASMS;BURKHOLDERIA CEPACIA COMPLEX;BURKHOLDERIA INFECTIONS;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HERPES SIMPLEX;HYPERCHOLESTEROLEMIA;LUNG NEOPLASMS;VENOUS THROMBOSIS","20;10;8;8;7;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4","CHEMICAL GLYCOBIOLOGY AND THERAPEUTIC APPLICATIONS;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DIAGNOSIS AND MANAGEMENT OF EOSINOPHILIC ESOPHAGITIS;DIAGNOSIS AND MANAGEMENT OF PANCREATITIS;DIAGNOSIS AND MANAGEMENT OF PLEURAL DISEASES;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;DIAGNOSIS AND TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;EFFECTS OF LASER RADIATION ON OCULAR HEALTH;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENITOURINARY SOFT TISSUE TUMORS AND ANOMALIES;HEMATOPOIETIC STEM CELL BIOLOGY;IMPACT OF GESTATIONAL DIABETES MELLITUS ON PREGNANCY;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;MECHANISMS OF SKIN AGING AND PHOTODAMAGE;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;MOYAMOYA DISEASE AND SYNDROME;POLYOMAVIRUS-ASSOCIATED CARCINOGENESIS AND CLINICAL MANIFESTATIONS;PREVENTION AND MANAGEMENT OF POSTOPERATIVE NAUSEA AND VOMITING;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REGIMEN;PERFORMANCE STATUS;ALPHA-THALASSEMIA;ANTI-THYMOCYTE GLOBULIN;ANTIOXIDANT ACTIVITIES;AORTIC DISSECTION;APLASTIC ANEMIA;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;AUTOIMMUNE GASTRITIS;AUTOIMMUNE PANCREATITIS;BETA (PROGRAMMING LANGUAGE);BETA THALASSEMIA;BLADDER CANCER;BREAST RECONSTRUCTION;BURKHOLDERIA CENOCEPACIA;BURKHOLDERIA CEPACIA COMPLEX;CAGA;CARBONIC ANHYDRASE I;CARBONIC ANHYDRASE II;CLONE (JAVA METHOD)","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACQUIRED SEVERE;ADRENAL TUMOR;ALTERNATIVE DONOR;ANTI-HSV- PROPERTIES;ANTI-THYMOCYTE GLOBULIN;ANTIOXIDANT EFFECT;AORTIC SURGERY;APLASTIC ANEMIA;AUTOIMMUNE PANCREATITIS;BIOCATALYSED SYNTHESIS;BLADDER CANCER;BREAST CANCER;CANCER LONG-TERM;CANCER PERSONAL;CARBONIC ANHYDRASE;CELL TUMOR;CENTRAL NERVOUS;CEPACIAI COMPLEX;CHEST WALL;CHRONIC OBSTRUCTIVE;CLINICAL EVALUATION;CLONES INFECTING;COMPLEX EVIDENCE;CYPROTERONE ACETATE;CYSTIC FIBROSIS;DAY SURGERY;DEEP VENOUS;DIABETES MELLITUS;DIRECT OCCUPATIONAL;DOCETAXEL SCHEDULE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AUTOIMMUNE PANCREATITIS;CEPACIA COMPLEX;PFGE CLUSTERS;RFLP TYPE;CF CENTERS;HELICOBACTER PYLORI;RECA RFLP;ANHYDRASE II;BOX-PCR CLONES;CARBONIC ANHYDRASE;CF PATIENTS;CLINICAL SEVERITY;COMPLEX ISOLATES;DYSFERLINOPATHIC PATIENTS;GENOMOVAR STATUS;ISOLATES BELONGED;ISOLATES BELONGING;MUSCLE DISORDERS;ABNORMALITIES REVERSED;ACETATE CPA;ACQUIRED MUSCLE;ACTIVELY PARTICIPATE;ADRENAL GLAND;ADRENAL TUMOR;AFFECTED SUBJECTS;ALPHA-CARBONIC ANHYDRASE;AMERICAN CF;AMOUNTS PARALLELED;ANABOLIC STEROID;ANALYZE NATIONAL","4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,4.67,375.67,5.26,1,0.33,55.33,0,0,1,0,2,0,0,0,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,"Switzerland","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","3;2;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;AGING;BRAIN DISORDERS;HEMATOLOGY;LUNG;LUNG CANCER;LYMPHATIC RESEARCH;LYMPHOMA;NEURODEGENERATIVE;NEUROSCIENCES;PARKINSON'S DISEASE;RARE DISEASES","3;3;2;1;1;1;1;1;1;1;1;1;1;1","CANCER","2","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","2;1;1","LUNG CANCER;NON-HODGKIN'S LYMPHOMA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2006,31,7.83870967741935,1.48387096774194,0.548387096774194,0.193548387096774,0.580645161290323,1.21052631578947,1.13333333333333,1,1.125,0.225806451612903,0,11,4,2,10,0.35,0.13,0.06,0.32,30.74,0.601860111794453,NA,0.161290322580645,0.67741935483871,0.366,0.214,0.229,0.207,"P BARRESI;GIUSEPPE VITA;ALDO QUATTRONE;SALVATORE BENVENGA;ANGELO SCHENONE;IRENE APRILE;R PAVIA;DAVIDE PAREYSON;TIZIANA CAVALLARO;LUCA PADUA;P. TONALI;B MONDELLO;N. RIZZUTO;BÁRBARA ADAMO;CLAUDIO GUARNERI;R. URGESI;FABRIZIO GUARNERI;LIBERO SANTARPIA;R. SCARFÌ;GIUSEPPA FERRARO","3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;1;1","SALVATORE BENVENGA;P BARRESI;R PAVIA;B MONDELLO;LIBERO SANTARPIA;CLAUDIO GUARNERI;FABRIZIO GUARNERI;GIUSEPPE CANNELLA;ERNESTO PAOLETTI;R. URGESI;DANIELA SAPIENZA;VINCENZO FODALE;FEDERICA MAFRICA;DANIELA LAPA;ALESSIO ASMUNDO;FRANCESCO PERRI;B LETTERIO;GIUSEPPE VITA;ALDO QUATTRONE;ANGELO SCHENONE","0.83;0.6;0.6;0.6;0.58;0.5;0.5;0.5;0.5;0.4;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.29;0.29;0.29","GIUSEPPE VITA;SALVATORE BENVENGA;R PAVIA;BÁRBARA ADAMO;CLAUDIO GUARNERI;FABRIZIO GUARNERI;M ROSSITTO;S LAZZARA;GRAZIELLA MENTO;B. GUARNERI;DANIELA SAPIENZA;VINCENZO FODALE;F ROVERE;FABIO MORANDI;IGNAZIO BARBERI;PIETRO FAMILIARI;GIOVANNI TUCCARI;CARLO SANSOTTA;GIOVANNI GIACOBBE;FEDERICA MAFRICA","3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SALVATORE BENVENGA;R PAVIA;CLAUDIO GUARNERI;FABRIZIO GUARNERI;ERNESTO PAOLETTI;DANIELA SAPIENZA;VINCENZO FODALE;FEDERICA MAFRICA;ALESSIO ASMUNDO;FRANCESCO PERRI;B LETTERIO;GIUSEPPE VITA;BÁRBARA ADAMO;GRAZIELLA MENTO;B. GUARNERI;IGNAZIO BARBERI;R CARUSO;A. IOLI;PIETRO FAMILIARI;PIETRO IMPELLIZZERI","0.83;0.6;0.5;0.5;0.5;0.33;0.33;0.33;0.33;0.33;0.33;0.29;0.26;0.25;0.25;0.25;0.25;0.25;0.2;0.2","ALAIN VERLOÈS;CLARISSE BAUMANN;DAGMAR WIECZOREK;DELPHINE HÉRON;DOMINIQUE BONNEAU;GABRIELE GILLESSEN‐KAESBACH;GIOVANNI NERI;GIUSEPPINA CORONA;HIROFUMI OHASHI;HÉLÈNE CAVÉ;KENJI KUROSAWA;KENJI NARITOMI;KUMI KATO;LOUISE C. WILSON;MARIA INÊS KAVAMURA;NAOMICHI MATSUMOTO;NOBUHIKO OKAMOTO;RAOUL C. M. HENNEKAM;SHIGEO KURE;TADASHI KANAME","568;568;568;568;568;568;568;568;568;568;568;568;568;568;568;568;568;568;568;568","GIUSEPPINA CORONA;SALVATORE BENVENGA;VINCENZO ADAMO;GIUSEPPE VITA;BÁRBARA ADAMO;ANTÓNIO TOSCANO;CARMELO RODOLICO;OLIMPIA MUSUMECI;CLAUDIO GUARNERI;FABRIZIO GUARNERI;CARLO SANSOTTA;ANNALISA PEZZOLO;ELISA FERRETTI;FABIO MORANDI;VITO PISTOIA;GIOVANNI TUCCARI;A. IOLI;GRAZIELLA MENTO;GIOVANNI GIACOBBE;B. GUARNERI","568;67;48;44;43;35;35;35;27;27;24;20;20;20;20;16;15;15;13;12","SALVATORE BENVENGA;R PAVIA;GIUSEPPE VITA;CLAUDIO GUARNERI;FABRIZIO GUARNERI;A. IOLI;ADAMO;ALESSIO ASMUNDO;ANNALISA PEZZOLO;ANTÓNIO TOSCANO;B. GUARNERI;BÁRBARA ADAMO;CARLO SANSOTTA;CARMELO RODOLICO;DANIELA SAPIENZA;ELENA FERRARI;ELISA FERRETTI;ERNESTO PAOLETTI;F ROVERE;FABIO MORANDI","3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;SOCIOLOGY;COMPUTER SCIENCE;ECONOMICS;HISTORY;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY","28;14;3;3;3;2;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;SURGERY;INTENSIVE CARE MEDICINE;CANCER RESEARCH;DEMOGRAPHY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;NURSING;PALEONTOLOGY;ANATOMY;BIOCHEMISTRY;CARDIOLOGY;DERMATOLOGY;GASTROENTEROLOGY;GENERAL SURGERY;GERONTOLOGY;ONCOLOGY;PEDIATRICS;RADIOLOGY","18;7;6;6;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","CANCER;GENE;POPULATION;DISEASE;CARCINOMA;QUALITY OF LIFE (HEALTHCARE);IDENTIFICATION (BIOLOGY);IMMUNE SYSTEM;LUNG;LYMPH NODE;MALIGNANCY;MALNUTRITION;MULTIVARIATE ANALYSIS;PARENTERAL NUTRITION;PATHOGENESIS;PERIOPERATIVE;RESPIRATORY SYSTEM;STAGE (STRATIGRAPHY);ABSCESS;ALLERGY;ANALGESIC;ANTIBODY;ANTIGEN;APOPTOSIS;BLOOD PRESSURE;BLUNT;BURNING SENSATION;CARDIOTHORACIC SURGERY;CLINICAL DIAGNOSIS;CONTEXT (ARCHAEOLOGY);CORONARY ARTERY DISEASE;CORRELATION;DEPRESSION (ECONOMICS);DOCUMENTATION;DORSUM;ECTASIA;EDEMA;ELASTIN;EMERGENCY SURGERY;ENDOMETRIUM;ENDOSCOPY;ESTROGEN;FAMILY TREE;GENETIC COUNSELING;GENETIC TESTING;HEMANGIOBLASTOMA;HEMODYNAMICS;HEMOLYTIC ANEMIA;HISTAMINE;HORMONE;IMMUNOHISTOCHEMISTRY;INCIDENCE (GEOMETRY);INFESTATION;INHALATION;ISCHEMIA;ITCHING;KIDNEY DISEASE;KINASE;LAPAROSCOPY;LIFE SPAN;LONGEVITY;LUNG CANCER;MASTITIS;MENOPAUSE;MORTALITY RATE;MUSCLE HYPERTROPHY;MYOPATHY;NEUROENDOCRINE TUMORS;NEUROLOGY;NEUROPHYSIOLOGY;NOONAN SYNDROME;NORMATIVE;OSTEOPOROSIS;PALLIATIVE CARE;PANCREAS;PARASITE HOSTING;PHYSICAL DISABILITY;POSTOPERATIVE PAIN;PREPUTIAL GLAND;QUALITY (PHILOSOPHY);RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;SCRATCHING;SELENIUM;THYROID;TYPE (BIOLOGY)","11;9;6;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;ESOPHAGEAL CANCER;MUTATION;ENTERAL ADMINISTRATION;METASTASIS;ABDOMINAL TRAUMA;ADENOCARCINOMA;ALLELE;ALLOIMMUNITY;ANDROGEN;AUTOANTIBODY;AUTOIMMUNE HEMOLYTIC ANEMIA;AUTOIMMUNITY;BRONCHOALVEOLAR LAVAGE;CELL CYCLE;CLEAR CELL;COLORECTAL CANCER;ENDOMETRIAL CANCER;ENDOSCOPIC ULTRASONOGRAPHY;EPITOPE;ESCHERICHIA COLI;EXON;GERMLINE;GRANULOMATOUS MASTITIS;GRAVES' DISEASE;IN SILICO;INCISION AND DRAINAGE;INHALATION EXPOSURE;KI-67;LAPAROSCOPIC SURGERY;LEFT VENTRICULAR HYPERTROPHY;LIFE EXPECTANCY;LYMPHADENECTOMY;MAJOR HISTOCOMPATIBILITY COMPLEX;MAPK/ERK PATHWAY;MERKEL CELL CARCINOMA;METHYLATION;MULTICENTER STUDY;MUTATION RATE;NEUROENDOCRINE CARCINOMA;NONSENSE;OVARIAN CANCER;PEPTIDE SEQUENCE;PHENOTYPE;PROGRAMMED CELL DEATH;TETRAZOLIUM CHLORIDE;THYROID PEROXIDASE;THYROIDITIS;TOOTH DISEASE;UNIVARIATE ANALYSIS;VON HIPPEL–LINDAU DISEASE","5;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GERMLINE MUTATION;ESTROGEN RECEPTOR;PRIMARY TUMOR;ALLELE FREQUENCY;EVANS SYNDROME;FRAMESHIFT MUTATION;HORMONE THERAPY;KRAS;LOSS OF HETEROZYGOSITY;MERKEL CELL;MICROSATELLITE;MISSENSE MUTATION;MOLECULAR MEDICINE;ONCOGENE;PROBAND;PROPIDIUM IODIDE;SEX HORMONE-BINDING GLOBULIN;THYROTROPIN RECEPTOR","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;ADULT;FEMALE;MIDDLE AGED;ESOPHAGEAL NEOPLASMS;MALE;;AGED;CARCINOMA, MERKEL CELL;ITALY;SKIN NEOPLASMS;AGED, 80 AND OVER;BREAST;MASTITIS;ABSCESS;ADOLESCENT;BREAST DISEASES;BREAST NEOPLASMS;CARCINOMA;CELLULITIS","24;10;10;9;8;8;6;6;6;6;6;5;5;5;4;4;4;4;4;4","GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;;ADVANCEMENTS IN LUNG CANCER RESEARCH;BODY DYSMORPHIC DISORDER: PSYCHOSOCIAL, CLINICAL, AND TREATMENT ASPECTS;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND MANAGEMENT OF APPENDICITIS;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DISEASES RELATED TO BLOOD GROUP VARIANTS;ESOPHAGEAL INTERVENTION TECHNIQUES;GENETIC RESEARCH ON BRCA MUTATIONS AND CANCER RISK;GENOMIC ANALYSIS OF ANCIENT DNA;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;HEALTH EFFECTS OF AIR POLLUTION;IMPACT OF OBESITY ON CANCER RISK AND PROGNOSIS;MALE CIRCUMCISION FOR HIV PREVENTION AND PENILE HEALTH;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;METABOLIC REPROGRAMMING IN CANCER BIOLOGY;METASTATIC CARCINOMAS FROM LUNG AND BREAST;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER RISK;CHARCOT-MARIE-TOOTH DISEASE;ENTERAL ADMINISTRATION;IDENTIFICATION (BIOLOGY);NUTRITIONAL STATUS;PATHOGENESIS;PRIMARY TUMOR;;ADAPTIVE IMMUNITY REGULATION;ALLOIMMUNITY;ASBESTOS EXPOSURE;BRCA1;BRCA2;BREAST CANCER;BURNING SENSATION;CANCER GENOMICS;CANCER SUSCEPTIBILITY;CANCER THERAPY;CARDIOTHORACIC SURGERY;CLINICAL DIAGNOSIS","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CMT PATIENTS;ESOPHAGEAL CANCER;PATIENTS ITALIAN;ABDOMINAL EMERGENCIES;ACID SEQUENCE;ACTIVITY METHODS;ACUTE RESPIRATORY;AGE INDICATIONS;ALLELE DISTRIBUTION;ALLOGENEIC BMT;AMINO ACID;ANDOR OVARIAN;ARTIFICIAL NUTRITION;BINDING MOTIFS;BMT NOTWITHSTANDING;BRAF MUTATIONS;BRCA GENETIC;BREAST ANDOR;CANCER FAMILIES;CARCINOMA ENDOSCOPIC;CARCINOMA METASTASIS;CARCINOMAS RELATIONSHIPS;CARDIO-FACIO-CUTANEOUS SYNDROME;CATASTROPHIC RELAPSE;CHARCOT MARIE;CHARCOTMARIETOOTH TYPE;CHIMERISM TERMINAL;CHRONIC KIDNEY;COASTAL SICILIAN;COLI VIABILITY","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PUBLIC HEALTH;ACTIVELY RESPIRING;COLI CELLS;CTC CELLS;ELECTRON MICROSCOPY;ENDOMETRIOID TYPE;LF ID-SCORE;LF IMMUNOEXPRESSION;MEMBRANE-DAMAGED CELLS;NONSENSE PARGX;SIGNIFICANTLY RELATED;ABUSE DEPENDENCE;ACTIVE PHLOGOSIS;ACTIVE RESPIRING;ACTIVITY RATES;ACTIVITY TEST;ACUTE ALVEOLITIS;ADVERSE ENVIRONMENTAL;AGARTHE TOTAL;AGL GENE;AGNOR QUANTIFICATION;AGNOR TECHNIQUE;ALTERNATELY SPLICED;ALVEOLAR MACROPHAGES;ANAES THESIOLOGISTS;ANALYSES HIGHLIGHTED;ANALYSIS KI-RAS;ANCESTORS DETAILED;ANDOR PINKA;ANDOR TP","3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,4,430,5.26,0,0,40,0,0,0,0,1,0,0,1,0,1,1,0,0,0,0,0,0,1,1,0,2,0,0,0,0,0,0,0,0,0,"Canada;Italy","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE","2;1;1;1","CANCER;CARDIOVASCULAR;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CONTRACEPTION/REPRODUCTION;DIABETES;HYPERTENSION;LUNG;LUNG CANCER;MATERNAL HEALTH;MATERNAL MORBIDITY AND MORTALITY;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PREGNANCY;WOMEN'S HEALTH","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;REPRODUCTIVE HEALTH AND CHILDBIRTH","1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS","1;1","LUNG CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2007,25,7.6,3.12,0.68,0.32,0.72,1.02631578947368,1,0.888888888888889,0.947368421052632,0.08,1,10,3,5,7,0.4,0.12,0.2,0.28,53.84,1.02016085422693,NA,0.2,0.64,0.356,0.104,0.097,0.13,"B MONDELLO;FRANCESCO STILO;SALVATORE BENVENGA;FILIPPO FLAVIO ANGILERI;G L BAGNATO;VINCENZO RIZZO;GABRIELLA BOTTARI;A SALATINO;F. JAVIER OCHOA-ERENA;A. PRELLE;FRANCESCA POLITO;M'H. DAHMANE;F MIRENDA;MARIA CRISTINA GUERRERA;G. STEVEN BOVA;ROSSELLA MUSOLINO;MICHELE BONAIUTO;GREGORI MARTINO;SERENA PAGLIARANI;MICHELA GUGLIERI","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","P. DELIA;FRANCESCO STILO;A CARDITELLO;B MONDELLO;ENRICA VITARELLI;VALERIA BARRESI;GAETANO BARRESI;G L BAGNATO;LUIS SALVADOR MONTICELLI;GABRIELLA CARUSO;A. BERGAMASCO;R CARUSO;A. CALIRI;L DE FILIPPIS;G F BAGNATO;SALVATORE BENVENGA;F MIRENDA;DOMENICO PUZZOLO;GRAZIA MARIA PALADINO;GIOVANNI DE CARIDI","1;0.7;0.5;0.44;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.21;0.2;0.2;0.2;0.2","B MONDELLO;SALVATORE BENVENGA;GABRIELLA BOTTARI;FRANCESCA POLITO;M'H. DAHMANE;MICHELE BONAIUTO;GREGORI MARTINO;P BARRESI;DOMENICO PUZZOLO;T MANDOLFINO;BIAGIO ZUCCARELLO;CARLA LUBRANO;ALESSANDRA BITTO;MARIO BARONE;M. AGUENNOUZ;A CARDITELLO;ENRICA VITARELLI;LETTERIA MINUTOLI;F ROVERE;FRANCESCA GUALANDI","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","P. DELIA;A CARDITELLO;B MONDELLO;ENRICA VITARELLI;VALERIA BARRESI;GAETANO BARRESI;R CARUSO;A. CALIRI;SALVATORE BENVENGA;DOMENICO PUZZOLO;ANTONIO MICALI;FRANCESCO SPINELLI;R. M. RUGGERI;M'H. DAHMANE;P BARRESI;BIAGIO ZUCCARELLO;MARIO BARONE;F ROVERE;R PAVIA;GIUSEPPE CANNELLA","1;0.5;0.44;0.33;0.33;0.33;0.25;0.25;0.21;0.2;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.17","AGOSTINO GAUDIO;ALESSANDRA BITTO;ALESSIA FRISINA;CARLA LUBRANO;DOMENICA ALTAVILLA;ELENA BIANCA ADAMO;FRANCESCA POLITO;FRANCESCO CORRADO;FRANCESCO SQUADRITO;HERBERT MARINI;LETTERIA MINUTOLI;MARCO ATTERITANO;MARIA LETIZIA CANNATA;MICHELE BONAIUTO;N FRISINA;ROSARIO D’ANNA;STEVEN WILSON;SUSANNA MAZZAFERRO;P. DELIA;A. PRELLE","310;310;310;310;310;310;310;310;310;310;310;310;310;310;310;310;310;310;284;183","AGOSTINO GAUDIO;ALESSANDRA BITTO;ALESSIA FRISINA;CARLA LUBRANO;DOMENICA ALTAVILLA;ELENA BIANCA ADAMO;FRANCESCA POLITO;FRANCESCO CORRADO;FRANCESCO SQUADRITO;HERBERT MARINI;LETTERIA MINUTOLI;MARCO ATTERITANO;MARIA LETIZIA CANNATA;MICHELE BONAIUTO;N FRISINA;ROSARIO D’ANNA;STEVEN WILSON;SUSANNA MAZZAFERRO;P. DELIA;ANTÓNIO TOSCANO","310;310;310;310;310;310;310;310;310;310;310;310;310;310;310;310;310;310;284;183","B MONDELLO;FRANCESCO TRIMARCHI;SALVATORE BENVENGA;A CARDITELLO;A MARMONT;A. CALIRI;AGOSTINO GAUDIO;ALESSANDRA BITTO;ALESSIA FRISINA;ANDREA BACIGALUPO;ANTONIO MICALI;ANTÓNIO TOSCANO;BENEDETTO BRUNO;BIAGIO ZUCCARELLO;C. FERRO;CARLA LUBRANO;CARMELO RODOLICO;DAVIDE ROLLA;DOMENICA ALTAVILLA;DOMENICO PUZZOLO","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;ENGINEERING;ENVIRONMENTAL SCIENCE;GEOLOGY;MATERIALS SCIENCE;PSYCHOLOGY","23;11;6;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;IMMUNOLOGY;RADIOLOGY;CELL BIOLOGY;GENETICS;ANATOMY;ANESTHESIA;GASTROENTEROLOGY;NEUROSCIENCE;PALEONTOLOGY;PHYSICAL THERAPY;PSYCHIATRY;ASTROBIOLOGY;CARDIOLOGY;DERMATOLOGY;ECOLOGY;ENVIRONMENTAL ENGINEERING;INTENSIVE CARE MEDICINE;METALLURGY;MICROBIOLOGY;MOLECULAR BIOLOGY;NURSING;ONCOLOGY;OPHTHALMOLOGY;OPTICS;ORGANIC CHEMISTRY;PEDIATRICS;PHARMACOLOGY;REMOTE SENSING;UROLOGY","16;10;9;5;5;4;4;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;ALTERNATIVE MEDICINE;ARTERIOVENOUS FISTULA;CANCER;CLINICAL TRIAL;DIARRHEA;DISEASE;IMMUNOHISTOCHEMISTRY;OSTEOPOROSIS;RECEPTOR;THYROID;TRANSPLANTATION;ACNE;ADVERSE EFFECT;ANTIBIOTICS;ANTIBODY;AQUATIC ECOSYSTEM;AQUATIC ENVIRONMENT;ASBESTOS;ATRESIA;AUTOPSY;BACTERIA;BLOOD PRESSURE;BONE REMODELING;BRONCHOSCOPY;CALCIUM;CELL;CENTRAL NERVOUS SYSTEM;CEREBELLUM;CEREBROSPINAL FLUID;CHEST PAIN;CHRONIC BRONCHITIS;CHRONIC PAIN;CIRRHOSIS;CONJUNCTIVA;CONTEXT (ARCHAEOLOGY);CORTICOTOMY;CRANIOFACIAL;DELIVERY SYSTEM;DRUG;DRUG DELIVERY;EMBRYO;ENZYME;EPITHELIUM;ETIOLOGY;FAMILY HISTORY;FIBROUS JOINT;GANGLION;GENISTEIN;HEMORRHOIDS;HORMONE;IMPLANT;IN VITRO;INCIDENCE (GEOMETRY);INHIBITORY POSTSYNAPTIC POTENTIAL;INTRACRANIAL INFECTION;INTRATHECAL;KIDNEY;LEAK;LESION;LUNG;MAST CELL;MEDIASTINUM;MENINGITIS;MESOTHELIOMA;MORPHINE;MUCIN;MULTIPLE SCLEROSIS;MUSCLE HYPERTROPHY;MUSCULAR DYSTROPHY;MYOCYTE;NERVOUS SYSTEM;NEUROLOGY;NEUROSURGERY;OCCLUSION;OPTICAL DENSITY;OSTEOTOMY;PATHOGENESIS;PATHOLOGICAL;PERCUTANEOUS;PERITONEUM;PNEUMOTHORAX;POPLITEAL ARTERY;POSTOPERATIVE PAIN;PULMONARY FUNCTION TESTING;QUALITY OF LIFE (HEALTHCARE);RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;REFRACTORY (PLANETARY SCIENCE);RESECTION;RETROSPECTIVE COHORT STUDY;SALINE;SKELETAL MUSCLE;SKULL;SODIUM HYALURONATE;STAGE (STRATIGRAPHY);STAINING;STENT;STIMULATION;STROMAL CELL;TRIGEMINAL NERVE;TRIGEMINAL NEURALGIA;URINARY RETENTION","3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MUTATION;PLACEBO;ACETYLCHOLINE RECEPTOR;AGE OF ONSET;ALKALINE PHOSPHATASE;ANAL STENOSIS;ANTERIOR CRANIAL FOSSA;AUTOIMMUNE DISEASE;AUTOLOGOUS STEM-CELL TRANSPLANTATION;BONE DENSITY;BONE MINERAL;BREAST CANCER;CALCIUM-BINDING PROTEIN;CANCER PAIN;CEREBELLAR CORTEX;CEREBROSPINAL FLUID LEAK;CONGENITAL HYPOTHYROIDISM;CYTOSKELETON;DAIDZEIN;DIABETIC NEPHROPATHY;DYSFERLIN;DYSTROPHIN;ENTEROCOCCUS;ENTEROCOCCUS FAECIUM;EXCITATORY POSTSYNAPTIC POTENTIAL;FEMORAL NECK;GENOTYPE;GERMLINE;GOBLET CELL;GOITER;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEPATOCYTE GROWTH FACTOR;INTEGRIN;ITGA7;KIDNEY TRANSPLANTATION;LEFT VENTRICULAR HYPERTROPHY;LOPERAMIDE;LUNG FUNCTION;MOTOR CORTEX;MYOGENESIS;NEURAL CREST;NEURORADIOLOGY;PERIODIC ACID–SCHIFF STAIN;PERITONEAL MESOTHELIOMA;PHENOTYPE;PNEUMOMEDIASTINUM;PNEUMONECTOMY;PORTAL HYPERTENSION;POTENCY;PROBIOTIC;S100 PROTEIN;SARCOLEMMA;STAIN;SUBCUTANEOUS EMPHYSEMA;THYROID NODULES;THYROIDITIS;TRANSCRANIAL MAGNETIC STIMULATION;WESTERN BLOT;ZEBRAFISH","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACTIN CYTOSKELETON;AGRIN;DANIO;DIFFUSING CAPACITY;ESTROGEN RECEPTOR;GASTRIC VARICES;GENETIC HETEROGENEITY;GERMLINE MUTATION;LIMB-GIRDLE MUSCULAR DYSTROPHY;MAMMARY GLAND;MISSENSE MUTATION;OSTEOCALCIN;OSTEOPENIA;PROBAND;RENAL HYPERTROPHY;SILENT PERIOD;TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;MIDDLE AGED;DIARRHEA;ADULT;AGED;ARTERIOVENOUS FISTULA;BRAIN;MUSCULAR DYSTROPHIES, LIMB-GIRDLE;PROBIOTICS;BACTERIAL INFECTIONS;CARCINOMA, NON-SMALL-CELL LUNG;CARCINOMA, SQUAMOUS CELL;ESOPHAGUS;GASTROINTESTINAL DISEASES;HYPOTHYROIDISM;LUNG NEOPLASMS;LUPUS ERYTHEMATOSUS, SYSTEMIC;MEDIASTINAL EMPHYSEMA","21;14;13;8;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4","MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;ANORECTAL SURGICAL PROCEDURES;BIOLOGICAL AND CLINICAL EFFECTS OF IONIZING RADIATION;CHALLENGES IN PAIN MANAGEMENT AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIA;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF LUNG CANCER;EFFECTS OF BRAIN STIMULATION ON MOTOR CORTEX;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;ESOPHAGEAL INTERVENTION TECHNIQUES;HEALTH EFFECTS OF SOY ISOFLAVONES AND PHYTOESTROGENS;INCIDENCE AND MANAGEMENT OF HIP FRACTURES;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;MECHANISMS AND TREATMENT OF LIVER FIBROSIS;PAPER-BASED DIAGNOSTIC DEVICES;PATHOBIOLOGY AND MANAGEMENT OF MUCOSITIS IN CANCER THERAPY;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;PATHOLOGY AND MANAGEMENT OF TRIGEMINAL NEURALGIA;S100 PROTEINS: STRUCTURE, FUNCTION, AND PATHOLOGY","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACNE INVERSA;AGRIN;ANAL STENOSIS;ANTERIOR CRANIAL FOSSA;ASBESTOS EXPOSURE;AUTOIMMUNE DISEASE EPIDEMIOLOGY;AUTOLOGOUS STEM-CELL TRANSPLANTATION;BONE DENSITY;BONE MINERAL DENSITY;BONE REMODELING;CANCER;CEREBROSPINAL FLUID LEAK;CEREBROSPINAL FLUID LEAKS;CHRONIC BRONCHITIS;CONGENITAL HYPOTHYROIDISM;CORTICAL EXCITABILITY;CORTICOTOMY;DANIO;DELIVERY SYSTEM;DEOXYPYRIDINOLINE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","RADIATION-INDUCED DIARRHEA;ACE INHIBITORS;ACNE INVERSA;ADULT HYPOTHYROIDISM;ADULT PATIENTS;ADULT ZEBRAFISH;AMPLATZER VASCULAR;ANTERIOR SKULL;ANTIBODY METHOD;AQUATIC ENVIRONMENT;AUTOIMMUNE DISEASES;AUTOLOGOUS STEM;BASE RECONSTRUCTION;BONE METABOLISM;BREAST CANCER;CANCER PAIN;CELL CARCINOMA;CELL LUNG;CELL TRANSPLANTATION;CHRONIC CANCER;CLINICAL MOLECULAR;CLINICAL TRIAL;COASTAL AQUATIC;CONGENITAL HYPOTHYROIDISM;CONJUNCTIVAL EPITHELIUM;CONTINUOUS INTRATHECAL;DEFINITIVE IMPLANT;DELIVERY SYSTEM;DEVICE AMPLATZER;DIAGNOSED ITALIAN","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","RADIATION-INDUCED DIARRHEA;BOWEL MOVEMENTS;CANCER PATIENTS;EARLIER ONSET;HIGH-POTENCY PROBIOTIC;PLACEBO PATIENTS;PROBIOTIC PREPARATION;VSL PATIENTS;VSL RECIPIENTS;ACID-PRODUCING BACTERIA;ADJUVANT POSTOPERATIVE;AIMTO INVESTIGATE;ANALYSIS IDENTIFIED;AUTOSOMAL DOMINANT;AUTOSOMAL RECESSIVE;CALPAIN- DEFICIENCY;CALPAIN- LGMDB;CALPAINOPATHY DYSFERLINOPATHY;CAVEOLIN- LGMDA;CAVEOLINOPATHY LGMDI;CERVICAL CANCER;CLINICAL HETEROGENEITY;CLINICAL PATTERN;CLINICAL SEVERITY;CONCLUSION PROBIOTIC;DAILY BOWEL;DECREASING CLINICAL;DEFICIENCY STANDARD;DETERMINED EARLIER;DEVIATION SD","4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,6.8,128.6,6.58,1,0.2,34.6,0,0,3,1,1,0,0,0,0,5,0,0,0,0,0,0,0,3,2,0,5,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY","5;2;2;1;1;1","AGING;CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;COMPLEMENTARY AND INTEGRATIVE HEALTH;CONTRACEPTION/REPRODUCTION;ESTROGEN;HEMATOLOGY;RARE DISEASES;WOMEN'S HEALTH;CARDIOVASCULAR;DIABETES;NUTRITION;PREVENTION;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;TRANSPLANTATION;UTERINE CANCER","3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;METABOLIC AND ENDOCRINE","1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","3;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;ENDOMETRIAL CANCER","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2008,29,9.68965517241379,2.37931034482759,0.586206896551724,0.172413793103448,0.655172413793103,1.15,1.0625,0.833333333333333,1.05555555555556,0.241379310344828,0,10,7,3,8,0.34,0.24,0.1,0.28,26.93,0.490798548420361,NA,0.206896551724138,0.862068965517241,0.407,0.267,0.133,0.254,"VINCENZO ADAMO;BERNADETTE PAVONE;ANNABELLA TRAMICE;FRANCESCA POLITO;ROBERTA GRANESE;IDA GIORDANO;ALESSANDRA BITTO;ADRIANA ARENA;SALVATORE BENVENGA;SALVATORE PISCONTI;AMBRA DE GREGORIO;GIOVANNI SCAMBIA;LETTERIA MINUTOLI;NICOLETTA ARENA;GABRIELLA FERRANDINA;HERBERT MARINI;ROSANNA MACCARI;FRANCESCO SQUADRITO;GIUSEPPE TONINI;ROSARIA OTTANÀ","5;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ROBERTA GRANESE;SALVATORE BENVENGA;FRANCESCO TRIMARCHI;VINCENZO ADAMO;B ADILE;MADDALENA GROSSO;GIUSEPPE FERRERI;VALERIA BARRESI;PASQUALE ARAGONA;F. FERRERI;GAETANO BARRESI;SALVATORE PISCONTI;GIOVANNI SCAMBIA;GABRIELLA FERRANDINA;IDA GIORDANO;ROCCO AGOSTINO;BERNADETTE PAVONE;ANNABELLA TRAMICE;RENATO VENEZIA;N ARCUDI","0.7;0.62;0.62;0.51;0.5;0.33;0.33;0.33;0.33;0.33;0.33;0.24;0.24;0.24;0.24;0.24;0.2;0.2;0.2;0.2","VINCENZO ADAMO;BERNADETTE PAVONE;FRANCESCA POLITO;ROBERTA GRANESE;IDA GIORDANO;ALESSANDRA BITTO;ADRIANA ARENA;SALVATORE BENVENGA;LETTERIA MINUTOLI;HERBERT MARINI;FRANCESCO SQUADRITO;AGOSTINO GAUDIO;DOMENICA ALTAVILLA;G GALTIERI;GIUSEPPA FERRARO;CATRAMBONE GIUSEPPE;DOMENICO CUCINOTTA;MADDALENA GROSSO;L RICCIARDI;BÁRBARA ADAMO","5;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","ROBERTA GRANESE;SALVATORE BENVENGA;VINCENZO ADAMO;MADDALENA GROSSO;GIUSEPPE FERRERI;VALERIA BARRESI;PASQUALE ARAGONA;F. FERRERI;GAETANO BARRESI;IDA GIORDANO;BERNADETTE PAVONE;ADRIANA ARENA;G LEGATO;G GALTIERI;SILVERIO PERROTTA;AGOSTINO GAUDIO;ANTONIETTA MELCHINI;R. DE PASQUALE;MARIA GIOFFRÉ‐FLORIO;ROCCO CAMINITI","0.7;0.62;0.51;0.33;0.33;0.33;0.33;0.33;0.33;0.24;0.2;0.2;0.2;0.17;0.17;0.15;0.14;0.14;0.14;0.14","FRANCESCO TRIMARCHI;SALVATORE BENVENGA;ANTONIA RUSSO;DANIELA LAPA;GIOVANNA SARACENO;GRAZIA GIORGIANNI;L. BARTOLONE;MARIA PAPPALARDO;VINCENZO ADAMO;ALESSANDRA BITTO;DOMENICA ALTAVILLA;FRANCESCA POLITO;FRANCESCO SQUADRITO;HERBERT MARINI;LETTERIA MINUTOLI;AGOSTINO GAUDIO;A. TROVATO;ANTONIETTA MELCHINI;CHIARA COSTA;J.J.A. HEFFRON","273;273;178;178;178;178;178;178;144;91;91;91;91;91;91;86;84;84;84;84","SALVATORE BENVENGA;GRAZIA GIORGIANNI;VINCENZO ADAMO;AGOSTINO GAUDIO;A. TROVATO;ANTONIETTA MELCHINI;CHIARA COSTA;R. DE PASQUALE;SALVATORE CATANIA;ALESSANDRA BITTO;ALESSIA FRISINA;DOMENICA ALTAVILLA;ELENA BIANCA ADAMO;FRANCESCA POLITO;FRANCESCO CANCELLIERI;FRANCESCO CORRADO;FRANCESCO SQUADRITO;HERBERT MARINI;LETTERIA MINUTOLI;MARCO ATTERITANO","273;178;140;86;84;84;84;84;84;76;76;76;76;76;76;76;76;76;76;76","VINCENZO ADAMO;ADRIANA ARENA;AGOSTINO GAUDIO;BERNADETTE PAVONE;ROBERTA GRANESE;SALVATORE BENVENGA;A. DI BENEDETTO;A. TROVATO;ALESSANDRA BITTO;ALESSIA FRISINA;ANNA MEO;ANNALISA GIANDALIA;ANTONIETTA MELCHINI;BÁRBARA ADAMO;CATRAMBONE GIUSEPPE;CHIARA COSTA;D IANNELLO;DOMENICA ALTAVILLA;DOMENICO CUCINOTTA;ELENA BIANCA ADAMO","4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;ENGINEERING;MATERIALS SCIENCE;COMPUTER SCIENCE;ECONOMICS;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY","27;12;5;4;3;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;GENETICS;IMMUNOLOGY;GASTROENTEROLOGY;OPTICS;PALEONTOLOGY;PHARMACOLOGY;RADIOLOGY;ANESTHESIA;CLINICAL PSYCHOLOGY;GYNECOLOGY;INTENSIVE CARE MEDICINE;OBSTETRICS;STEREOCHEMISTRY;UROLOGY","17;10;8;7;6;5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2","CANCER;ALTERNATIVE MEDICINE;POPULATION;PREGNANCY;CHEMOTHERAPY;COHORT;DISEASE;EPIDEMIOLOGY;ETIOLOGY;GENE;IN VITRO;LUNG CANCER;LYMPH NODE;PROPORTIONAL HAZARDS MODEL;TOXICITY;ABSORPTION (ACOUSTICS);AFFECT (LINGUISTICS);ALLERGY;ANOMER;ANTIBODY;ARTERY;ASTHMA;ASYMPTOMATIC;BIOBANK;BIOPSY;BLUNT;BONE REMODELING;BONE RESORPTION;BREATHING;CARBOHYDRATE;CLINICAL TRIAL;COHORT STUDY;COMORBIDITY;COMPUTED TOMOGRAPHY;CONFOCAL;CONNECTION (PRINCIPAL BUNDLE);CREATININE;CYTOKINE;DIABETES MELLITUS;DIAGNOSTIC TEST;DISSECTION (MEDICAL);DISTRESS;DNA;ENDOMETRIOSIS;ENDOPLASMIC RETICULUM;ENZYME;ESTROGEN;EXISTENTIALISM;GALACTOSE;GENISTEIN;GLAUCOMA;GLYCOCONJUGATE;GLYCOSIDE;HEART FAILURE;HOMOCYSTEINE;IMMUNOHISTOCHEMISTRY;INCIDENCE (GEOMETRY);INSULIN;INTRAOCULAR PRESSURE;JAUNDICE;KINASE;LAPAROSCOPY;LASER;LEUKEMIA;LIPOPOLYSACCHARIDE;MAGNESIUM;MAGNETIC RESONANCE IMAGING;MEANING (EXISTENTIAL);MECHANICAL VENTILATION;MENOPAUSE;MESOTHELIOMA;MYOCARDIAL INFARCTION;MYOCYTE;MYOPATHY;NATURAL HISTORY;NITRIC OXIDE;NODULE (GEOLOGY);OPTIC NERVE;OSTEOPOROSIS;PATHOLOGICAL;PESTICIDE;PREDNISONE;PRESENTATION (OBSTETRICS);PROSPECTIVE COHORT STUDY;PSYCHOLOGICAL STRESS;PULMONARY SURFACTANT;REACTIVE OXYGEN SPECIES;RECEPTOR;REFERRAL;REGIMEN;RESECTION;RESPIRATORY DISTRESS;RETINAL;SEVERITY OF ILLNESS;SIGNAL TRANSDUCTION;SKELETAL MUSCLE;STAGE (STRATIGRAPHY);STRESS (LINGUISTICS);SURGICAL ONCOLOGY;SURVIVAL ANALYSIS;TABLE (DATABASE);TEST (BIOLOGY);THALASSEMIA;THYROID;TRANSPLANTATION;TUMOR NECROSIS FACTOR ALPHA;TURNOVER;UNIT (RING THEORY);URINARY INCONTINENCE;URINARY SYSTEM;VENTILATION (ARCHITECTURE);VIRUS;VITAMIN B12;VITAMIN D AND NEUROLOGY;WORK (PHYSICS)","7;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;COLORECTAL CANCER;PERIPHERAL BLOOD MONONUCLEAR CELL;ACTIVATOR (GENETICS);AGLYCONE;AUTOANTIBODY;BALAYAGE;BETA THALASSEMIA;BIOREPOSITORY;BONE MINERAL;CAVEOLAE;CHEMICAL SYNTHESIS;CHEMOTHERAPY REGIMEN;CISPLATIN;CYTOTOXICITY;DEFERIPRONE;DICHLOROFLUORESCEIN;DNA DAMAGE;DOXORUBICIN;EPISIOTOMY;FETUS;FUCOSE;GALACTOSIDES;GEMCITABINE;GENOTOXICITY;GENOTYPE;GLUCOSIDE;GLYCOSIDE HYDROLASE;HEART TRANSPLANTATION;HERPES SIMPLEX VIRUS;HYPOGLYCEMIA;HYPOMAGNESEMIA;IMIDACLOPRID;INTERMITTENT POSITIVE PRESSURE VENTILATION;LAPAROSCOPIC SURGERY;METASTASIS;MICRONUCLEUS TEST;NERVE FIBER LAYER;NITRIC OXIDE SYNTHASE;OBSTETRICS AND GYNAECOLOGY;OCCULT;OPHTHALMOSCOPY;OPTIC DISK;OVARIAN CANCER;PHASES OF CLINICAL RESEARCH;PHYTOESTROGENS;PLACEBO;PROSTATE;PROSTATE CANCER;RETINOIC ACID;SARCOPLASM;SOLITARY PULMONARY NODULE;STRESS INCONTINENCE;THORACIC TRAUMA;THYROGLOBULIN;THYROID PEROXIDASE;THYROIDITIS;TOXICOKINETICS;VAGINAL DELIVERY;WEDGE RESECTION;WORK STRESS","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE PROMYELOCYTIC LEUKEMIA;ANTI-THYROID AUTOANTIBODIES;CAVEOLIN 3;CETUXIMAB;COMET ASSAY;IRINOTECAN;MAMMARY GLAND;METASTATIC BREAST CANCER;METHYLENETETRAHYDROFOLATE REDUCTASE;MICRONUCLEUS;NEONICOTINOID;OSTEOPENIA;OSTEOPROTEGERIN;PROSTATE-SPECIFIC ANTIGEN;RANKL;SCANNING LASER POLARIMETRY;SENTINEL LYMPH NODE;VINORELBINE","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ADULT;MIDDLE AGED;MALE;AGED;ANTIVIRAL AGENTS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ITALY;LEUKOCYTES, MONONUCLEAR;BREAST NEOPLASMS;FLUORENES;ADENOCARCINOMA;AGED, 80 AND OVER;BIOMARKERS, TUMOR;COLORECTAL NEOPLASMS;COMMON BILE DUCT NEOPLASMS;HERPESVIRUS 2, HUMAN;OCCUPATIONAL DISEASES;OVARIAN NEOPLASMS","24;16;13;12;10;9;8;7;7;7;6;6;5;5;5;5;5;5;5;5","CHEMICAL GLYCOBIOLOGY AND THERAPEUTIC APPLICATIONS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND TREATMENT OF LUNG CANCER;EFFECTS OF CAFFEINE ON HUMAN HEALTH;EPIDEMIOLOGY OF MULTIPLE PRIMARY CANCERS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;GLOBAL PREVALENCE AND TREATMENT OF GLAUCOMA;HEALTH EFFECTS OF SOY ISOFLAVONES AND PHYTOESTROGENS;IMPACT OF PESTICIDES ON HONEY BEE HEALTH;LIPID METABOLISM AND STORAGE IN ORGANISMS;MALIGNANT PLEURAL MESOTHELIOMA RESEARCH;MANAGEMENT OF RIB FRACTURES IN TRAUMA PATIENTS;MEDICINAL PLANTS: CHEMICAL CONSTITUENTS AND BIOLOGICAL ACTIVITIES;MORTALITY AND SEQUELAE OF PRETERM BIRTH;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ETIOLOGY;PRETERM INFANTS;ACUTE PROMYELOCYTIC LEUKEMIA;AFFECT (LINGUISTICS);AGLYCONE;ANTI-THYROID AUTOANTIBODIES;ANTIMICROBIAL ACTIVITY;BALAYAGE;BETA THALASSEMIA;BIOREPOSITORY;BONE REMODELING;BREAST CANCER;CAFFEINE;CANCER REGISTRY DATA;CARBOHYDRATE-BASED DRUG DESIGN;CAVEOLIN;CAVEOLIN 3;CHEMOTHERAPY;CHEMOTHERAPY REGIMEN;COFFEE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER PATIENTS;SCANNING LASER;ADVANCED COLORECTAL;ALLERGIC PATHOLOGY;ALLERGIC RHINITIS;ALLERGOMETRIC TESTS;ALTERED INTESTINAL;AMPULLARY CANCER;ANTI-HERPES SIMPLEX;ANTI-INFLAMMATORY EFFECTS;ANTIVIRAL ACTIVITY;BIOCATALYTIC ACCESS;BLADDER ENDOMETRIOSIS;BREAST CANCER;BREATHING LATE;CALABRIA REGION;CALABRIA SOUTHERN;CANCER RELAPSING;CARDIAC TRANSPLANT;CAVEOLIN- EXPRESSION;CHANARINDORFMAN DISEASE;CHANGED PRESENTATION;CLINICAL OUTCOME;COLORECTAL CANCER;COMMERCIAL PRODUCT;CONFOCAL SCANNING;CORONARY INTERVENTION;COSTS EDUCATIONAL;CREST BIOREPOSITORY;DEFERIPRONE TREATMENTS","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER PATIENTS;CREST BIOREPOSITORY;ALLERGIC RHINITIS;BREAST CANCER;COLORECTAL CANCER;MALIGNANT MESOTHELIOMA;PLEURAL MALIGNANT;PULMONARY NODULE;RECURRENTMETASTATIC BREAST;ADVANCED COLORECTAL;AMPLT VERSUS;BIOREPOSITORY INCLUDES;CHEMOTHERAPY-NAÏVE RECURRENTMETASTATIC;CIRCULATING LEVELS;EPIDEMIOLOGIC INFORMATION;LUNG CANCER;MEDIAN TIME;MG CIRCULATING;MG REDUCTION;MG SERUM;MODERATE-SEVERE GRADE;PATIENTS RECEIVED;PLEURAL FLUID;POST-RELAPSE SURVIVAL;POSTMENOPAUSAL WOMEN;RESPIRATORY TRACT;RESPONSE RATE;SERUM LEVELS;SRANKLOPG RATIO;SURVIVAL OS","6;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,5,222.8,8.33,0,0,38.4,0,0,0,0,5,0,0,0,0,5,0,0,0,0,0,0,0,4,0,1,5,0,0,0,0,0,0,0,0,0,"Italy;United States","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3213 PAEDIATRICS;3215 REPRODUCTIVE MEDICINE;39 EDUCATION;3904 SPECIALIST STUDIES IN EDUCATION","5;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;PEDIATRIC;RARE DISEASES;AGING;ATHEROSCLEROSIS;ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD);BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CANCER;CARDIOVASCULAR;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;MENTAL HEALTH;MENTAL ILLNESS;PREVENTION;PROSTATE CANCER;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","5;4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BLOOD;CANCER;CARDIOVASCULAR","1;1;1","6.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","4;1;1","LEUKEMIA / LEUKAEMIA;PROSTATE CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2009,37,9.35135135135135,2.67567567567568,0.702702702702703,0.351351351351351,0.837837837837838,1.2375,1.04,1.3,1.06896551724138,0.189189189189189,0,10,7,9,9,0.27,0.19,0.24,0.24,24.76,0.535197652764879,NA,0.108108108108108,0.648648648648649,0.419,0.337,0.317,0.334,"GIOVANNI TUCCARI;VALERIA BARRESI;SALVATORE LENTINI;MADDALENA GROSSO;FRANCESCA POLITO;ALESSANDRA BITTO;GIUSEPPE GIUFFRÈ;ANTONIO IENI;FRANCESCO SQUADRITO;DOMENICA ALTAVILLA;G BARRESI;R. SCARFÌ;L FAMILIARI;MARIA VISALLI;GIUSEPPE VITA;MARIO BARONE;ALESSANDRA BOSETTI;E JULIANI;SAMIR GIUSEPPE SUKKAR;LETTERIA MINUTOLI","6;6;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","GIOVANNI TUCCARI;VALERIA BARRESI;MADDALENA GROSSO;G BARRESI;IGNAZIO BARBERI;LUCIA MARSEGLIA;ANTONIO IENI;GIUSEPPE GIUFFRÈ;SALVATORE LENTINI;ROSA MA;DOMENICA CLAUDIA RISITANO;ANTONIO DAVID;CESARE DE GREGORIO;GIUSEPPE ANDÒ;OLIMPIA TRIO;EMANUELA RAFFONE;P. RIZZO;VINCENZO DI BENEDETTO;MARIO BARONE;FRANCESCO MONACO","1.36;1.33;0.54;0.51;0.5;0.5;0.49;0.46;0.45;0.4;0.34;0.34;0.33;0.33;0.33;0.33;0.33;0.33;0.31;0.31","GIOVANNI TUCCARI;VALERIA BARRESI;SALVATORE LENTINI;MADDALENA GROSSO;FRANCESCA POLITO;ALESSANDRA BITTO;GIUSEPPE GIUFFRÈ;ANTONIO IENI;FRANCESCO SQUADRITO;DOMENICA ALTAVILLA;G BARRESI;R. SCARFÌ;L FAMILIARI;GIUSEPPE VITA;LETTERIA MINUTOLI;ISABELLA VENZA;DOMENICA CLAUDIA RISITANO;ANTONIO DAVID;FRANCESCO MONACO;LAURA IMBRUGLIA","6;6;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","GIOVANNI TUCCARI;VALERIA BARRESI;MADDALENA GROSSO;G BARRESI;IGNAZIO BARBERI;ANTONIO IENI;GIUSEPPE GIUFFRÈ;SALVATORE LENTINI;DOMENICA CLAUDIA RISITANO;ANTONIO DAVID;CESARE DE GREGORIO;GIUSEPPE ANDÒ;OLIMPIA TRIO;EMANUELA RAFFONE;P. RIZZO;VINCENZO DI BENEDETTO;FRANCESCO MONACO;ISABELLA VENZA;MARIO VENZA;LAURA IMBRUGLIA","1.36;1.33;0.54;0.51;0.5;0.49;0.46;0.45;0.34;0.34;0.33;0.33;0.33;0.33;0.33;0.33;0.31;0.31;0.31;0.27","ALESSANDRA BITTO;DOMENICA ALTAVILLA;FRANCESCA POLITO;FRANCESCO SQUADRITO;HERBERT MARINI;LETTERIA MINUTOLI;GIOVANNI TUCCARI;ALDO FILOSA;ANGELA CIANCIO;ANGELA VITRANO;ANNA MEO;AURELIO MAGGIO;CALOGERA GERARDI;CARMELO FIDONE;CARMELO MAGNANO;CROCETTA ARGENTO;DOMENICO GIUSEPPE D’ASCOLA;FRANCESCA VALERIA COMMENDATORE;FRANCESCO CANTELLA;FRANCESCO GAGLIARDOTTO","193;193;193;193;130;130;99;97;97;97;97;97;97;97;97;97;97;97;97;97","ALESSANDRA BITTO;DOMENICA ALTAVILLA;LETTERIA MINUTOLI;ANNA MEO;EMANUELA RAFFONE;P. RIZZO;VINCENZO DI BENEDETTO;VALERIA BARRESI;FRANCESCA POLITO;FRANCESCO SQUADRITO;ROSARIO D’ANNA;GIUSEPPE VITA;CHIARA COSTA;ROBERTA GRANESE;MARIO VENZA;ALBA MIGLIORATO;ANNA MAZZEO;ANTONINO NARO;GIAN LUCA VITA;M. AGUENNOUZ","130;130;130;97;91;91;91;84;83;83;83;82;80;68;64;63;63;63;63;63","VALERIA BARRESI;G BARRESI;GIOVANNI TUCCARI;ALESSANDRA BITTO;ANTONIO IENI;DOMENICA ALTAVILLA;FRANCESCO MONACO;GIUSEPPE GIUFFRÈ;GIUSEPPE VITA;LETTERIA MINUTOLI;MARIA TERESA VAN LINT;MARIO VENZA;R. SCARFÌ;A VERSACI;A. SPADA;ALBA MIGLIORATO;ALBERTO NOTO;ANGELA DE SIMONE;ANNA MAZZEO;ANNA MEO","6;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;ENGINEERING;COMPUTER SCIENCE;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE","37;12;7;3;2;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;SURGERY;GENETICS;CANCER RESEARCH;ENDOCRINOLOGY;PSYCHIATRY;ANATOMY;BIOCHEMISTRY;CARDIOLOGY;GYNECOLOGY;ONCOLOGY;ENVIRONMENTAL HEALTH;MECHANICAL ENGINEERING;ORGANIC CHEMISTRY;ALGORITHM;ANESTHESIA;ASTROBIOLOGY;BIOTECHNOLOGY;BOTANY;CELL BIOLOGY;EMERGENCY MEDICINE;FAMILY MEDICINE;GASTROENTEROLOGY;GENERAL SURGERY;HUMANITIES;INTENSIVE CARE MEDICINE;LAW;MARKET ECONOMY;MEDICAL EMERGENCY;MOLECULAR BIOLOGY;NEUROSCIENCE;NURSING;OBSTETRICS;OPTICS;PEDIATRICS;PHARMACOLOGY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;PHYSIOLOGY;QUANTUM MECHANICS","21;12;12;8;6;5;5;4;3;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;IMMUNOHISTOCHEMISTRY;GENE;HORMONE;PREGNANCY;ABNORMALITY;CARCINOMA;CARDIAC SURGERY;DYSPHAGIA;ETIOLOGY;LACTOFERRIN;METHYLPREDNISOLONE;POPULATION;PROSPECTIVE COHORT STUDY;RECEPTOR;ABDOMINAL SURGERY;ANEURYSM;ANGIOGENESIS;AORTA;APOPTOSIS;ASCITES;ATRESIA;AXILLARY LINES;BASAL CELL;BASILAR ARTERY;BLOOD PRESSURE;BLUNT;BOLUS (DIGESTION);BONE MARROW;BONE REMODELING;BONE RESORPTION;CALCIFICATION;CARDIAC TAMPONADE;CARDIOPULMONARY BYPASS;CARTILAGE;CELL;CELL GROWTH;CHONDROMA;CHONDROMYXOID FIBROMA;CIRRHOSIS;CLINICAL PREDICTION RULE;CLINICAL TRIAL;CLOSURE (PSYCHOLOGY);COMPLICATION;CREATINE KINASE;DEHISCENCE;DISEASE;DUCHENNE MUSCULAR DYSTROPHY;EMBRYO;EMERGENCY DEPARTMENT;ENDOMETRIUM;ENDOSCOPY;ERUCA;ESTROGEN;FORCEPS;GANGLION;GENETICIST;GENISTEIN;GLYCOSIDE;HEART FAILURE;HEMODYNAMICS;IN VIVO;INCIDENCE (GEOMETRY);INFLAMMATION;INSULIN;INTERCOSTAL SPACE;INTERNAL FIXATION;LAPAROSCOPY;LAYER (ELECTRONICS);LIGATION;LOGISTIC REGRESSION;LUMEN (ANATOMY);LUNG CANCER;MALIGNANCY;MAXILLA;MEDIAN STERNOTOMY;MENINGIOMA;MENOPAUSE;NATURAL HISTORY;NEURAL ACTIVITY;NEUROLOGY;NEUROSURGERY;OBESITY;OBSERVATIONAL STUDY;OPEN SURGERY;OSTEOID;OSTEOPOROSIS;OSTEOSARCOMA;OSTEOSYNTHESIS;OXIDATIVE STRESS;PATHOPHYSIOLOGY;PERICARDIAL EFFUSION;PERIOPERATIVE;PHEOCHROMOCYTOMA;PLASMA;POSTMENOPAUSAL WOMEN;QUALITY OF LIFE (HEALTHCARE);RECEIVER OPERATING CHARACTERISTIC;REFERRAL;REFRACTORY (PLANETARY SCIENCE);RENAL CELL CARCINOMA;SCLEROTHERAPY;SKULL;SOMATOSTATIN;SPINA BIFIDA;STATE (COMPUTER SCIENCE);STERNUM;STROKE (ENGINE);STROMAL CELL;SUBARACHNOID HEMORRHAGE;SULFORAPHANE;SUSPECT;TAMPONADE;THALASSEMIA;THORACOSCOPY;THORACOTOMY;THYROID;TRIAGE;TUBE (CONTAINER);TUMOR NECROSIS FACTOR ALPHA;VAGINA;VEGF RECEPTORS;VIDEO-ASSISTED THORACOSCOPIC SURGERY","8;7;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","METASTASIS;BREAST CANCER;CARCINOGENESIS;FETUS;INSULIN RESISTANCE;A549 CELL;ABDOMINAL AORTIC ANEURYSM;ABORTION;ACTIVATOR (GENETICS);ADENOCARCINOMA;ADHESIVE;ADRENOCORTICOTROPIC HORMONE;AGLYCONE;AMELOBLASTOMA;AORTIC SURGERY;BONE MINERAL;CANCER CELL;CARDIAC OUTPUT;CARDIOMYOPATHY;CD30;CELL CYCLE;CHROMOGRANIN A;CHROMOSOME;DEFERIPRONE;EPIGENETICS;EX VIVO;FIXATION (POPULATION GENETICS);GENE EXPRESSION;GESTATION;HEART RATE;HEPATORENAL SYNDROME;HISTOGENESIS;HUMAN SKULL;IMMUNOSTAINING;INFERTILITY;INTESTINAL METAPLASIA;LAPAROSCOPIC SURGERY;LOCUS (GENETICS);LUTEINIZING HORMONE;METFORMIN;METHYLATION;NATURAL HISTORY STUDY;NEURAL TUBE;NEURORADIOLOGY;OVULATION;PHENETHYL ISOTHIOCYANATE;PNEUMOMEDIASTINUM;PREGNANCY RATE;PROSTATE CANCER;PSEUDOPODIA;SKIN CANCER;SOMATIC CELL;SOMATOSTATIN RECEPTOR;THYROID CARCINOMA;TIBOLONE;TOKAMAK;VAGINAL VAULT;VAGINAL VAULT PROLAPSE;VARICES;VASCULAR ENDOTHELIAL GROWTH FACTOR;VASCULAR RESISTANCE;VASCULAR SURGERY","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADAMANTINOMA;ADIPONECTIN;BALLOONING;CARDIAC INDEX;CELL CYCLE CHECKPOINT;CYANOACRYLATE;DNA METHYLATION;ESTROGEN RECEPTOR;FOLLICLE-STIMULATING HORMONE;GASTRIC VARICES;KARYOTYPE;MEAN ARTERIAL PRESSURE;NEURAL TUBE DEFECT;NEUROENDOCRINE DIFFERENTIATION;NEUROPILIN 1;OSTEOPENIA;OSTEOPROTEGERIN;OVULATION INDUCTION;PLACENTA;POLYCYSTIC OVARY;PRENATAL DIAGNOSIS;SOMATOSTATIN RECEPTOR 2;TERLIPRESSIN;VARIX","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;AGED;MIDDLE AGED;ADULT;SKIN NEOPLASMS;THORACIC INJURIES;;LACTOFERRIN;AGED, 80 AND OVER;CARCINOMA, SQUAMOUS CELL;FRACTURES, BONE;GENISTEIN;IMMUNOHISTOCHEMISTRY;TREATMENT OUTCOME;YOUNG ADULT;ADOLESCENT;ANTIGENS, CD;BETA-THALASSEMIA","26;21;18;17;14;12;10;9;8;7;6;6;6;6;6;6;6;5;5;5","COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DYSPHAGIA AND SWALLOWING DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF SKIN CANCER;CANCER STEM CELLS AND TUMOR METASTASIS;DIAGNOSIS AND MANAGEMENT OF PERICARDIAL DISEASES;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;ESOPHAGEAL INTERVENTION TECHNIQUES;EVOLUTION OF CHILD HEALTH SERVICES IN EUROPE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC AND DEVELOPMENTAL STUDIES OF LIMB MALFORMATIONS;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HEALTH EFFECTS OF SOY ISOFLAVONES AND PHYTOESTROGENS;IMMUNOLOGICAL MECHANISMS IN PREGNANCY AND FETAL-MATERNAL INTERFACE;INFLAMMATION AND OBESITY-RELATED METABOLIC DISORDERS;LIVER CIRRHOSIS AND ASSOCIATED COMPLICATIONS;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT AND PATHOPHYSIOLOGY OF ABDOMINAL AORTIC ANEURYSMS","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DYSPHAGIA;LACTOFERRIN;ABNORMALITY;ETIOLOGY;NUTRITIONAL SUPPORT;OROPHARYNGEAL DYSPHAGIA;ABDOMINAL WALL DEFECTS;ADAMANTINOMA;ADIPOSE TISSUE;AGLYCONE;ANEURYSM RUPTURE;ANEURYSM SCREENING;ANOVULATION;ANTIGEN PRESENTATION;ANTIOXIDANT RESPONSE ELEMENT;AORTIC SURGERY;APICAL BALLOONING SYNDROME;AXILLARY LINES;BALLOONING;BOLUS (DIGESTION)","3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADI NUTRITIONAL;BREAST CANCER;CELL CARCINOMA;CUTANEOUS SQUAMOUS;NUTRITIONAL RECOMMENDATIONS;PROSPECTIVE MULTICENTER;SQUAMOUS CELL;ABDOMINAL AORTIC;ABERRANT METHYLATION;ABNORMAL SKULL;ABNORMALITIES ROLE;ADIPONECTIN RECEPTORS;ADRENAL PHAEOCHROMOCYTOMA;ANEURYS REVIEW;ANTI-PROLIFERATIVE ACTIVITY;AORTIC ANEURYS;APICAL BALLOONING;APPROPRIATENESS GUIDELINES;ARTERY AGENESIA;BALLOONING SYNDROME;BASILAR ARTERY;BONE TISSUE;CANCER BC;CANCER CELLS;CANCER CHEMOPREVENTIVE;CARCINOMA REPORT;CARDIAC DYSFUNCTION;CARDIAC SURGERY;CARDIAC TAMPONADE;CARTILAGE-FORMING NEOPLASMS","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GEN AGLYCONE;LF IMMUNOREACTIVITY;APICAL BALLOONING;LEFT VENTRICULAR;SPONTANEOUS ABORTIONS;TP BOLUS;TRANSIENT LEFT;VENTRICULAR APICAL;ACUTE BRAIN;ARTERIAL PRESSURE;ATRETIC SEGMENTS;BALLOONING SYNDROME;BASAL CELL;BONE LOSS;BONE MINERAL;BRAIN INJURY;CARDIAC DYSFUNCTION;CDCD-L SYSTEM;CONTROL ANIMALS;DECIDUAS OBTAINED;DYNESCM NA;LMINM NA;LOW SVR;MMHG NA;MMOLL NA;PHYSIOLOGICAL PREGNANCIES;POST CPB;PULMONARY PRESSURE;REFRACTORY LOW;SOMATOSTATIN RECEPTOR","4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,3,150,4,2,0.67,37.33,0,0,2,0,1,0,0,0,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","3;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD);BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CANCER;GENETICS;HEMATOLOGY;MENTAL HEALTH;MENTAL ILLNESS;PEDIATRIC;RARE DISEASES","3;2;1;1;1;1;1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","3;1;1","LEUKEMIA / LEUKAEMIA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2010,28,8.32142857142857,2.25,0.607142857142857,0.357142857142857,0.714285714285714,1.08620689655172,0.944444444444444,0.909090909090909,0.952380952380952,0.25,1,7,12,4,4,0.25,0.43,0.14,0.14,29.04,0.642516770806128,NA,0.107142857142857,0.75,0.286,0.172,0.133,0.169,"L FAMILIARI;SALVATORE LENTINI;MARIA CRISTINA GUERRERA;MARIA LE DONNE;E. CIRIACO;F. COLISTRO;VALENTINA AMATO;GIUSEPPE MONTALBANO;GIOVANNI TUCCARI;IRENE IOZZA;JOSÉ A. VEGA;ANTONELLA DIAMANTI;ELSA GIORGIO;ANTONIO IENI;SALVATORE CAMPO;VALERIA BARRESI;FABIO PANETTA;ANTONINO GERMANÀ;ANGELA DINATALE;SALVATORE POLITI","2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BARRESI;SALVATORE LENTINI;VALERIA BARRESI;MARIO VENZA;MARIA LE DONNE;ANGELA DINATALE;CARMELA CARUSO;GIOVANNI TUCCARI;ANTONIO IENI;IRENE IOZZA;ELSA GIORGIO;SALVATORE POLITI;GIOVANNA GAROFALO;VITO BRUSASCO;FABRIZIO TANCREDI;F. COLISTRO;EMANUELE CRIMI;ANTONELLA DIAMANTI;FABIO PANETTA;GIOVANNI BARISIONE","1;0.42;0.37;0.29;0.29;0.29;0.29;0.28;0.28;0.27;0.27;0.27;0.27;0.25;0.25;0.25;0.25;0.25;0.25;0.25","L FAMILIARI;SALVATORE LENTINI;MARIA LE DONNE;GIOVANNI TUCCARI;ELSA GIORGIO;ANTONIO IENI;SALVATORE CAMPO;VALERIA BARRESI;FABIO PANETTA;ANGELA DINATALE;MARIO VENZA;CARMELA CARUSO;S BARTOLONE;MADDALENA GROSSO;MARIA VISALLI;ALESSANDRA BITTO;G SPECIALE;SALVATORE BENVENGA;GIUSEPPE DATTILO;GIANLUCA DI BELLA","2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","BARRESI;SALVATORE LENTINI;VALERIA BARRESI;MARIO VENZA;MARIA LE DONNE;ANGELA DINATALE;CARMELA CARUSO;GIOVANNI TUCCARI;ANTONIO IENI;ELSA GIORGIO;FABIO PANETTA;ANDREA BACIGALUPO;SALVATORE CAMPO;G BARRESI;MADDALENA GROSSO;G SPECIALE;GIUSEPPE DATTILO;GIANLUCA DI BELLA;MARIA CRUPI;SCIPIONE CARERJ","1;0.42;0.37;0.29;0.29;0.29;0.29;0.28;0.28;0.27;0.25;0.25;0.21;0.2;0.17;0.17;0.17;0.17;0.17;0.17","L FAMILIARI;ALBERTO MARIANI;ANTONELLA GIUSSANI;ANTONIO SPADACCINI;CRISTIAN VAILATI;E. MASCI;G LOMBARDI;G. TALAMINI;GIAMPIERO MACARRI;LUCIA PIAZZI;LUIGI GHEZZO;MASSIMILIANO MUTIGNANI;NICOLA GIARDULLO;PIER ALBERTO TESTONI;R BRIGLIA;VALERIA BARRESI;CARMELA CARUSO;MARIA LE DONNE;ALFREDO MANCUSO;G. PIZZIMENTI","277;271;271;271;271;271;271;271;271;271;271;271;271;271;271;85;77;77;70;70","L FAMILIARI;ALFREDO MANCUSO;CARMELA CARUSO;MARIA LE DONNE;FABIO PANETTA;SALVATORE CAMPO;ACHILLE MILETO;ALFREDO BLANDINO;ANTONIO BOTTARI;FABIO MINUTOLI;MICHELE GAETA;ROCCO DONATO;SERGIO RACCHIUSA;SALVATORE BENVENGA;ELSA GIORGIO;VALERIA BARRESI;A. DI PASQUALE;NICOLA SETTINERI;BARRESI;G BARRESI","277;70;70;70;65;62;54;54;54;54;54;54;54;46;45;39;38;38;29;28","FABIO PANETTA;L FAMILIARI;SALVATORE CAMPO;SALVATORE LENTINI;VALERIA BARRESI;A VERSACI;A. DI PASQUALE;ACHILLE MILETO;ALESSANDRA BITTO;ALFREDO BLANDINO;ALFREDO MANCUSO;ANDREA BACIGALUPO;ANGELA DINATALE;ANTONIO BOTTARI;ANTONIO IENI;BARRESI;CARMELA CARUSO;CARMELO SALPIETRO;CHIARA DI BELLA;CONCETTA ZITO","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;MATHEMATICS;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE","23;15;5;4;3;2;1;1","INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;PATHOLOGY;SURGERY;CARDIOLOGY;RADIOLOGY;STATISTICS;ANATOMY;CANCER RESEARCH;CELL BIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;GENERAL SURGERY;GYNECOLOGY;METALLURGY;MOLECULAR BIOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;OBSTETRICS;ONCOLOGY;PALEONTOLOGY;VIROLOGY","17;8;7;7;7;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CANCER;GENE;ENZYME;PREGNANCY;PROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;BIOMARKER;DISEASE;ENDOSCOPY;GENISTEIN;HEPATOLOGY;KIDNEY;RENAL CELL CARCINOMA;ABDOMINAL PAIN;ACCIDENTAL;ACUTE ABDOMEN;ACUTE PANCREATITIS;ANEMIA;AORTIC VALVE;ARTHRITIS;ASTHMA;ATROPHY;ATYPIA;BIOPSY;CARCINOMA;CARTILAGE;CELL;CENTRAL NERVOUS SYSTEM;CEREBELLUM;CHEMOTHERAPY;CHONDROMA;COMPUTED TOMOGRAPHY;CONTRAST (VISION);CONTRAST MEDIUM;DIABETES MELLITUS;DIFFERENTIAL DIAGNOSIS;DIGESTIVE TRACT;DOSIMETRY;ENDOMETRIOSIS;ENDOMETRIUM;ESTROGEN;FOREIGN BODIES;FOREIGN BODY;GALLBLADDER;GASTROINTESTINAL TRACT;GLYCOSIDE;HEMOGLOBIN;HERNIA;HISTOLOGY;HORMONE;HUMAN IMMUNODEFICIENCY VIRUS (HIV);HUMAN PAPILLOMAVIRUS;HYPERPLASIA;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;INGESTION;IODINE;LATERAL VENTRICLES;LESION;LEUKOCYTOSIS;LIPOCALIN;LOGISTIC REGRESSION;LUNG;LYMPHATIC SYSTEM;MAGNETIC RESONANCE IMAGING;MALIGNANCY;MAXILLA;MEDLINE;MEMBRANE;MENOPAUSE;MONTE CARLO METHOD;MULTIVARIATE ANALYSIS;MULTIVARIATE STATISTICS;NODULE (GEOLOGY);OBESITY;OSTEOID;OXIDATIVE PHOSPHORYLATION;OXIDATIVE STRESS;PANCREATITIS;PLETHYSMOGRAPH;PNEUMATOCELE;POPULATION;PROSTHESIS;PUNCHING;RECEIVER OPERATING CHARACTERISTIC;RECEPTOR;RED BLOOD CELL;RHEUMATOID ARTHRITIS;RHEUMATOLOGY;SEX ORGAN;STAGE (STRATIGRAPHY);STEPWISE REGRESSION;THIRD VENTRICLE;THYROID;TRANSPLANTATION;ULTRASOUND;VAGINA;VALUE (MATHEMATICS);VIRUS;VOLUME (THERMODYNAMICS)","5;4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FETUS;METASTASIS;CARCINOGENESIS;CERVICAL CANCER;ZEBRAFISH;AGLYCONE;ALKALINE PHOSPHATASE;AMELOBLASTOMA;ANDROGEN;AUTOCRINE SIGNALLING;BRONCHODILATOR;CAESAREAN SECTION;CAESARIAN SECTION;CELL CYCLE;CLEAR CELL;CLEAR CELL RENAL CELL CARCINOMA;COELIAC DISEASE;COLORECTAL CANCER;CYTOSKELETON;DNA REPAIR;ENDOCHONDRAL OSSIFICATION;ENDOMETRIAL HYPERPLASIA;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;GENOTYPE;GESTATION;GLOBIN;GLUTATHIONE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEMOGLOBIN VARIANTS;HOUNSFIELD SCALE;INFLAMMATORY BOWEL DISEASE;INGUINAL HERNIA;IODINATED CONTRAST;KIDNEY CANCER;LUNG TRANSPLANTATION;LUNG VOLUMES;LUTEINIZING HORMONE;MEAN CORPUSCULAR VOLUME;MEMBRANE PROTEIN;MISCARRIAGE;NEPHRECTOMY;NEUROTROPHIC FACTORS;NEUROTROPHIN;NORETHISTERONE ACETATE;OLFACTORY BULB;OSTEOARTHRITIS;PARACRINE SIGNALLING;PARVOVIRUS;PEDIATRIC GASTROENTEROLOGY;PERFORATION;PLACEBO;PROSTHESIS DESIGN;RESEARCH METHODOLOGY;SALVAGE THERAPY;SHOULDER DYSTOCIA;SPIROMETRY;THYROID CANCER;THYROID CARCINOMA;TISSUE TRANSGLUTAMINASE;TRANSCRIPTION FACTOR;UNIVARIATE;UNIVARIATE ANALYSIS;VAGINAL ATROPHY;VIRAL LOAD;WESTERN BLOT","3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADAMANTINOMA;ADVANCED MATERNAL AGE;ANTIRETROVIRAL THERAPY;BAND 3;BRAIN-DERIVED NEUROTROPHIC FACTOR;BRONCHIOLITIS OBLITERANS;BRONCHODILATION;CALPROTECTIN;CHROMOPHOBE CELL;COLPOSCOPY;FETAL DEATH;FOLLICLE-STIMULATING HORMONE;FUNCTIONAL RESIDUAL CAPACITY;GENOTYPING;GESTATIONAL DIABETES;HPV INFECTION;INGUINAL CANAL;LATERAL LINE;LYMPHATIC VESSEL;MEAN CORPUSCULAR HEMOGLOBIN;MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION;NORETHISTERONE;ONCOGENE;OSTEOCALCIN;PRENATAL DIAGNOSIS;SEX HORMONE-BINDING GLOBULIN;SOX2;SPECTRIN;TROPOMYOSIN RECEPTOR KINASE B;VILLOUS ATROPHY","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MIDDLE AGED;FEMALE;MALE;ADULT;AGED;CARCINOMA, RENAL CELL;KIDNEY NEOPLASMS;BIOMARKERS;BIOMARKERS, TUMOR;GENISTEIN;;AGED, 80 AND OVER;LUNG INJURY;PHYTOESTROGENS;ZEBRAFISH;ALBUTEROL;BRONCHODILATOR AGENTS;COLORECTAL NEOPLASMS;CYSTS","21;15;14;12;10;8;7;7;6;6;6;5;5;5;5;5;4;4;4;4","DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;ETIOLOGY AND MANAGEMENT OF ABDOMINAL WALL DEFECTS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HEALTH EFFECTS OF SOY ISOFLAVONES AND PHYTOESTROGENS;HEALTH RISKS OF MEDICAL IMAGING RADIATION EXPOSURE;HUMAN PAPILLOMAVIRUS AND CERVICAL CANCER EPIDEMIOLOGY;IMPACT OF GESTATIONAL DIABETES MELLITUS ON PREGNANCY;LYMPHANGIOGENESIS IN CANCER METASTASIS AND DISEASE;MANAGEMENT AND OUTCOMES OF ACUTE KIDNEY INJURY;MANAGEMENT OF INGESTED FOREIGN BODIES AND FOOD IMPACTIONS;MANAGEMENT OF RIB FRACTURES IN TRAUMA PATIENTS;MANAGEMENT OF VALVULAR HEART DISEASE;MECHANOSENSITIVE ION CHANNELS IN PHYSIOLOGY AND DISEASE;MICRORNA REGULATION IN CANCER AND DEVELOPMENT;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACCIDENTAL;ACUTE ABDOMEN;ADAMANTINOMA;ADVANCED MATERNAL AGE;ADVERSE PREGNANCY OUTCOMES;AGLYCONE;ANTIRETROVIRAL THERAPY;ATYPIA;BAND 3;BRAIN DEVELOPMENT;BRONCHIOLITIS OBLITERANS SYNDROME;BRONCHODILATION;CAESARIAN SECTION;CARDIOVASCULAR RISK;CELIAC DISEASE;CHONDROMA;CHROMOPHOBE CELL;COMPUTED TOMOGRAPHY;CORTICAL DEVELOPMENT;DIAGNOSIS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CELL CARCINOMA;ACUTE BRONCHODILATOR;ADMINISTERED GENISTEIN;ANION TRANSPORT;ANTITISSUE TRANSGLUTAMINASE;AORTIC VALVE;APICAL OBLITERATION;ATROPHIC EPITHELIUM;BACKGROUND REGIMENS;BIVENTRICULAR APICAL;BOWEL DISEASE;BRAIN-DERIVED NEUROTROPHIC;BRONCHIOLITIS OBLITERANS;BRONCHODILATOR RESPONSIVENESS;CALPROTECTIN ASSAY;CANAL ENDOMETRIOSIS;CARCINOMA REVIEW;CARTILAGE HUMAN;CELIAC DISEASE;CELL TRANSPLANTATION;CELLS COUNT;CGGTA POLYMORPHISM;CLINICAL ACCURACY;CLINICAL FEATURES;COLORECTAL CARCINOMA;CONTRAST MEDIUM;DIAGNOSTIC WORK-UP;DIGESTIVE TRACT;DOSE INCREASE;DSS CGGTA","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLORECTAL CANCER;DSS EXPRESSION;CALPROTECTIN ASSAY;CELL CARCINOMA;CGA POLYMORPHISM;DSS PROTEIN;PROTEIN LEVELS;RENAL TUMORS;ABDOMINAL PAIN;DISEASE PROGRESSION;HOMOLOGOUS RECOMBINATION;NGAL EXPRESSION;QUANTITATIVE REAL-TIME;RECURRENT ABDOMINAL;SQUAMOUS CELL;THYROID METASTASES;VEGF EXPRESSION;ADJACENT NORMAL;AFFECTS DSS;ALTERED BOWEL;ALTERED TRAFFIC;CARCINOMA SCC;CELL RCC;CGA SYNONYMOUS;CGA VARIANT;CGG GENOTYPE;CODING SEQUENCE;DNA REPAIR;DSS CGA;DSS CODING","6;6;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,1.8,193.8,9.09,1,0.2,16,0,0,1,2,0,0,0,2,0,3,2,0,0,0,0,0,0,4,1,0,5,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES;4201 ALLIED HEALTH AND REHABILITATION SCIENCE","5;1;1;1;1;1;1;1","CLINICAL RESEARCH;BRAIN DISORDERS;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEURODEGENERATIVE;NEUROSCIENCES;AGING;AUTOIMMUNE DISEASE;CANCER;CONTRACEPTION/REPRODUCTION;ESTROGEN;HEMATOLOGY;INFANT MORTALITY;LUNG;LYMPHATIC RESEARCH;LYMPHOMA;MULTIPLE SCLEROSIS;NEONATAL RESPIRATORY DISTRESS;ORPHAN DRUG;PARKINSON'S DISEASE;PEDIATRIC","4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL;REPRODUCTIVE HEALTH AND CHILDBIRTH;CANCER","2;2;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","1;1;1;1;1","LEUKEMIA / LEUKAEMIA","1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2011,49,10.9591836734694,2.46938775510204,0.428571428571429,0.346938775510204,0.551020408163265,1.39080459770115,1.23529411764706,1.0625,1.22727272727273,0.448979591836735,1,13,14,8,8,0.27,0.29,0.16,0.16,26.9,0.632382980755792,NA,0.142857142857143,0.795918367346939,0.383,0.336,0.308,0.34,"MICHELE GAETA;ACHILLE MILETO;SAVERIA CAMPISI;GIORGIO ASCENTI;VINCENZO ADAMO;MARCO GATTORNO;GIANLUCA BAGNATO;FRANCESCO ZULIAN;ANTONELLA MELONI;ROMINA GALLIZZI;ALESSIA PEPE;JORDI ANTÓN;ALBERTO MARTINI;ROBERTA CAORSI;G CALCAGNO;ENTELA HYSENI;GIOVANNI TUCCARI;SILVIA FEDERICI;ELSA GIORGIO;FOSCA A F DI PRIMA","5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","ANTONIO LACQUANITI;MICHELE GAETA;ACHILLE MILETO;VINCENZO ADAMO;GIOVANNI TUCCARI;GIANLUCA BAGNATO;ANTONIO IENI;GIORGIO ASCENTI;ENTELA HYSENI;ELSA GIORGIO;FOSCA A F DI PRIMA;ROBERTA DE DOMENICO;SANTO MONTE;MARIANNA FARACI;ORIANA VALENTI;MARCO MIRODDI;FABRIZIO CALAPAI;GIOACCHINO CALAPAI;NICOLA SETTINERI;PIETRO DEL MEDICO","1;0.95;0.95;0.56;0.55;0.51;0.45;0.45;0.39;0.39;0.39;0.39;0.39;0.39;0.39;0.33;0.33;0.33;0.31;0.29","MICHELE GAETA;ACHILLE MILETO;GIORGIO ASCENTI;VINCENZO ADAMO;GIANLUCA BAGNATO;ROMINA GALLIZZI;G CALCAGNO;GIOVANNI TUCCARI;ROBERTA DE DOMENICO;NICOLA SETTINERI;MARIANNA FARACI;BASILIA PIRAINO;A. CARUSO;GIUSEPPE VIENI;FRANCESCA CUCINOTTA;MONICA CURRÒ;RICCARDO IENTILE;L.G. DE FILIPPIS;L M MURABITO;GIOVANNI EGITTO","5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","ANTONIO LACQUANITI;MICHELE GAETA;ACHILLE MILETO;VINCENZO ADAMO;GIOVANNI TUCCARI;GIANLUCA BAGNATO;ANTONIO IENI;GIORGIO ASCENTI;ROBERTA DE DOMENICO;MARIANNA FARACI;FABRIZIO CALAPAI;GIOACCHINO CALAPAI;NICOLA SETTINERI;GIOVANNI EGITTO;MARIA BOTTARI;MARIO NARDI;L.G. DE FILIPPIS;A. CALIRI;SILVIO MAZZIOTTI;CLAUDIO GUARNERI","1;0.95;0.95;0.56;0.55;0.51;0.45;0.45;0.39;0.39;0.33;0.33;0.31;0.29;0.29;0.29;0.27;0.27;0.25;0.25","ACHILLE MILETO;MICHELE GAETA;GIORGIO ASCENTI;NICOLA SETTINERI;CARMELO RODOLICO;ANTONIO BOTTARI;FABIO MINUTOLI;A. NASCIMENTO;ANDERS OLDFORS;ANDONI URTIZBEREA;ANGELA ABICHT;ANGELA HÜBNER;ARIANA KARIMINEJAD;BEATE SCHLOTTER;BENEDIKT SCHOSER;BITA BOZORGMEHR;C. JIMÉNEZ-MALLEBRERA;CHRISTOPHER LINDBERGH;DAVID BEESON;HANNS LOCHMÜLLER","333;333;323;251;246;192;166;161;161;161;161;161;161;161;161;161;161;161;161;161","MICHELE GAETA;ACHILLE MILETO;GIORGIO ASCENTI;ANTONIO BOTTARI;FABIO MINUTOLI;NICOLA SETTINERI;CARMELO RODOLICO;DANIELE BRUSCHETTA;GIAN LUCA VITA;GIUSEPPE VITA;SERGIO LUCIO VINCI;SERGIO RACCHIUSA;SONIA MESSINA;G CALCAGNO;EMANUELA RAFFONE;PIERO RIZZO;GIUSEPPE VIENI;CLAUDIO GIARDINA;FABRIZIO ZIMBARO;SILVIO MAZZIOTTI","333;248;238;192;166;166;161;120;120;120;120;120;120;105;93;93;76;72;72;72","MICHELE GAETA;ACHILLE MILETO;GIANLUCA BAGNATO;BASILIA PIRAINO;GIORGIO ASCENTI;G CALCAGNO;VINCENZO ADAMO;A. CARUSO;ALEJANDRA BECCARIA;ANTONIO BOTTARI;ANTONIO IENI;CALOGERO FOTI;FABIO MINUTOLI;FAUSTO FAMÀ;FRANCESCA CUCINOTTA;GIOVANNI EGITTO;GIOVANNI TUCCARI;GIUSEPPE VIENI;L M MURABITO;MARIA BOTTARI","5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;MATHEMATICS;CHEMISTRY;ENGINEERING;MATERIALS SCIENCE;COMPUTER SCIENCE;ECONOMICS;PSYCHOLOGY","46;19;8;6;4;3;2;1;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;ENVIRONMENTAL HEALTH;ANATOMY;PEDIATRICS;RADIOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;NUCLEAR MEDICINE;ONCOLOGY;STATISTICS;SURGERY;CARDIOLOGY;IMMUNOLOGY;NURSING;OPTICS;PHYSICAL THERAPY","34;11;9;8;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4","DISEASE;POPULATION;CANCER;GENE;MAGNETIC RESONANCE IMAGING;PREGNANCY;QUALITY OF LIFE (HEALTHCARE);RHEUMATOLOGY;ALTERNATIVE MEDICINE;ENZYME;INCIDENCE (GEOMETRY);OBSERVATIONAL STUDY;POWER (PHYSICS);RANDOMIZED CONTROLLED TRIAL;REGIMEN;REPRODUCIBILITY;RHEUMATOID ARTHRITIS;APOPTOSIS;CHEMOTHERAPY;DIABETES MELLITUS;ELECTROMYOGRAPHY;HEART FAILURE;IMMUNOHISTOCHEMISTRY;INFLAMMATION;INSULIN;LUNG CANCER;MITOCHONDRION;MULTIVARIATE ANALYSIS;POISON CONTROL;POLYTRAUMA;RETROSPECTIVE COHORT STUDY;THALASSEMIA","8;8;7;5;5;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ALKALINE PHOSPHATASE;FAMILIAL MEDITERRANEAN FEVER;FETUS;RELIABILITY (SEMICONDUCTOR);BREAST CANCER;CHROMOSOME;COLORECTAL CANCER;EJECTION FRACTION;GESTATION;GLYCEMIC;INJURY PREVENTION;LIFE EXPECTANCY;MUTATION;PLACEBO;TYPE 2 DIABETES;UNIVARIATE ANALYSIS;ADJUVANT THERAPY;AMPHETAMINE;ARGININE;ARTERIAL STIFFNESS;AURA;AUTOANTIBODY;AUTOIMMUNE DISEASE;BIOENERGETICS;BLAND–ALTMAN PLOT;BONE MINERAL;BRONCHODILATOR;CALCIFIC TENDINITIS;CARDIAC FUNCTION CURVE;CARDIAC MAGNETIC RESONANCE;CD34;CISPLATIN;CLINICAL ENDPOINT;DIALLYL DISULFIDE;DIALLYL TRISULFIDE;EPIDERMAL GROWTH FACTOR RECEPTOR;EXCIMER LASER;FAT DISTRIBUTION;FATTY LIVER;FLIP ANGLE;GAIT ANALYSIS;GEE;GEMCITABINE;GENOTYPE;GROUND REACTION FORCE;HAEMATOPOIESIS;HEAD AND NECK CANCER;HISTOGENESIS;HYPOGLYCEMIA;IMAGE QUALITY;IN VITRO FERTILISATION;INFERTILITY;INFLAMMASOME;INTRAEPITHELIAL LYMPHOCYTE;LASER ABLATION;LUPUS ERYTHEMATOSUS;LUPUS NEPHRITIS;MDM2;METASTASIS;MIXED CONNECTIVE TISSUE DISEASE;MUCOSITIS;MUSCLE BIOPSY;MYOCARDIAL FIBROSIS;NEUROBLASTOMA;NEURORADIOLOGY;NORMAL POPULATION;OOCYTE;OSTEOARTHRITIS;PEPTIC;PHENOTYPE;PREGNANCY RATE;PROFILOMETER;PROGENITOR CELL;PROGRAMMED CELL DEATH;PROPYL GALLATE;PSAMMOMA BODY;PULSE PRESSURE;PULSE WAVE VELOCITY;RESTLESS LEGS SYNDROME;ROTENONE;RUGOSITY;SPIROMETRY;SYSTEMIC DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS;TENDONITIS;THERAPEUTIC APPROACH;TOOTH DISEASE;UPPER GASTROINTESTINAL BLEEDING;VASTUS MEDIALIS;WILCOXON SIGNED-RANK TEST","3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INJURY SEVERITY SCORE;KARYOTYPE;OXALIPLATIN;PRENATAL DIAGNOSIS;AGMATINE;ANTI-DSDNA ANTIBODIES;ANTI-NUCLEAR ANTIBODY;BRONCHODILATATION;BRONCHODILATION;CARBOPLATIN;CD117;COMPARATIVE GENOMIC HYBRIDIZATION;CONNECTIVE TISSUE DISEASE;DIABETES MANAGEMENT;DOUBLE BLIND;DUAL ENERGY;ELEVATED ALKALINE PHOSPHATASE;EMBRYO QUALITY;ERLOTINIB;FETAL GROWTH;FOLLICULAR FLUID;GENE MUTATION;GESTATIONAL DIABETES;GROWTH RESTRICTION;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;HORMONAL THERAPY;IIF;INTRAUTERINE GROWTH RESTRICTION;MIGRAINE WITH AURA;ORAL HYPOGLYCEMIC AGENTS;OSTEOCALCIN;PENETRANCE;PYRIN DOMAIN;SH-SY5Y;STEREOTYPY;STROKE VOLUME;TRIPLE-NEGATIVE BREAST CANCER","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ADULT;;MIDDLE AGED;AGED;ITALY;MAGNETIC RESONANCE IMAGING;ADOLESCENT;MUSCLE, SKELETAL;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ARTHRITIS, RHEUMATOID;BREAST NEOPLASMS;LUNG NEOPLASMS;ADIPOSE TISSUE;ANTIRHEUMATIC AGENTS;CHILD;RETROSPECTIVE STUDIES;YOUNG ADULT","32;27;24;20;17;17;15;9;9;8;8;7;7;7;7;6;6;6;6;6","MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;ADVANCEMENTS IN LUNG CANCER RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;BIOLOGICAL PROPERTIES OF GARLIC AND ITS COMPOUNDS;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;CANCER STEM CELLS AND TUMOR METASTASIS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF FIBROMYALGIA SYNDROME;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;DUAL-ENERGY COMPUTED TOMOGRAPHY;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIDEMIOLOGY AND MANAGEMENT OF RESTLESS LEGS SYNDROME","4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REGIMEN;CONTINUOUS GLUCOSE MONITORING;DIABETES;FETAL DNA ANALYSIS;FOLFOX;GERIATRIC TRAUMA;MAGNETIC RESONANCE IMAGING;METASTATIC COLORECTAL CANCER;POLYTRAUMA;PRENATAL DIAGNOSIS;UNIVARIATE ANALYSIS;;ADAPTIVE IMMUNE SYSTEM;ADENITIS;ADJUVANT THERAPY;ADVERSE DRUG EVENTS;ADVERSE DRUG REACTIONS;AGMATINE;AMNIOCENTESIS;ANKYLOSING SPONDYLITIS","3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","ALKALINE PHOSPHATASE;CANCER TREATED;COLORECTAL CANCER;DISEASE DISTRIBUTION;FAT FRACTION;FEASIBILITY REPRODUCIBILITY;FOLFOX REGIMEN;GERIATRIC PATIENTS;IRON EVALUATION;LUNG CANCER;LUPUS ERYTHEMATOSUS;METASTATIC COLORECTAL;MONOINSTITUTIONAL RETROSPECTIVE;MUSCLE FAT;OOCYTE QUALITY;PHOSPHATASE LEVELS;PROGNOSTIC FACTOR;RETROSPECTIVE STUDY;SYSTEMIC LUPUS;THALASSEMIA MAJOR;ACCESSIBLE TOOL;ACTIVATION PATTERNS;ACUTE BRACHIAL;ADVANCED NSCLC;ALLERGIC RHINITIS;ANKYLOSING SPONDYLITIS;ANTI-NUCLEOSOME ANTIBODIES;ARCHITECTURALLY NORMAL;ARRAY COMPARATIVE;ARTERIES FEASIBILITY","2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","INTRAEPITHELIAL LYMPHOCYTES;IRON BURDEN;ANTI-NUCLEOSOME ANTIBODIES;COMBINED DESE;DESE DUAL-PHASE;DUAL-PHASE PROTOCOL;SIGNIFICANT DIFFERENCE;STRUCTURAL MUTATIONS;COELIAC DISEASE;GLOBAL HEART;LIVER IRON;PERIODIC FEVER;RHEUMATOID ARTHRITIS;DOSE REDUCTION;FEVER EPISODES;LYMPHOCYTES COUNTS;MID-VENTRICULAR SEPTUM;MSV RANGE;RANGE MSV;RENAL INVOLVEMENT;SE TRIPLE-PHASE;TNFRSFA STRUCTURAL;TRIPLE-PHASE PROTOCOL;ANTI-DSDNA ANTIBODIES;ARTERIAL STIFFNESS;AUTOSOMAL RECESSIVE;CAROTID STRAIN;DIAGNOSTIC RELIABILITY;DISEASE ACTIVITY;ENTEROPATHY COELIAC","8;8;7;6;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,4.17,159.5,7.32,0,0,29,0,0,2,0,0,0,1,3,0,4,2,0,0,0,0,0,0,5,1,0,6,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE;4203 HEALTH SERVICES AND SYSTEMS","5;3;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AGING;BEHAVIORAL AND SOCIAL SCIENCE;CANCER;HEMATOLOGY;ORPHAN DRUG;PEDIATRIC;RARE DISEASES;ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD);BRAIN DISORDERS;CHILDHOOD LEUKEMIA;COMPLEMENTARY AND INTEGRATIVE HEALTH;DIABETES;DIETARY SUPPLEMENTS;ESTROGEN;HEALTH SERVICES;LYMPHATIC RESEARCH;LYMPHOMA;MENTAL HEALTH","6;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","SKIN","1","6.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES;7.1 INDIVIDUAL CARE NEEDS","4;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2012,36,11.8333333333333,2.86111111111111,0.555555555555556,0.416666666666667,0.638888888888889,1.30379746835443,1.17647058823529,1.15384615384615,1.15,0.277777777777778,0,15,8,5,6,0.42,0.22,0.14,0.17,191.78,4.59146333159006,4.78472222222222,0.194444444444444,0.722222222222222,0.418,0.285,0.258,0.283,"MARIA VISALLI;ISABELLA VENZA;DIANA TETI;GIOVANNI TUCCARI;SILVIO MAZZIOTTI;GIORGIO ASCENTI;VINCENZO ADAMO;MICHELE GAETA;ACHILLE MILETO;MARIO VENZA;BÁRBARA ADAMO;GIUSEPPE MILETO;GIUSEPPE VITA;ROSARIA OTERI;VALENTINA LEONARDI;CONCETTA ELISABETTA DI BARTOLO;BENEDETTO MAURIZIO CELESIA;ANTONIO IENI;ADELE POSTORINO;ELVIRA PUNTORIERI","4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MARIA VISALLI;ISABELLA VENZA;DIANA TETI;MARIO VENZA;EMANUELA RAFFONE;ROSALBINO ISABELLA;SILVIO MAZZIOTTI;GIORGIO ASCENTI;MICHELE GAETA;ACHILLE MILETO;ROSARIA OTERI;MARIA CUCINOTTA;GIOVANNI TUCCARI;GIUSEPPE MILETO;VALENTINA LEONARDI;CONCETTA ELISABETTA DI BARTOLO;ANTONIO IENI;ADELE POSTORINO;ELVIRA PUNTORIERI;DOMENICO ZAGARI","0.8;0.8;0.8;0.6;0.5;0.5;0.49;0.49;0.49;0.49;0.4;0.4;0.35;0.33;0.33;0.33;0.33;0.33;0.33;0.33","MARIA VISALLI;ISABELLA VENZA;DIANA TETI;GIOVANNI TUCCARI;SILVIO MAZZIOTTI;GIORGIO ASCENTI;VINCENZO ADAMO;MICHELE GAETA;ACHILLE MILETO;MARIO VENZA;BÁRBARA ADAMO;GIUSEPPE MILETO;GIUSEPPE VITA;ROSARIA OTERI;VALENTINA LEONARDI;CONCETTA ELISABETTA DI BARTOLO;ANTONIO IENI;ADELE POSTORINO;ELVIRA PUNTORIERI;ANNA MAZZEO","4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MARIA VISALLI;ISABELLA VENZA;DIANA TETI;MARIO VENZA;EMANUELA RAFFONE;SILVIO MAZZIOTTI;GIORGIO ASCENTI;MICHELE GAETA;ACHILLE MILETO;ROSARIA OTERI;MARIA CUCINOTTA;GIOVANNI TUCCARI;GIUSEPPE MILETO;VALENTINA LEONARDI;CONCETTA ELISABETTA DI BARTOLO;ANTONIO IENI;ADELE POSTORINO;ELVIRA PUNTORIERI;DOMENICO ZAGARI;GIUSEPPE VITA","0.8;0.8;0.8;0.6;0.5;0.49;0.49;0.49;0.49;0.4;0.4;0.35;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.27","A. VERGNENÈGRE;ALESSANDRA BEARZ;ALFONSO ILLIANO;AMELIA INSA;ANA DROZDOWSKYJ;BARTOMEU MASSUTÍ;CHRISTIAN ROLFO;CINTA PALLARÉS;CRISTINA QUERALT;DELVYS RODRÍGUEZ‐ABREU;DOLORES ISLA;ENRIC CARCERENY;ENRICO CORTESI;ENRIQUETA FELIP;FILIPPO DE MARINIS;FLAVIA LONGO;G. ROBINET;GIUSEPPE ALTAVILLA;GUILLERMO LÓPEZ-VIVANCO;ISABEL BOVER","5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176;5176","GIUSEPPE ALTAVILLA;CATERINA MUSOLINO;ALDO SPADARO;M. FRENI;ISABELLA VENZA;ANTONIO CASCIO;GIOVANNI TUCCARI;AGATA VITALE;G CALCAGNO;EMANUELA RAFFONE;ACHILLE MILETO;GIORGIO ASCENTI;MICHELE GAETA;SILVIO MAZZIOTTI;F. CAVAGNETTO;FRANCESCO MONETTI;GIUSEPPE RESCINITO;MASSIMO CALABRESE;R. ROSASCO;DIANA TETI","5176;719;231;231;103;75;72;68;68;65;63;63;63;63;55;55;55;55;55;47","ISABELLA VENZA;ACHILLE MILETO;GIORGIO ASCENTI;MICHELE GAETA;SILVIO MAZZIOTTI;VINCENZO ADAMO;BÁRBARA ADAMO;DIANA TETI;GIOVANNI TUCCARI;GIUSEPPE VITA;GIUSEPPINA ROSARIA RITA RICCIARDI;MARIA VISALLI;MARIO VENZA;AGATA VITALE;ALDO SPADARO;ALFIO PROIETTO;ALFONSA PIZZO;AM BONANNO;ANNA MAZZEO;ANTONIO CASCIO","4;3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;MATERIALS SCIENCE;PSYCHOLOGY;MATHEMATICS;SOCIOLOGY","36;11;4;3;2;2;1;1","INTERNAL MEDICINE;PATHOLOGY;ENDOCRINOLOGY;GENETICS;IMMUNOLOGY;SURGERY;BIOCHEMISTRY;DERMATOLOGY;GASTROENTEROLOGY;ONCOLOGY;OPHTHALMOLOGY;PHYSIOLOGY;RADIOLOGY;INTENSIVE CARE MEDICINE;OPTICS;PSYCHIATRY;ANATOMY;ENVIRONMENTAL HEALTH;NEUROSCIENCE;PEDIATRICS","29;14;9;6;6;6;5;4;4;4;4;4;4;3;3;3;2;2;2;2","DISEASE;CANCER;GENE;CHEMOTHERAPY;MACULAR DEGENERATION;OXIDATIVE STRESS;ADVERSE EFFECT;RECEPTOR;VIRUS;ADJUVANT;AGEING;ALTERNATIVE MEDICINE;ANTIBODY;ANTIOXIDANT;CLINICAL TRIAL;DACRYOCYSTITIS;DIFFERENTIAL DIAGNOSIS;DNA;HUMAN IMMUNODEFICIENCY VIRUS (HIV);INCIDENCE (GEOMETRY);OBSERVATIONAL STUDY;POPULATION;REGIMEN","9;6;6;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BREAST CANCER;CATALASE;MALONDIALDEHYDE;SUPEROXIDE DISMUTASE;MUTATION;DACRYOADENITIS;DNA DAMAGE;DOCETAXEL;EPSTEIN–BARR VIRUS;MONONUCLEOSIS;PHENOTYPE;SEROLOGY;VIRAL LOAD;ADENOCARCINOMA;AMELOBLASTOMA;BIG FIVE PERSONALITY TRAITS;CHEMOKINE;CISPLATIN;CLINICAL ENDPOINT;DIGITAL ENHANCED CORDLESS TELECOMMUNICATIONS;EMOTIONAL EXHAUSTION;EPIDERMAL GROWTH FACTOR RECEPTOR;EXON;FAMILIAL MEDITERRANEAN FEVER;FATTY LIVER;FINE-NEEDLE ASPIRATION;GEMCITABINE;GENOTYPE;GERMLINE;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;HEMOTHORAX;HEPATOSPLENOMEGALY;HISTIOCYTOSIS;HOUNSFIELD SCALE;IMAGE QUALITY;INCLUSION BODY MYOSITIS;INFERTILITY;INOSITOL;INSULIN RESISTANCE;MACROPHAGE ACTIVATION SYNDROME;MARAVIROC;MINNESOTA MULTIPHASIC PERSONALITY INVENTORY;MYCOBACTERIUM TUBERCULOSIS;NEURORADIOLOGY;OVULATION;PACLITAXEL;PANCYTOPENIA;PERIPHERAL NEUROPATHY;PINEAL GLAND;PITUITARY ADENOMA;PLACEBO;PSORIATIC ARTHRITIS;RHODOPSIN;SALVAGE THERAPY;SMOOTH MUSCLE TUMOR;SPIROMETRY;THYROID CARCINOMA;THYROID NODULES;TOLERABILITY;TRADITIONAL CHINESE MEDICINE;TROPISM;UTERINE LEIOMYOMA;UTERINE SARCOMA;WESTERN BLOT;WILCOXON SIGNED-RANK TEST;ZEBRAFISH","4;4;4;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GLUTATHIONE PEROXIDASE;ADJUVANT CHEMOTHERAPY;ANTIRETROVIRAL THERAPY;AXILLARY LYMPH NODES;CARBOPLATIN;CHEMOKINE RECEPTOR;ERLOTINIB;GENE MUTATION;GERMLINE MUTATION;HEMOPHAGOCYTOSIS;LATENT TUBERCULOSIS;MAMMOGRAPHY;METASTATIC BREAST CANCER;NONALCOHOLIC FATTY LIVER DISEASE;OCCUPATIONAL BURNOUT;OPSIN;PENETRANCE;PHLEGM;PINEALOCYTE;POLYCYSTIC OVARY;PROBAND;SINGLE-NUCLEOTIDE POLYMORPHISM;TRIPLE-NEGATIVE BREAST CANCER","4;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;;BREAST NEOPLASMS;LUNG NEOPLASMS;AGED, 80 AND OVER;ADOLESCENT;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CARCINOMA, NON-SMALL-CELL LUNG;MACULAR DEGENERATION;TOMOGRAPHY, X-RAY COMPUTED;THYROID NODULE;YOUNG ADULT;AMELOBLASTOMA;CARCINOMA;CATALASE","24;20;17;16;13;12;10;8;8;7;6;6;6;6;6;5;5;4;4;4","AGE-RELATED MACULAR DEGENERATION RESEARCH;ADVANCEMENTS IN LUNG CANCER RESEARCH;BIOCHEMISTRY OF DIABETIC COMPLICATIONS;BREAST CANCER SCREENING TECHNOLOGY;CLASSIFICATION AND MANAGEMENT OF ODONTOGENIC TUMORS;CUTANEOUS ADNEXAL NEOPLASMS AND RELATED SYNDROMES;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;DIAGNOSIS AND TREATMENT OF LUNG CANCER;DUAL-ENERGY COMPUTED TOMOGRAPHY;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;EPIDEMIOLOGY, CLASSIFICATION, AND CLINICAL FEATURES OF INFLAMMATORY MYOPATHIES;GENETIC BASIS OF NEUROPATHIES AND RELATED DISORDERS;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;HER2 SIGNALING IN BREAST CANCER TREATMENT;HERPESVIRUSES: EPIDEMIOLOGY, PATHOGENESIS, AND MANAGEMENT;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME;MAMMALIAN CIRCADIAN RHYTHMS AND PHYSIOLOGY;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MACULAR DEGENERATION;MALONDIALDEHYDE;ANTIRETROVIRAL THERAPY;BREAST CANCER;DACRYOADENITIS;DACRYOCYSTITIS;MONONUCLEOSIS;REGIMEN;ACADEMIC STRESS;ADENOSINE RECEPTORS;ADJUVANT CHEMOTHERAPY;ADRENAL VEIN SAMPLING;AMELOBLASTOMA;AXILLARY LYMPH NODES;BLUNT TRAUMA;BREAST CANCER SCREENING;BREAST DENSITY;BREAST TISSUE COMPOSITION;BREAST TOMOSYNTHESIS;CARBOPLATIN","4;4;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","AGE-RELATED MACULAR;MACULAR DEGENERATION;BREAST CANCER;ALCOHOL CONSUMPTION;ANTIOXIDANTOXIDANT BALANCE;CIGARETTE SMOKING;COMBINED EFFECTS;ELDERLY PATIENTS;MACROMOLECULAR DAMAGE;OXIDATIVE STRESS;ACUTE INFECTIOUS;ADENOSINE RECEPTOR;ADJUVANT CHEMOTHERAPY;ADOLESCENT COEXISTENT;ADULT STAGE;ADVANCED EGFR;AIP GENE;ASPIRATION CYTOLOGY;AUTOMATED SOFTWARE;BACKBONE REGIMENS;BIOLOGIC THERAPY;BIOLOGICAL CHARACTERIZATION;BODY MYOSITIS;BREAST TOMOSYNTHESIS;CANCER EURTAC;CANCER EXPERIENCE;CANCER PATIENTS;CARDIOVASCULAR EVENTS;CAUCASIAN POPULATION;CCR TROPISM","4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EPSTEINBARR VIRUS;ADJUVANT CHEMOTHERAPY;ACUTE DACRYOADENITIS;INFECTIOUS MONONUCLEOSIS;INSULIN RESISTANCE;TRIPLE NEGATIVE;ADVERSE EVENTS;BREAST CANCER;POLYCYTHEMIA VERA;ROUTINE CLINICAL;BEGINNING SYMPTOMS;CD T-CELL;CORTICOSTEROID THERAPY;ENZYME PLASMA;FAST FOODS;FOOD ADDITIVES;HAZARD RATIO;HEMATOCRIT TARGET;INITIALLY MONOLATERAL;INTENSIVE TREATMENT;LACRIMAL GLAND;LEUKEMIC TRANSFORMATION;LIVER ENZYME;LIVER ENZYMES;LIVER HISTOLOGY;MEDIAN FOLLOW-UP;MILLION PEOPLE;MYELOFIBROSIS MYELODYSPLASIA;NAFLD PATIENTS;PHOSPHORUS SERUM","6;5;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,4.18,136.45,14.86,2,0.18,30.36,0,0,4,0,1,0,2,4,0,8,3,0,0,0,0,0,0,9,1,1,11,0,0,0,0,0,0,0,0,0,"United States;Italy","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3203 DENTISTRY;3215 REPRODUCTIVE MEDICINE;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","11;4;3;3;2;1;1;1;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;ORPHAN DRUG;PEDIATRIC;BRAIN DISORDERS;LYMPHATIC RESEARCH;LYMPHOMA;NEUROSCIENCES;PEDIATRIC CANCER;BEHAVIORAL AND SOCIAL SCIENCE;CHILDHOOD LEUKEMIA;CYSTIC FIBROSIS;DIGESTIVE DISEASES;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;EPILEPSY;HEALTH DISPARITIES;LUNG","10;8;7;7;5;4;4;2;2;2;2;2;1;1;1;1;1;1;1;1","CANCER;GENERIC HEALTH RELEVANCE;MENTAL HEALTH","2;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","7;2;2;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;MYELOMA;PANCREATIC CANCER","3;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","5",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2013,47,12.4893617021277,2.97872340425532,0.340425531914894,0.382978723404255,0.468085106382979,1.27027027027027,1,1.2,1.1,0.404255319148936,0,23,7,13,2,0.49,0.15,0.28,0.04,28.32,0.811609842595095,6.31937172774869,0.25531914893617,0.893617021276596,0.373,0.222,0.28,0.211,"GIANLUCA BAGNATO;SALVATORE BENVENGA;CARLO SAITTA;GIUSEPPE GIUFFRÈ;R. LO GULLO;CATERINA MUSOLINO;ANTONINO SAITTA;GIOACCHINO CALAPAI;SEBASTIANO GANGEMI;ALBERTO LO GULLO;GIUSEPPE MANDRAFFINO;M. PROTO;ELENA COLLOVÀ;ROBERTA FEDELE;EVARISTO BELLI;LUIGINO ANTONIO GIANCOTTI;ELISABETTA CHIODI;OLGA MARTELLI;PATRIZIA ALVISI;ROSALBA ROSSELLO","5;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","SALVATORE BENVENGA;ROBERTO VITA;MARIO BARONE;FRANCESCO MONACO;GIANLUCA BAGNATO;GIUSEPPE GIUFFRÈ;GIOACCHINO CALAPAI;CESARE DE GREGORIO;SEBASTIANO GANGEMI;EVARISTO BELLI;E. MICI;FRANCESCO SAVERIO DE PONTE;GIOVANNI TUCCARI;VALERIA BARRESI;MARCO MIRODDI;FERDINANDO MANCARI;CATERINA MUSOLINO;CARLO SAITTA;R. LO GULLO;ANTONINO SAITTA","0.91;0.75;0.5;0.5;0.49;0.44;0.44;0.42;0.36;0.34;0.34;0.34;0.33;0.33;0.31;0.31;0.31;0.27;0.27;0.27","GIANLUCA BAGNATO;SALVATORE BENVENGA;CARLO SAITTA;GIUSEPPE GIUFFRÈ;R. LO GULLO;CATERINA MUSOLINO;ANTONINO SAITTA;GIOACCHINO CALAPAI;SEBASTIANO GANGEMI;ALBERTO LO GULLO;GIUSEPPE MANDRAFFINO;EVARISTO BELLI;ROSALBA ROSSELLO;M.A. SARDO;GUIDO FERLAZZO;F. MAMONE;CLAUDIO ROMANO;MAURIZIO CINQUEGRANI;R. MANDRAFFINO;IRENE BONACCORSI","5;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","SALVATORE BENVENGA;MARIO BARONE;FRANCESCO MONACO;GIANLUCA BAGNATO;GIUSEPPE GIUFFRÈ;GIOACCHINO CALAPAI;CESARE DE GREGORIO;SEBASTIANO GANGEMI;EVARISTO BELLI;E. MICI;FRANCESCO SAVERIO DE PONTE;GIOVANNI TUCCARI;VALERIA BARRESI;CATERINA MUSOLINO;CARLO SAITTA;R. LO GULLO;ANTONINO SAITTA;ALBERTO LO GULLO;GIUSEPPE MANDRAFFINO;AMIEL WARM","0.91;0.5;0.5;0.49;0.44;0.44;0.42;0.36;0.34;0.34;0.34;0.33;0.33;0.31;0.27;0.27;0.27;0.27;0.27;0.25","A. REGHAN FOLEY;AKANCHHA KESARI;ALEXANDER HOISCHEN;CARLA GROSMANN;CAROLINE A. SEWRY;CARSTEN G. BÖNNEMANN;DANIEL G. MACARTHUR;DEREK L. STEMPLE;DIRK LEFEBER;ELIZABETH STEVENS;ELIZABETH WRAIGE;ENRICO BERTINI;ERIC P. HOFFMAN;FRANCESCO MUNTONI;HANS VAN BOKHOVEN;HELEN YOUNG;JAYA PUNETHA;JOSÉ E. ABDENUR;KATHRYN N. NORTH;KEREN CARSS","212;212;212;212;212;212;212;212;212;212;212;212;212;212;212;212;212;212;212;212","SONIA MESSINA;CATERINA MUSOLINO;ACHILLE MILETO;ALFREDO BLANDINO;EMANUELE SCRIBANO;GIORGIO ASCENTI;MICHELE GAETA;NICOLA SETTINERI;SILVIO MAZZIOTTI;SALVATORE BENVENGA;DOMENICO CUCINOTTA;ANDREA BACIGALUPO;CESARE DE GREGORIO;FRANCESCO SAPORITO;GAETANO MORABITO;GIUSEPPE ANDÒ;GIUSEPPE ORETO;OLIMPIA TRIO;ADRIANA ARENA;BASILIA PIRAINO","212;132;125;125;125;125;125;125;125;124;101;95;84;80;80;80;80;80;61;56","GIUSEPPE GIUFFRÈ;SALVATORE BENVENGA;ANGELA DE SIMONE;CATERINA MUSOLINO;CESARE DE GREGORIO;E. MICI;FRANCESCO SAVERIO DE PONTE;GIOACCHINO CALAPAI;GIOVANNI TUCCARI;GREGORIO COSTA;GUIDO FERLAZZO;IRENE BONACCORSI;ROSALBA ROSSELLO;SEBASTIANO GANGEMI;VALERIA BARRESI;ACHILLE MILETO;ACHILLE P. CAPUTI;ADRIANA ARENA;ALESSANDRO CALVO;ALESSANDRO SINDONI","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;MATHEMATICS;PSYCHOLOGY;SOCIOLOGY;BUSINESS;GEOGRAPHY","45;23;3;2;2;2;2;1;1","INTERNAL MEDICINE;IMMUNOLOGY;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;SURGERY;ENDOCRINOLOGY;GENETICS;PATHOLOGY;CELL BIOLOGY;ONCOLOGY;BIOCHEMISTRY;ANATOMY;PALEONTOLOGY;RADIOLOGY;CARDIOLOGY;FAMILY MEDICINE;GYNECOLOGY;BOTANY;DENTISTRY;DERMATOLOGY;EMERGENCY MEDICINE;INTENSIVE CARE MEDICINE;PHARMACOLOGY;PHYSICAL THERAPY;PSYCHIATRY","36;15;9;8;8;7;7;7;6;6;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2","DISEASE;POPULATION;CHEMOTHERAPY;ADVERSE EFFECT;CANCER;ANTIBODY;BIOPSY;DIABETES MELLITUS;GENE;IMMUNE SYSTEM;RECEPTOR;RETROSPECTIVE COHORT STUDY;STAGE (STRATIGRAPHY);STEM CELL;THYROID;ASYMPTOMATIC;BACTERIA;BLOOD PRESSURE;COMPLICATION;CYTOKINE;ENDOTHELIAL DYSFUNCTION;FIBRINOGEN;HEART FAILURE;HYALURONIC ACID;IMMUNOHISTOCHEMISTRY;LEUKEMIA;MYELOID LEUKEMIA;MYOCARDIAL INFARCTION;OBSERVATIONAL STUDY;PATHOLOGICAL;PROSPECTIVE COHORT STUDY;RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;RASH;REGIMEN;RHEUMATOID ARTHRITIS;RHEUMATOLOGY","7;6;5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COELIAC DISEASE;PROGENITOR CELL;BREAST CANCER;CD34;IMATINIB;MUTATION;SEROLOGY;AIR POLLUTANTS;ALPHA INTERFERON;ANAPLASTIC CARCINOMA;ANTIPHOSPHOLIPID SYNDROME;ARTERIAL STIFFNESS;ASCOSPORE;ASTHMA EXACERBATIONS;AUTOANTIBODY;AUTOIMMUNE DISEASE;CARDIAC FIBROSIS;CATALASE;CD8;CERVICAL CANCER;CHRONIC LIVER DISEASE;CHRONIC LYMPHOCYTIC LEUKEMIA;CHRONIC MYELOGENOUS LEUKEMIA;CLINICAL ENDPOINT;CYCLOPHOSPHAMIDE;DUODENAL BULB;ECHOGENICITY;EJECTION FRACTION;EPIDERMAL GROWTH FACTOR RECEPTOR;ESSENTIAL THROMBOCYTHEMIA;FETUS;FINE NEEDLE ASPIRATION CYTOLOGY;GENE DUPLICATION;GENETIC PREDISPOSITION;GLYCEMIC;GOITER;GRAVES' DISEASE;HAZARD RATIO;HEAD AND NECK CANCER;HEART RATE;HEPATITIS B VIRUS;HEPATITIS C VIRUS;HEPATOCYTE GROWTH FACTOR;HYDROXYCARBAMIDE;IMMUNOSTAINING;INNATE IMMUNE SYSTEM;INTERLEUKIN;INTERNALIZATION;LEVOTHYROXINE;MARINE BACTERIOPHAGE;MELPHALAN;MUCOSITIS;MULTICENTER STUDY;MYOCARDIAL FIBROSIS;NEPHROPATHY;NEURORADIOLOGY;ORTHOSTATIC VITAL SIGNS;PANTOPRAZOLE;PERCUTANEOUS CORONARY INTERVENTION;PI3K/AKT/MTOR PATHWAY;POSTPRANDIAL;PROTEIN KINASE B;PULSE WAVE VELOCITY;RITUXIMAB;SALVAGE THERAPY;SEROMA;STAPHYLOCOCCUS AUREUS;STAT3;SUPEROXIDE DISMUTASE;SYNOVITIS;T CELL;THYROID CANCER;THYROID CARCINOMA;THYROID DISEASE;THYROID NODULES;THYROIDITIS;TOLERABILITY;TYPE 2 DIABETES;TYROSINE KINASE;VIRAL LOAD;VITAMIN D DEFICIENCY","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DUCTAL CARCINOMA;ENDOTHELIAL PROGENITOR CELL;HORMONE RECEPTOR;HORMONE THERAPY;MALE BREAST CANCER;MASTECTOMY;ADOPTIVE CELL TRANSFER;ANAGRELIDE;ANTIGEN PRESENTATION;ANTIRETROVIRAL THERAPY;ASCUS (BRYOZOA);AUTONOMIC NERVOUS SYSTEM;BENDAMUSTINE;C-MET;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHLORAMBUCIL;COLPOSCOPY;CONTRAST-INDUCED NEPHROPATHY;EGFR INHIBITORS;FLUDARABINE;GEFITINIB;GENE MUTATION;GLUTATHIONE PEROXIDASE;HEART RATE VARIABILITY;HPV INFECTION;IMATINIB MESYLATE;LIMB-GIRDLE MUSCULAR DYSTROPHY;MEDULLARY CARCINOMA;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MHC CLASS I;PURE AUTONOMIC FAILURE;TOLL-LIKE RECEPTOR;VILLOUS ATROPHY","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;AGED;ADULT;MIDDLE AGED;;ITALY;BREAST NEOPLASMS, MALE;PROTEIN KINASE INHIBITORS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;TREATMENT OUTCOME;ADOLESCENT;AGED, 80 AND OVER;ANTINEOPLASTIC AGENTS, HORMONAL;DENDRITIC CELLS;HEART DISEASES;ANTIGENS, NEOPLASM;BENZAMIDES;KIDNEY DISEASES","32;25;22;18;17;17;15;13;12;9;8;8;7;7;7;7;7;6;6;6","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;IMMUNOBIOLOGY OF DENDRITIC CELLS;EFFICACY AND RESISTANCE IN CML TREATMENT;MALE BREAST CANCER AND GYNECOMASTIA RESEARCH;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;ATOPIC DERMATITIS AND SKIN MICROBIOME;AUTOIMMUNE ENCEPHALITIS: CLINICAL CHARACTERISTICS AND MANAGEMENT;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CLASSIFICATION AND MANAGEMENT OF ODONTOGENIC TUMORS;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DIAGNOSIS AND MANAGEMENT OF SJÖGREN'S SYNDROME;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DUAL-ENERGY COMPUTED TOMOGRAPHY;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV","3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CELIAC DISEASE;DIAGNOSIS;BREAST CANCER;DENDRITIC CELLS;ENDOTHELIAL DYSFUNCTION;ENDOTHELIAL PROGENITOR CELL;GLUTEN SENSITIVITY;HORMONE THERAPY;IMATINIB;MALE BREAST CANCER;REGIMEN;ADOPTIVE CELL TRANSFER;ADVERSE DRUG REACTIONS;ANAGRELIDE;ANAPLASTIC CARCINOMA;ANTIBIOTIC RESISTANCE;ANTIGEN PRESENTATION;ANTIPHOSPHOLIPID SYNDROME;ANTIRETROVIRAL THERAPY;ASCUS (BRYOZOA)","3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","CELIAC DISEASE;PROGENITOR CELLS;BREAST CANCER;CANCER CLINICAL;CLINICAL FEATURES;DENDRITIC CELLS;ENDOTHELIAL PROGENITOR;ITALIAN CENTERS;MALE BREAST;MULTICENTER STUDY;MULTICENTRE STUDY;MULTIMODAL TREATMENT;RETROSPECTIVE SURVEY;RHEUMATOID ARTHRITIS;SURVEY ANALYSIS;AB OXIDATIVE;AB TOLL-LIKE;ACHIEVING COMPLETE;ACUTE MYOCARDIAL;ADVERSE DRUG;AFFERENT LYMPH;AGE GLOMERULAR;AGEF SCORE;AIR POLLUTION;ANNUAL INCREASE;ANTIPHOSPHOLIPID SYNDROME;ARTERIAL STIFFNESS;ARTHRITIS CORRELATES;ASTHMA EXACERBATION;AUREUS CONTROL","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CELIAC DISEASE;AFFERENT LYMPH;MUSCULAR DYSTROPHY;AC PATIENTS;BOTANICAL PRODUCTS;CARDIAC COMPLICATIONS;LIMB-GIRDLE MUSCULAR;MUSCULAR DYSTROPHIES;POTENTIAL CD;THYROID AUTOANTIGENS;TM PATIENTS;WILD-TYPE GMPPB;BINDING MOTIFS;CD CENTERS;DC SUBSETS;DIAGNOSTIC SCORE;FOOD SUPPLEMENTS;GLUTEN-FREE DIET;HYPERKINETIC ARRHYTHMIAS;HYPERSENSITIVITY REACTION;MEMBRANE PATCHES;MYOCARDIAL FIBROSIS;ORAL CAVITY;ORAL SPRAY;THYROID DYSFUNCTION;TYPE DIABETES;ABDOMINAL PAIN;ACID MEDICATIONS;ACID SEQUENCE;ACQUIRE MEMBRANE","8;6;6;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,5.5,209.88,7.84,3,0.38,46.88,0,1,2,0,2,0,0,3,0,5,3,0,0,0,0,0,0,5,1,2,8,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3215 REPRODUCTIVE MEDICINE","8;3;3;1;1;1;1","RARE DISEASES;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;PEDIATRIC;CANCER;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;MUSCULAR DYSTROPHY;ORPHAN DRUG;AGING;CHRONIC LIVER DISEASE AND CIRRHOSIS;CONTRACEPTION/REPRODUCTION;DIABETES;DIGESTIVE DISEASES;HEPATITIS;HEPATITIS - B;INFECTIOUS DISEASES;LIVER DISEASE;LYMPHATIC RESEARCH;LYMPHOMA","6;5;4;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;BLOOD;CARDIOVASCULAR;METABOLIC AND ENDOCRINE;MUSCULOSKELETAL;REPRODUCTIVE HEALTH AND CHILDBIRTH","2;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","6;1;1","LEUKEMIA / LEUKAEMIA;HODGKIN'S DISEASE;LIVER CANCER;MYELOMA;NON-HODGKIN'S LYMPHOMA","4;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2014,50,11.2,3.2,0.46,0.36,0.52,1.1865671641791,1.0952380952381,1.125,1.08333333333333,0.54,0,22,10,9,6,0.44,0.2,0.18,0.12,15.34,0.405909222508098,6.53439153439153,0.3,0.8,0.527,0.219,0.236,0.231,"GIAMPIERO VIZZARI;SALVATORE BENVENGA;BIJOY K. KHANDHERIA;ROSA MA;PATRIZIA MONDELLO;FAUSTO PIZZINO;DOMENICO FENGA;SEBASTIANO GANGEMI;FRANCESCO TRIMARCHI;FRANCESCO STILO;CLAUDIO F. DONNER;GIULIO GIORDANO;NICOLINO AMBROSINO;MARIA VISALLI;GUIDO FERLAZZO;SALVATORE SAITTA;ROSA TAMBARO;FRANCESCO EQUITANI;GIUSEPPE GIRBINO;IRENE BONACCORSI","3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","GIUSEPPE GIRBINO;PAOLO RUGGERI;GIAMPIERO VIZZARI;BIJOY K. KHANDHERIA;FAUSTO PIZZINO;ROSA MA;DOMENICO FENGA;SEBASTIANO GANGEMI;ANNA MARIA ROSZKOWSKA;L. TORRISI;SALVATORE BENVENGA;FRANCESCO TRIMARCHI;EGIDIO IMBALZANO;TANVIR BAJWA;MARIA VISALLI;LUCIA ALTUCCI;CARMELA DELL’AVERSANA;DIANA TETI;MARIO VENZA;GUIDO FERLAZZO","0.83;0.83;0.73;0.73;0.73;0.6;0.6;0.57;0.5;0.5;0.48;0.48;0.46;0.4;0.37;0.37;0.37;0.37;0.37;0.34","GIAMPIERO VIZZARI;SALVATORE BENVENGA;ROSA MA;PATRIZIA MONDELLO;FAUSTO PIZZINO;DOMENICO FENGA;SEBASTIANO GANGEMI;FRANCESCO TRIMARCHI;FRANCESCO STILO;MARIA VISALLI;GUIDO FERLAZZO;GIUSEPPE GIRBINO;IRENE BONACCORSI;FRANCESCO SPINELLI;SALVATORE GIOVINAZZO;EGIDIO IMBALZANO;CATERINA MUSOLINO;GIUSEPPE IATÌ;FILIPPO ANDÒ;VINCENZO ADAMO","3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","GIUSEPPE GIRBINO;PAOLO RUGGERI;GIAMPIERO VIZZARI;FAUSTO PIZZINO;ROSA MA;DOMENICO FENGA;SEBASTIANO GANGEMI;ANNA MARIA ROSZKOWSKA;SALVATORE BENVENGA;FRANCESCO TRIMARCHI;EGIDIO IMBALZANO;MARIA VISALLI;CARMELA DELL’AVERSANA;DIANA TETI;MARIO VENZA;GUIDO FERLAZZO;IRENE BONACCORSI;FRANCESCO STILO;MARIO BARONE;GIUSEPPE DATTILO","0.83;0.83;0.73;0.73;0.6;0.6;0.57;0.5;0.48;0.48;0.46;0.37;0.37;0.37;0.37;0.34;0.34;0.33;0.33;0.33","BARBARA MORANDI;GUIDO FERLAZZO;IRENE BONACCORSI;EMMA DI CARLO;GIUSEPPE CIPOLLONE;GIUSEPPE NAVARRA;LORENZO MORETTA;MARIA CRISTINA MINGARI;PAOLO CARREGA;PETRA PAUL;VALERIA RIZZELLO;FRANCESCO TRIMARCHI;SALVATORE BENVENGA;GIOVANNA SARACENO;ROBERTO VITA;CESARE DE GREGORIO;FRANCESCO SAPORITO;GAETANO MORABITO;GIUSEPPE ANDÒ;GIUSEPPE ORETO","205;205;205;197;197;197;197;197;197;197;197;141;141;89;89;63;63;63;63;63","GUIDO FERLAZZO;IRENE BONACCORSI;SALVATORE BENVENGA;CESARE DE GREGORIO;FRANCESCO SAPORITO;GAETANO MORABITO;GIUSEPPE ANDÒ;GIUSEPPE ORETO;OLIMPIA TRIO;ANNA MAZZEO;DOMENICO FENGA;ROSA MA;LEONARDO FISICHELLA;DIANA TETI;MARIA VISALLI;MARIO VENZA;CARMELO FEDE;GIOVANNI CONTI;GIUSEPPE GIRBINO;PAOLO RUGGERI","205;205;141;63;63;63;63;63;63;59;56;56;50;36;36;36;31;31;24;24","DOMENICO FENGA;ROSA MA;FAUSTO PIZZINO;GIAMPIERO VIZZARI;SALVATORE BENVENGA;ANTONIO POTAMI;DAVID BARILLÀ;DIANA TETI;EGIDIO IMBALZANO;FILIPPO ANDÒ;GIOVANNA MESSINA;GIUSEPPE GIRBINO;GIUSEPPE IATÌ;GUIDO FERLAZZO;IRENE BONACCORSI;MARIA VISALLI;MARIO VENZA;PAOLO RUGGERI;PATRIZIA MONDELLO;A. BROGNA","3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;PSYCHOLOGY;CHEMISTRY;ECONOMICS;ENGINEERING;GEOGRAPHY;GEOLOGY;SOCIOLOGY","48;10;5;2;2;2;2;2;1;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;GASTROENTEROLOGY;PATHOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;RADIOLOGY;CARDIOLOGY;GENETICS;ONCOLOGY;DERMATOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;PHYSICAL THERAPY;PSYCHIATRY;ANATOMY;BIOCHEMISTRY;PHARMACOLOGY;ANESTHESIA;ASTROBIOLOGY;CANCER RESEARCH;CELL BIOLOGY;COMPOSITE MATERIAL;COMPUTATIONAL BIOLOGY;FAMILY MEDICINE;GENERAL SURGERY;LINGUISTICS;MEDICAL PHYSICS;OPTICS;PALEONTOLOGY;PEDIATRICS;UROLOGY","32;21;9;9;7;6;6;5;5;5;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CANCER;COMPLICATION;DISEASE;DIABETES MELLITUS;GENE;POPULATION;ANEMIA;COPD;ADVERSE EFFECT;ALTERNATIVE MEDICINE;ANEURYSM;ASYMPTOMATIC;BIOPSY;BLOOD PRESSURE;CHEST PAIN;DORSUM;EMBOLIZATION;ERYTHROPOIETIN;FIBROUS JOINT;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);MELANOMA;MULTIPLE SCLEROSIS;MYOCARDIAL INFARCTION;NEUROLOGY;ODDS RATIO;PREDNISONE;RADIATION THERAPY;RECEIVER OPERATING CHARACTERISTIC;REFRACTORY (PLANETARY SCIENCE);REGIMEN;RENAL FUNCTION;RETROSPECTIVE COHORT STUDY;STENOSIS;THYROID","5;5;5;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BREAST CANCER;CLINICAL ENDPOINT;MICRORNA;T CELL;ULCERATIVE COLITIS;ABDOMINAL AORTIC ANEURYSM;ACUTE RESPIRATORY FAILURE;AGGRESSIVE FIBROMATOSIS;AMYOTROPHIC LATERAL SCLEROSIS;AORTIC ANEURYSM;ARTERIAL STIFFNESS;BETA THALASSEMIA;BORTEZOMIB;BRACHYTHERAPY;C-REACTIVE PROTEIN;CARCINOGENESIS;CD34;CHEMOKINE;CHROMOSOME;CLEAR-CELL SARCOMA;COLORECTAL CANCER;CRONBACH'S ALPHA;CYCLOPHOSPHAMIDE;CYTOTOXIC T CELL;DEFERASIROX;DEFERIPRONE;DOCETAXEL;EJECTION FRACTION;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;ENDOVASCULAR TREATMENT;EPIDERMAL GROWTH FACTOR RECEPTOR;ESTIMATING EQUATIONS;EUTHYROID;EXECUTIVE FUNCTIONS;EXON;FEMTOSECOND;FOREFOOT;GENE EXPRESSION;GENETIC DISORDER;GENOTYPE;GERMLINE;GLATIRAMER ACETATE;GLYCATION;IMMUNOPHENOTYPING;INTERLEUKIN;INTERLEUKIN 18;INTERSTITIAL LUNG DISEASE;INTRACLASS CORRELATION;INTRAOCULAR LENSES;LEFT VENTRICULAR HYPERTROPHY;LENALIDOMIDE;LEVOTHYROXINE;MAJOR HISTOCOMPATIBILITY COMPLEX;MELPHALAN;METASTASIS;MISMATCH NEGATIVITY;MOTOR NEURON;MUTATION;MYELIN;NEUROMUSCULAR DISEASE;NEURORADIOLOGY;PERCUTANEOUS CORONARY INTERVENTION;PHACOEMULSIFICATION;PLACEBO;PLASMA CELL MYELOMA;PLASMAPHERESIS;PNEUMOMEDIASTINUM;POLYRADICULONEUROPATHY;PROGENITOR CELL;PROTEIN KINASE B;PROVOCATION TEST;PSORIATIC ARTHRITIS;PULSE WAVE VELOCITY;QUARTILE;RADIATION TREATMENT PLANNING;RELAPSING REMITTING;RHINOPLASTY;RITUXIMAB;SPINAL MUSCULAR ATROPHY;SPIROMETRY;THALIDOMIDE;THROMBOTIC THROMBOCYTOPENIC PURPURA;THYROID NODULES;THYROIDITIS;TROPONIN;VAGINAL VAULT","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANTHRACYCLINE;ANTIGEN PRESENTATION;ANTIGEN-PRESENTING CELL;BENDAMUSTINE;BONE METASTASIS;BREAST CARCINOMA;COLONOSCOPY;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;ENDOTHELIAL PROGENITOR CELL;ENDOVASCULAR ANEURYSM REPAIR;ERLOTINIB;FLUDARABINE;GENE EXPRESSION PROFILING;GERMLINE MUTATION;INTERLEUKIN 21;INTERLEUKIN 23;KARYOTYPE;MHC CLASS I;MIRBASE;MULTIFOCAL MOTOR NEUROPATHY;NEOPLASTIC TRANSFORMATION;REMYELINATION;SINGLE-NUCLEOTIDE POLYMORPHISM;TAXANE;TRASTUZUMAB","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;MALE;AGED;FEMALE;MIDDLE AGED;ADULT;AORTIC VALVE STENOSIS;BLOOD VESSEL PROSTHESIS IMPLANTATION;BONE NEOPLASMS;ENDOVASCULAR PROCEDURES;POSTOPERATIVE COMPLICATIONS;ARTERIOVENOUS MALFORMATIONS;FOREIGN-BODY MIGRATION;ITALY;MULTIPLE MYELOMA;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;ADOLESCENT;AGED, 80 AND OVER","25;25;17;16;15;13;12;7;7;7;7;7;5;5;5;5;5;5;4;4","MANAGEMENT OF VALVULAR HEART DISEASE;MICRORNA REGULATION IN CANCER AND DEVELOPMENT;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;ROLE OF ERYTHROPOIETIN IN DISEASE TREATMENT AND MANAGEMENT;STANDARDISATION AND MANAGEMENT OF COPD;THYROID DISEASE AND HORMONE REGULATION;ADVANCEMENTS IN LUNG CANCER RESEARCH;CANCER OF UNKNOWN PRIMARY SITE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;CATARACT SURGERY TECHNIQUES AND COMPLICATIONS;CLINICOPATHOLOGY OF FIBROUS TUMORS AND TREATMENT STRATEGIES;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND MANAGEMENT OF ENDOMETRIOSIS;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC AND MOLECULAR STUDIES OF CONNECTIVE TISSUE DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;CLINICAL ENDPOINT;COPD;ERYTHROPOIESIS-STIMULATING AGENTS;HYPOTHYROIDISM;MICRORNAS;PULMONARY DISEASE;REFRACTORY (PLANETARY SCIENCE);REGIMEN;TRANSFUSION THERAPY;ACUTE KIDNEY INJURY;ACUTE RESPIRATORY FAILURE;AGGRESSIVE FIBROMATOSIS;ANEURYSM RUPTURE;ANEURYSM SCREENING;AORTIC ANEURYSMS;ARTERIOVENOUS MALFORMATION;ARTERIOVENOUS MALFORMATIONS;ARTIFICIAL TEARS;ATRIAL SEPTAL DEFECT","2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","ERYTHROPOIETIN ALPHA;BIOSIMILAR ERYTHROPOIETIN;BREAST CANCER;CELL LINES;CHRONIC OBSTRUCTIVE;DRY EYE;EXPRESSION PATTERNS;LIPOSOMIAL IRON;MELANOMA CELL;MICRORNA EXPRESSION;OBSTRUCTIVE RESPIRATORY;ORIGINATOR ERYTHROPOIETIN;REFRACTORY ANEMIA;RESPIRATORY DISEASES;ULCERATIVE COLITIS;UVEAL MELANOMA;AB VASCULAR;ABCG POLYMORPHISMS;ACUTE KIDNEY;ADJUVANT TRASTUZUMAB;ADVANCED NON-SMALL;AFFERENT LYMPH;AGE DIABETES;AMPLATZER SEPTAL;ANATOMY MIDTERM;AORTIC ANEURYSM;AORTIC VALVE;ARTERIOVENOUS MALFORMATION;ARTHRITIS SCREENING;ARTIFICIAL TEAR","4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ERYTHROPOIETIN ALPHA;RISK FACTORS;NK CELLS;HT PATIENTS;RECEIVED HONORARIA;SURGICAL SITE;BILINGUAL CHILDREN;BIOSIMILAR ERYTHROPOIETIN;BONE MARROW;CONSENSUS CONFERENCE;COPD MANAGEMENT;ORAL SOLUTION;SKIN TOXICITY;TOTAL AGREEMENT;ABCG A-;ASA SCORE;CATARACT SURGERY;CELL SARCOMA;CHROMOSOME ABNORMALITIES;CHRONIC OBSTRUCTIVE;DUAL LANGUAGE;ENDOPROSTHETIC REPLACEMENT;EXTENDIBLE ENDOPROSTHETIC;HEALTHY SUBJECTS;LOWER LIMB;LUNG DISEASE;MULTIPLE MYELOMA;NEPHROTIC SYNDROME;NK SUBSETS;NON-INVASIVE EXTENDIBLE","8;7;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4,102.5,3.17,2,0.5,30,0,0,0,0,2,0,0,2,0,2,2,0,0,0,0,0,0,3,0,1,4,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3209 NEUROSCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","4;3;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;BACK PAIN;CANCER;CANNABINOID RESEARCH;CHRONIC LIVER DISEASE AND CIRRHOSIS;CHRONIC PAIN;DIGESTIVE DISEASES;DUCHENNE/ BECKER MUSCULAR DYSTROPHY;HEMATOLOGY;LIVER DISEASE;MINORITY HEALTH;MUSCULAR DYSTROPHY;NEURODEGENERATIVE;NEUROSCIENCES;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC;PERIPHERAL NEUROPATHY","4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;MUSCULOSKELETAL","1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","3;1","LEUKEMIA / LEUKAEMIA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2015,53,13.4905660377358,2.9811320754717,0.339622641509434,0.358490566037736,0.528301886792453,1.54901960784314,1.125,1.11764705882353,1.33333333333333,0.566037735849057,1,25,11,7,5,0.47,0.21,0.13,0.09,45,1.20746348068822,7.25550660792951,0.320754716981132,0.867924528301887,0.406,0.27,0.222,0.277,"CATERINA MUSOLINO;VINCENZO MONTESARCHIO;NATASHA IRRERA;ALESSANDRA BITTO;A. BENEDETTI;DOMENICO SANSONNO;ANTONIO GASBARRINI;BIJOY K. KHANDHERIA;GABRIELE PIZZINO;A.F. ATTILI;GIUSEPPE IATÌ;SALVATORE D’ANGELO;CARMELA ALOISI;TERESA ZOLFINO;VALERIA BARRESI;ANGELA BUONADONNA;C. ERMINERO;FRANCESCO SQUADRITO;STEFANO PERGOLIZZI;SANDRO BARNI","5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4","DANIELE BRUSCHETTA;VALERIA BARRESI;GIUSEPPE IATÌ;STEFANO PERGOLIZZI;ANTONIO PONTORIERO;GIOVANNI TUCCARI;ANTONIO IENI;CARMELA ALOISI;MICHELE BUEMI;ANNAMARIA BRUZZESE;JESSE ROMAN;ADRIANA ARENA;ANTONIO SPANÒ;GIANLUCA BAGNATO;BIJOY K. KHANDHERIA;NATASHA IRRERA;ALESSANDRA BITTO;GABRIELE PIZZINO;FRANCESCO SQUADRITO;GIOACCHINO CALAPAI","1;0.88;0.8;0.8;0.8;0.73;0.73;0.51;0.51;0.51;0.5;0.5;0.5;0.5;0.47;0.46;0.46;0.46;0.46;0.43","CATERINA MUSOLINO;NATASHA IRRERA;ALESSANDRA BITTO;GABRIELE PIZZINO;GIUSEPPE IATÌ;CARMELA ALOISI;VALERIA BARRESI;FRANCESCO SQUADRITO;MICHELE BUEMI;ANNAMARIA BRUZZESE;CARMELO ROMEO;LETTERIA MINUTOLI;GIANLUCA DI BELLA;GAETANO MONTALTO;SCIPIONE CARERJ;GIOVANNI TUCCARI;ANTONIO IENI;GIUSEPPE COSTANTINO;CONCETTA ZITO;GIUSEPPE ANDÒ","5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","DANIELE BRUSCHETTA;VALERIA BARRESI;GIUSEPPE IATÌ;GIOVANNI TUCCARI;ANTONIO IENI;CARMELA ALOISI;MICHELE BUEMI;ANNAMARIA BRUZZESE;JESSE ROMAN;ADRIANA ARENA;NATASHA IRRERA;ALESSANDRA BITTO;GABRIELE PIZZINO;FRANCESCO SQUADRITO;GIOACCHINO CALAPAI;SEBASTIANO GANGEMI;CATERINA MUSOLINO;MARIA VISALLI;ISABELLA VENZA;GAETANO MONTALTO","1;0.88;0.8;0.73;0.73;0.51;0.51;0.51;0.5;0.5;0.46;0.46;0.46;0.46;0.43;0.43;0.43;0.31;0.31;0.31","ANDREA GAGNOR;BERNARDO CORTESE;CARLO BRIGUORI;ENRICO FRIGOLI;GIUSEPPE ANDÒ;MARCO VALGIMIGLI;PAOLO CALABRÒ;PAOLO RUBARTELLI;ALESSANDRA REPETTO;ALESSANDRO LUPI;ANDREA SANTARELLI;ANTONIO ZINGARELLI;ARTURO AUSIELLO;DIK HEG;FERDINANDO VARBELLA;GENNARO SARDELLA;GIOVANNI ESPOSITO;MARTINA ROTHENBÜHLER;NICOLETTA DE CESARE;PAOLO SGANZERLA","1517;1517;1517;1517;1517;1517;1517;1517;1479;1479;1479;1479;1479;1479;1479;1479;1479;1479;1479;1479","GIUSEPPE ANDÒ;ANTONIO ZINGARELLI;ANTÓNIO TOSCANO;DANIELA PARISI;FRANCESCO SQUADRITO;GUIDO FERLAZZO;CARMELO ROMEO;ISABELLA VENZA;MARIO VENZA;ALESSANDRA BITTO;GABRIELE PIZZINO;NATASHA IRRERA;GIOACCHINO CALAPAI;I. IELO;CONCETTA ZITO;DOMENICA ALTAVILLA;GIANLUCA DI BELLA;GIUSEPPE IATÌ;GIUSEPPE ORETO;LETTERIA MINUTOLI","1517;351;116;116;114;106;100;91;91;81;81;81;66;52;43;43;43;43;43;43","CATERINA MUSOLINO;FRANCESCO SQUADRITO;GIUSEPPE IATÌ;GIUSEPPE ANDÒ;CARMELO ROMEO;GIOACCHINO CALAPAI;ALESSANDRA BITTO;GABRIELE PIZZINO;NATASHA IRRERA;ANTONIO IENI;CARLO SAITTA;CONCETTA ZITO;DOMENICA ALTAVILLA;G. RAIMONDO;GIANLUCA DI BELLA;GIUSEPPE ORETO;GUIDO FERLAZZO;I. IELO;ISABELLA VENZA;LETTERIA MINUTOLI","4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;ENGINEERING;PHILOSOPHY;PHYSICS;COMPUTER SCIENCE;HISTORY;MATERIALS SCIENCE;MATHEMATICS","49;13;4;3;3;3;2;1;1;1","INTERNAL MEDICINE;IMMUNOLOGY;SURGERY;GASTROENTEROLOGY;GENETICS;CARDIOLOGY;PATHOLOGY;ONCOLOGY;RADIOLOGY;BIOCHEMISTRY;PHARMACOLOGY;CANCER RESEARCH;INTENSIVE CARE MEDICINE;NUCLEAR MEDICINE;PEDIATRICS;CELL BIOLOGY;DERMATOLOGY;ENDOCRINOLOGY;COMPUTATIONAL BIOLOGY;ECOLOGY;ENVIRONMENTAL CHEMISTRY;MICROBIOLOGY;NEUROSCIENCE","45;13;13;8;8;7;7;6;6;5;5;4;4;4;4;3;3;3;2;2;2;2;2","ADVERSE EFFECT;CANCER;GENE;DISEASE;RADIATION THERAPY;CLINICAL TRIAL;CONFIDENCE INTERVAL;HEPATOCELLULAR CARCINOMA;INFLAMMATION;MYELOID LEUKEMIA;RECEPTOR;REGIMEN;COHORT;CYTOKINE;HEART FAILURE;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;LUNG;MYOCARDIAL INFARCTION;PROPORTIONAL HAZARDS MODEL;RANDOMIZED CONTROLLED TRIAL;TOXICITY","12;9;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","IMATINIB;SORAFENIB;ACUTE CORONARY SYNDROME;PERCUTANEOUS CORONARY INTERVENTION;RADIOSURGERY;TOLERABILITY;CHRONIC LYMPHOCYTIC LEUKEMIA;CLINICAL ENDPOINT;CONVENTIONAL PCI;DEFERASIROX;DEFERIPRONE;EPIGENETICS;GENE EXPRESSION;HAZARD RATIO;IMMUNOSTAINING;PROSTATE CANCER;SUBGROUP ANALYSIS;TYPE 2 DIABETES;TYROSINE-KINASE INHIBITOR;UNIVARIATE ANALYSIS","4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CYBERKNIFE;IMATINIB MESYLATE;BIVALIRUDIN;ABL;ADENOSINE RECEPTOR;ANAPHYLACTIC REACTION;ANAPHYLACTIC REACTIONS;ANAPHYLACTOID REACTIONS;ANTIRETROVIRAL THERAPY;CD38;COLONOSCOPY;DNA METHYLATION;DNA MICROARRAY;DOSE-VOLUME HISTOGRAM;ERBB3;GLYCATED HEMOGLOBIN;HENOCH-SCHONLEIN PURPURA;HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2;IGHV@;JADAD SCALE;LACTOBACILLUS REUTERI;LEVODOPA;LUNG FIBROSIS;MITOCHONDRIAL DISEASE;MITOCHONDRIAL MYOPATHY;NILOTINIB;PHILADELPHIA CHROMOSOME;PRASUGREL;STEREOTACTIC RADIOTHERAPY;TICAGRELOR;TRASTUZUMAB","3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;MALE;FEMALE;AGED;ACUTE CORONARY SYNDROME;MIDDLE AGED;MELANOMA;PERCUTANEOUS CORONARY INTERVENTION;SKIN NEOPLASMS;ADULT;CATHETERIZATION, PERIPHERAL;ARTHRITIS, RHEUMATOID;ITALY;PEPTIDE FRAGMENTS;RECOMBINANT PROTEINS;TREATMENT OUTCOME;ACUTE KIDNEY INJURY;ADENOCARCINOMA;BETA-THALASSEMIA","26;24;20;15;14;10;10;8;8;8;7;7;6;6;6;6;6;5;5;5","EFFICACY AND RESISTANCE IN CML TREATMENT;GENOMIC ABERRATIONS AND TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEPATOCELLULAR CARCINOMA;MANAGEMENT OF VALVULAR HEART DISEASE;METAL-INDUCED OXIDATIVE STRESS AND HEALTH EFFECTS;VASCULAR ACCESS FOR CORONARY PROCEDURES AND TRAUMA MANAGEMENT;CHOLESTEROL-LOWERING TREATMENT;CHRONIC KIDNEY DISEASE AND DIALYSIS TREATMENT;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY FOR HIV;EPIDEMIOLOGY AND MANAGEMENT OF SKIN CANCER;ESOPHAGEAL INTERVENTION TECHNIQUES;GASTRIC CANCER RESEARCH AND TREATMENT;GENE THERAPY FOR SPINAL MUSCULAR ATROPHY;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;GYNECOLOGIC ONCOLOGY","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","REGIMEN;CYBERKNIFE;IMATINIB MESYLATE;SORAFENIB;TOLERABILITY;BIVALIRUDIN;BRACHYTHERAPY DOSE CALCULATION;CHEMORADIOTHERAPY;CLINICAL ENDPOINT;DEFERASIROX;DEFERIPRONE;DIABETES;HEPATITIS B;HEPATOCELLULAR CARCINOMA;IMATINIB;IMMUNOSTAINING;INTENSITY-MODULATED RADIOTHERAPY;LEFT VENTRICULAR FUNCTION;LIVER DISEASE;METAL TOXICITY","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","FINAL RESULTS;ACUTE CORONARY;ACUTE KIDNEY;CHRONIC LYMPHOCYTIC;CORONARY SYNDROMES;DOSE IMATINIB;ELDERLY PATIENTS;GIDEON GLOBAL;GIDEON STUDY;GLOBAL INVESTIGATIONAL;HEAVY METALS;HEPATOCELLULAR CARCINOMA;ITALIAN COHORT;ITALIAN EXPERIENCE;LYMPHOCYTIC LEUKEMIA;PATIENT ETIOLOGY;PATIENTS FINAL;PROSTATE CANCER;SORAFENIB STUDY;THALASSEMIA INTERMEDIA;THERAPEUTIC DECISIONS;AB RISK;ACCESS SITE;ADENOSINERGIC PATHWAY;ADVANCED PARKINSON;ADVERSE HEMORRHAGIC;ANAPHYLACTIC REACTION;ANGIOSCPXSCP SUBSTUDY;ANIMAL MODEL;ANIMAL MODELS","4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","ADVERSE EVENTS;CVD RISK;ELDERLY PTS;HEAVY METALS;MEDIAN AGE;RISK FACTORS;CHELATION TREATMENT;LV GLS;SPECIAL ISSUE;TM VERSUS;CLINICAL PRACTICE;DIABETIC WOMEN;GIDEON STUDY;METHODS PATIENTS;MIR-A MIR-;MONTHS NA;RADIATION THERAPY;SURVIVAL CURVES;THALASSEMIA INTERMEDIA;TI PATIENTS;VERSUS TI;Β -ARRESTIN;BODY RADIATION;CELL LINES;CELL PROLIFERATION;DERMATOLOGIC HAND-FOOT;GENDER DIFFERENCES;GLOBAL PROSPECTIVE;HAND-FOOT SKIN;HCC UHCC","8;8;8;8;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,4.67,3360.17,6.9,4,0.67,181.67,0,0,1,0,4,0,0,1,0,6,0,0,0,0,0,0,0,6,0,0,5,0,0,1,0,0,0,0,0,0,"United States;Japan;United Kingdom","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","6;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;BIOMEDICAL IMAGING;CANCER;CARDIOVASCULAR;COMPLEMENTARY AND INTEGRATIVE HEALTH;CROHN'S DISEASE;HEART DISEASE;HEMATOLOGY;LYMPHATIC RESEARCH;LYMPHOMA;PATIENT SAFETY;PREVENTION;RARE DISEASES","5;4;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL","1;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES","4;1;1","COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"SCIELO JOURNALS","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1","CANCER;CLINICAL RESEARCH;HEMATOLOGY;LYMPHATIC RESEARCH;LYMPHOMA;ORPHAN DRUG;RARE DISEASES","1;1;1;1;1;1;1","CANCER","1",NA,NA,"CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","1","BLOOD CANCER;HEAD AND NECK CANCER;HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;MYELOMA;NON-HODGKIN'S LYMPHOMA;THYROID CANCER","1;1;1;1;1;1;1",NA,NA
"AOUSSN_GMARTINO",2016,48,20.1875,2.60416666666667,0.291666666666667,0.3125,0.458333333333333,1.48809523809524,1.07692307692308,1.25,1.1,0.458333333333333,0,29,11,3,3,0.6,0.23,0.06,0.06,21.48,0.661243110900937,7.01984126984127,0.333333333333333,0.916666666666667,0.388,0.326,0.289,0.321,"I. IELO;CATERINA MUSOLINO;STEFANO PERGOLIZZI;C. SIRAGUSA;M.C. ANGIOCCHI;A. BROGNA;F. MIDILI;A. DI PASQUALE;ANTONIO MICALI;GIUSEPPE IATÌ;V. MONGELLI;G. FETI;ANTONIO PONTORIERO;ILARIA BONAPARTE;SARA GALIMBERTI;ALESSANDRA IURLO;GIANANTONIO ROSTI;MARIO ANNUNZIATA;FAUSTO CASTAGNETTI;GABRIELE GUGLIOTTA","5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3","GIOVANNI TUCCARI;LARA GITTO;ANTONIO IENI;E. TRIMARCHI;C. SIRAGUSA;STEFANO PERGOLIZZI;I. IELO;M.C. ANGIOCCHI;A. BROGNA;F. MIDILI;A. DI PASQUALE;ANTONIO MICALI;V. MONGELLI;G. FETI;ILARIA BONAPARTE;GIUSEPPE IATÌ;ANTONIO PONTORIERO;SALVATORE LEOTTA;IGNAZIO SALAMONE;GIOVANNI MANNINO","0.7;0.5;0.5;0.5;0.39;0.37;0.34;0.31;0.31;0.31;0.31;0.31;0.31;0.31;0.31;0.28;0.28;0.25;0.25;0.25","I. IELO;CATERINA MUSOLINO;STEFANO PERGOLIZZI;C. SIRAGUSA;A. BROGNA;F. MIDILI;A. DI PASQUALE;GIUSEPPE IATÌ;V. MONGELLI;ANTONIO PONTORIERO;VALENTINA IENTILE;ROMINA GALLIZZI;IGNAZIO SALAMONE;FRANCESCO GIORGIANNI;G. GULLOTTI;GIOVANNI TUCCARI;GIUSEPPINA RUSSO;SERGIO BALDARI;GIANLUCA TRIFIRÓ;ILARIA MARCIANÒ","5;5;5;5;4;4;4;4;4;4;3;2;2;2;2;2;2;2;2;2","GIOVANNI TUCCARI;ANTONIO IENI;E. TRIMARCHI;C. SIRAGUSA;STEFANO PERGOLIZZI;I. IELO;A. BROGNA;F. MIDILI;A. DI PASQUALE;V. MONGELLI;GIUSEPPE IATÌ;ANTONIO PONTORIERO;IGNAZIO SALAMONE;MARIA GIOFFRÉ‐FLORIO;LETIZIA MARIA MURABITO;FAUSTO FAMÀ;GIOVANNI CRUPI;VALENTINA IENTILE;GIUSEPPINA RUSSO;GIOVANNI BRANCA","0.7;0.5;0.5;0.39;0.37;0.34;0.31;0.31;0.31;0.31;0.28;0.28;0.25;0.25;0.25;0.25;0.25;0.22;0.22;0.2","ANNA MARINA LIBERATI;ANTONIETTA FALCONE;ANTONIO PALUMBO;CATERINA MUSOLINO;CONCETTA CONTICELLO;GIULIA BENEVOLO;LORENZO DE PAOLI;MARIO BOCCADORO;MASSIMO OFFIDANI;SARA BRINGHEN;TOMMASINA GUGLIELMELLI;VITTORIO MONTEFUSCO;ALBERTO MARTINI;ANGELO RAVELLI;ANTONELLA INSALACO;DONATO RIGANTE;FABRIZIO DE BENEDETTI;MARCO CATTALINI;ROMINA GALLIZZI;ROBERTO PASSERA","129;129;129;129;129;129;129;129;129;129;129;129;108;108;108;108;108;108;108;104","CATERINA MUSOLINO;ANTONELLA GAGLIANO;ALBERTO NOTO;ROMINA GALLIZZI;GIUSEPPE NAVARRA;S LAZZARA;ACHILLE P. CAPUTI;FRANCESCO GIORGIANNI;ILARIA MARCIANÒ;VALENTINA IENTILE;YLENIA INGRASCIOTTA;G. GULLOTTI;LUCIANA RIGOLI;GIUSEPPINA RUSSO;C. SIRAGUSA;DIANA TETI;ISABELLA VENZA;MARIA VISALLI;MARIO VENZA;TERESA CATALANO","129;97;74;72;61;61;60;60;60;60;60;56;52;46;43;42;42;42;42;42","C. SIRAGUSA;CATERINA MUSOLINO;I. IELO;A. BROGNA;A. DI PASQUALE;ANTONIO PONTORIERO;F. MIDILI;STEFANO PERGOLIZZI;V. MONGELLI;ACHILLE P. CAPUTI;ANTONIO IENI;FRANCESCO GIORGIANNI;G. GULLOTTI;GIOVANNI TUCCARI;GIUSEPPINA RUSSO;IGNAZIO SALAMONE;ILARIA MARCIANÒ;VALENTINA IENTILE;YLENIA INGRASCIOTTA;ALBERTO NOTO","5;5;5;4;4;4;4;4;4;2;2;2;2;2;2;2;2;2;2;1","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;MATERIALS SCIENCE;MATHEMATICS;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;ART;HISTORY","45;13;7;4;4;4;3;3;3;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;NUCLEAR MEDICINE;GENETICS;ONCOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;OPTICS;PATHOLOGY;RADIOLOGY;ENDOCRINOLOGY;IMMUNOLOGY;NURSING;PEDIATRICS;PSYCHIATRY;GEOMETRY;INTENSIVE CARE MEDICINE;MEDICAL PHYSICS;PALEONTOLOGY;BIOCHEMISTRY;BIOINFORMATICS;CANCER RESEARCH;CARDIOLOGY;CELL BIOLOGY;CLINICAL PSYCHOLOGY;FAMILY MEDICINE;GENERAL SURGERY;LAW;MECHANICAL ENGINEERING;METALLURGY;ORGANIC CHEMISTRY;PHARMACOLOGY;QUANTUM MECHANICS;STATISTICS","32;11;9;8;8;6;6;6;6;6;5;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CANCER;RADIATION THERAPY;DIABETES MELLITUS;GENE;POPULATION;ADVERSE EFFECT;DISEASE;ATTENUATION;CELL;CHEMOTHERAPY;CONFIDENCE INTERVAL;MYELOID LEUKEMIA;QUALITY OF LIFE (HEALTHCARE);AMYLOIDOSIS;BEAM (STRUCTURE);BIOSIMILAR;CLINICAL TRIAL;COHORT;COMPUTED TOMOGRAPHY;CONTRAST (VISION);DISCONTINUATION;HEALTH CARE;HEPATITIS C;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);MECHANICAL VENTILATION;MEDICAL PRESCRIPTION;MONTE CARLO METHOD;MULTIPLE MYELOMA;MYOCARDIAL INFARCTION;ODDS RATIO;QUALITY (PHILOSOPHY);RANDOMIZED CONTROLLED TRIAL;RECEPTOR;VENTILATION (ARCHITECTURE);VIRUS","11;6;5;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","RADIOSURGERY;IMATINIB;BREAST CANCER;COLORECTAL CANCER;HEPATITIS C VIRUS;MUTATION;PERCUTANEOUS CORONARY INTERVENTION;PERIPHERAL NEUROPATHY;PROSTATE CANCER;RADIATION TREATMENT PLANNING;TYPE 2 DIABETES;ACNE SCARS;ANTIDEPRESSANT;BALLOON DILATION;BETA THALASSEMIA;BORTEZOMIB;BRACHYTHERAPY;BRONCHIOLITIS;CADHERIN;CARDIAC AMYLOIDOSIS;CELL CYCLE;CERVICAL CANCER;CHELATION THERAPY;CHROMOSOMAL TRANSLOCATION;COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS;CONTINUOUS POSITIVE AIRWAY PRESSURE;CONTRAST ENHANCEMENT;CYCLOPHOSPHAMIDE;CYTOTOXICITY;DEFERIPRONE;DEGRANULATION;DNA SEQUENCING;ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY;EPIGENETICS;ERYTHROPOIESIS;ETANERCEPT;EXTERNAL BEAM RADIATION;FAMILIAL MEDITERRANEAN FEVER;FATTY LIVER;GENE EXPRESSION;GENE SILENCING;GENOTYPE;GESTATIONAL AGE;GRANULOCYTE COLONY-STIMULATING FACTOR;GROWTH HORMONE;HAEMATOPOIESIS;HAZARD RATIO;HOUNSFIELD SCALE;HUMAN LEUKOCYTE ANTIGEN;IMAGE QUALITY;IMAGE-GUIDED RADIATION THERAPY;IMMUNOTHERAPY;INCISIONAL HERNIA;INCLUSION AND EXCLUSION CRITERIA;INNATE IMMUNE SYSTEM;INTERMEDIA;IONIZATION;ISOCENTER;LENALIDOMIDE;LIFE EXPECTANCY;MEAN AIRWAY PRESSURE;MELPHALAN;METABOLIC CONTROL ANALYSIS;METASTASIS;METHYLATION;MUCOSAL MELANOMA;NON-INVASIVE VENTILATION;NONINVASIVE VENTILATION;OXYGEN SATURATION;PALIVIZUMAB;PERFORATION;PHASES OF CLINICAL RESEARCH;PROSTATE;QUALITY ASSURANCE;SCINTILLATION;SCINTILLATOR;STROMA;SUICIDE PREVENTION;T CELL;THALIDOMIDE;TOMOTHERAPY;TYPE 1 DIABETES;TYROSINE-KINASE INHIBITOR;UNIVARIATE ANALYSIS","4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CYBERKNIFE;DASATINIB;COLONOSCOPY;IMATINIB MESYLATE;NILOTINIB;AA AMYLOIDOSIS;ACROMEGALY;AXILLA;CONTINUOUS GLUCOSE MONITORING;CRYOGLOBULINEMIA;DISASTER MEDICINE;DNA METHYLATION;EXTERNAL BEAM RADIOTHERAPY;FILGRASTIM;INTERLEUKIN 21;ION SEMICONDUCTOR SEQUENCING;IONIZATION CHAMBER;MASTECTOMY;NATURAL KILLER CELL;NEONATAL RESPIRATORY DISTRESS SYNDROME;NIVOLUMAB;NONALCOHOLIC FATTY LIVER DISEASE;ONCOGENE;PHILADELPHIA CHROMOSOME;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RIBAVIRIN;SANGER SEQUENCING;TIROFIBAN","4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;MIDDLE AGED;AGED;ADULT;TREATMENT OUTCOME;BETA-THALASSEMIA;DIABETES MELLITUS, TYPE 2;ITALY;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;MULTIPLE MYELOMA;ADOLESCENT;CITRATES;ACUTE CORONARY SYNDROME;ANTINEOPLASTIC AGENTS;BIOSIMILAR PHARMACEUTICALS;CHILD","30;23;22;17;15;13;10;9;8;7;7;7;6;6;5;5;4;4;4;4","EFFICACY AND RESISTANCE IN CML TREATMENT;RADIOTHERAPY PHYSICS AND TECHNOLOGY;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;GLOBAL TRENDS IN COLORECTAL CANCER RESEARCH;HEALTH RISKS OF MEDICAL IMAGING RADIATION EXPOSURE;HEPATITIS C INFECTION AND TREATMENT;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;AUTISM SPECTRUM DISORDERS;CANCER IMMUNOTHERAPY;CANCER STEM CELLS AND TUMOR METASTASIS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DEVELOPMENTAL ORIGINS OF ADULT HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;DISASTER RESPONSE AND PUBLIC HEALTH PREPAREDNESS;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS","4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CYBERKNIFE;BIOSIMILAR;DIAGNOSTIC IMAGING;DISCONTINUATION;DUAL-ENERGY CT;HEPATITIS C;IMATINIB;IMATINIB MESYLATE;INTERNATIONAL MYELOMA WORKING GROUP;TREATMENT;AA AMYLOIDOSIS;ACNE SCARS;ACROMEGALY;ADULT CONGENITAL HEART DISEASE;AMYLOID (MYCOLOGY);ATTENUATION CORRECTION;AXILLA;BALLOON DILATION;BETA THALASSEMIA;BILIARY DRAINAGE","4;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","POPULATION-BASED STUDY;CHRONIC MYELOID;CONTROLLED TRIAL;DOSE INCREMENT;EXPANDED ACCESS;MULTICENTER STUDY;MULTIPLE MYELOMA;MYELOID LEUKEMIA;TYPE DIABETES;X-RAY BEAM;ACCESS PROGRAM;ACCESS PROGRAMME;ACUTE CORONARY;ACUTE STENT;ADVANCED SQUAMOUS;ADVERSE EVENTS;AGENTS ESAS;AIP GENES;ALDH EXPRESSION;AMYLOID DEPOSITION;ANATOMICAL SITES;ANTIDEPRESSANT TREATMENT;ARTHRITIS TREATED;AUTOINFLAMMATORY DISEASE;AXILLARY NODES;BALLOON DILATION;BCR-ABL KINASE;BEAM OUTPUT;BEAM QUALITIES;BEAM QUALITY","4;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ITALY HEMATOLOGY;HEMATOLOGY UNIT;MAST CELLS;INJ NA;ROME ITALY;AD USERS;ADVERSE EVENTS;DIAGNOSTIC TESTS;ITALY DEPARTMENT;E-CADHERIN EXPRESSION;NK CELLS;CITRATE-BUFFERED TIROFIBAN;ESA USERS;HOSPITAL ROME;IRON CHELATION;NK CELL;RECRUITMENT MANEUVER;REFERENCE PRODUCT;SURFACTANT ADMINISTRATION;UNIT UNIVERSITY;BPI-SF PAIN;CELL EDUCATION;CHELATION THERAPY;CLINICAL PRACTICE;ESAS COVERED;EXTRA-HEMATOLOGICAL TOXICITY;HEMATOLOGY UNIVERSITY;INCREASED RISK;ITALY DIVISION;LADDER PAIN","20;17;8;7;7;6;6;6;6;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,4,317,15,6,0.5,72.5,0,0,1,0,5,0,1,5,0,10,2,0,0,0,0,0,0,12,0,0,12,0,0,0,0,0,0,0,0,0,"United States;Italy;Japan;Jersey","2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","10;8;3;2;2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;CANCER;DIGESTIVE DISEASES;PEDIATRIC;RARE DISEASES;AUTOIMMUNE DISEASE;BRAIN DISORDERS;COMPLEMENTARY AND INTEGRATIVE HEALTH;EYE DISEASE AND DISORDERS OF VISION;INFLAMMATORY BOWEL DISEASE;MINORITY HEALTH;NEURODEGENERATIVE;PREVENTION;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);BASIC BEHAVIORAL AND SOCIAL SCIENCE","11;10;4;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1","NEUROLOGICAL;CANCER;CARDIOVASCULAR;EYE;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH","3;1;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","9;1;1","BRAIN TUMOR;COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;LUNG CANCER;NOT SITE-SPECIFIC CANCER","1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_GMARTINO",2017,57,12.8947368421053,2.82456140350877,0.403508771929825,0.333333333333333,0.350877192982456,1.4,1.35294117647059,1.26666666666667,1.25,0.596491228070175,0,28,9,3,7,0.49,0.16,0.05,0.12,14.89,0.505334118676331,6.37979094076655,0.280701754385965,0.859649122807018,0.401,0.44,0.436,0.299,"SALVATORE BENVENGA;SERGIO BALDARI;ROBERTO VITA;SCIPIONE CARERJ;LUCA LONGOBARDO;FLAVIA DI BARI;ALBERTO BOI;ALESSANDRO DI GIORGIO;FRANCESCO PRATI;L. AUDITORE;CLAUDIO ROMANO;SIMONA LUCCHESI;MARCO VALGIMIGLI;PETER JÜNI;ALESSANDRO ANTONELLI;GIOVANNI TUCCARI;CATERINA MUSOLINO;ANTONIO IENI;DIK HEG;MARTINA ROTHENBÜHLER","12;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","SALVATORE BENVENGA;FLAVIA DI BARI;ROBERTO VITA;CLAUDIO ROMANO;ALESSANDRO ANTONELLI;MICHELE A. CATENA;SERGIO BALDARI;GUIDO FERLAZZO;PAOLO CARREGA;L. AUDITORE;ERNESTO AMATO;LUCA LONGOBARDO;GIOVANNI TUCCARI;ANTONIO IENI;SALVATORE SETTINERI;SCIPIONE CARERJ;ENRICO NASTRO SINISCALCHI;SALVATORE CRIMI;DAVID BARILLÀ;FRANCESCO SAVERIO DE PONTE","2.41;0.84;0.79;0.79;0.78;0.75;0.72;0.59;0.59;0.55;0.53;0.45;0.41;0.41;0.4;0.37;0.37;0.37;0.37;0.37","SALVATORE BENVENGA;SERGIO BALDARI;SCIPIONE CARERJ;LUCA LONGOBARDO;ALESSANDRO DI GIORGIO;L. AUDITORE;CLAUDIO ROMANO;GIOVANNI TUCCARI;CATERINA MUSOLINO;ANTONIO IENI;CONCETTA ZITO;MARIACARMELA SANTARPÍA;GIANLUCA TRIFIRÓ;GIUSEPPE ANDÒ;DARIO FORMICA;M. ZUCCO;GUIDO FERLAZZO;ENRICO NASTRO SINISCALCHI;SALVATORE CRIMI;JAFRIN SULTANA","12;5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","SALVATORE BENVENGA;CLAUDIO ROMANO;MICHELE A. CATENA;SERGIO BALDARI;GUIDO FERLAZZO;L. AUDITORE;LUCA LONGOBARDO;GIOVANNI TUCCARI;ANTONIO IENI;SCIPIONE CARERJ;ENRICO NASTRO SINISCALCHI;SALVATORE CRIMI;DAVID BARILLÀ;FRANCESCO SAVERIO DE PONTE;MARIACARMELA SANTARPÍA;ANTONINO SAITTA;GIANLUCA TRIFIRÓ;VALERIA DIPASQUALE;SIMONE MARIA CALOGERO GRAMAGLIA;DOMENICA CAMPOLO","2.41;0.79;0.75;0.72;0.59;0.55;0.45;0.41;0.41;0.37;0.37;0.37;0.37;0.37;0.34;0.32;0.31;0.25;0.25;0.25","DIK HEG;ENRICO FRIGOLI;GIUSEPPE ANDÒ;MARCO VALGIMIGLI;MARTINA ROTHENBÜHLER;PASCAL VRANCKX;PETER JÜNI;SALVATORE BENVENGA;BERNARDO CORTESE;CARLO BRIGUORI;SERGIO LEONARDI;ARTURO AUSIELLO;CAMILLO FALCONE;CARLO VIGNA;EMILIO DI LORENZO;GENNARO SARDELLA;NICOLETTA DE CESARE;PAOLO SGANZERLA;PAOLO TOSI;STEFANO GARDUCCI","332;332;332;332;332;332;332;311;276;276;276;194;194;194;194;194;194;194;194;194","GIUSEPPE ANDÒ;SALVATORE BENVENGA;GUIDO FERLAZZO;ALESSANDRO DI GIORGIO;ALESSANDRO ARRIGO;ALESSANDRO CALAMUNERI;ANGELO QUARTARONE;DEMETRIO MILARDI;ELISA IMELDE POSTORINO;ENRICOMARIA MORMINA;GIUSEPPE ANASTASI;LAURA RANIA;MICHELE GAETA;PASQUALE ARAGONA;ANTONIO IENI;GIOVANNI TUCCARI;SCIPIONE CARERJ;CONCETTA ZITO;LUCA LONGOBARDO;ALESSANDRA BITTO","332;290;67;46;44;44;44;44;44;44;44;44;44;44;42;42;37;36;36;34","SALVATORE BENVENGA;LUCA LONGOBARDO;SCIPIONE CARERJ;SERGIO BALDARI;ALESSANDRO DI GIORGIO;CATERINA MUSOLINO;CONCETTA ZITO;GIUSEPPE ANDÒ;L. AUDITORE;CLAUDIO ROMANO;DAVID BARILLÀ;GIUSEPPE ORETO;GUIDO FERLAZZO;ILARIA MARCIANÒ;LILIA ORETO;M. ZUCCO;MARIA LUDOVICA CARERJ;ROBERTA MANGANARO;VALENTINA IENTILE;A. BENE","11;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;1","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;MATHEMATICS;BUSINESS;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;PSYCHOLOGY;COMPUTER SCIENCE;GEOLOGY;HISTORY","52;12;9;6;3;2;2;2;2;2;1;1;1","INTERNAL MEDICINE;CARDIOLOGY;SURGERY;GASTROENTEROLOGY;ENDOCRINOLOGY;ONCOLOGY;PATHOLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PEDIATRICS;GENETICS;NUCLEAR PHYSICS;BIOCHEMISTRY;FAMILY MEDICINE;OPTICS;PALEONTOLOGY;PSYCHIATRY;UROLOGY;ACCOUNTING;BIOINFORMATICS;ECONOMIC GROWTH;INTENSIVE CARE MEDICINE;MICROBIOLOGY;NEUROSCIENCE;NUCLEAR MEDICINE;NURSING;PHARMACOLOGY;RADIOCHEMISTRY;STATISTICS","41;13;12;9;8;8;8;7;6;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CANCER;THYROID;MYOCARDIAL INFARCTION;POPULATION;DISEASE;HORMONE;AORTIC VALVE;COHORT;IMMUNE SYSTEM;INGESTION;OSTEOPOROSIS;STENT;ANEURYSM;AORTA;ARTERY;ARTHRITIS;ASYMPTOMATIC;ATRIAL FIBRILLATION;BIOSIMILAR;BLOOD PRESSURE;CAROTID ARTERIES;CONCOMITANT;CONFIDENCE INTERVAL;CONTEXT (ARCHAEOLOGY);CREATININE;ENZYME;FORMULARY;GENE;HEALTH CARE;HEART FAILURE;IN VITRO;INCIDENCE (GEOMETRY);INTERVENTION (COUNSELING);ISOTOPE;LUNG;LUNG CANCER;MONTE CARLO METHOD;OBSERVATIONAL STUDY;PLASMA;RANDOMIZED CONTROLLED TRIAL;SORE THROAT;VISUAL ANALOGUE SCALE","9;8;6;6;5;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","LEVOTHYROXINE;PROSTATE CANCER;ACUTE CORONARY SYNDROME;BREAST CANCER;PERCUTANEOUS CORONARY INTERVENTION;AUTOIMMUNITY;BICUSPID AORTIC VALVE;BRONCHIECTASIS;CLINICAL ENDPOINT;CYCLOTRON;INFLAMMATORY BOWEL DISEASE;METASTASIS;PULSE WAVE VELOCITY;RADIAL ARTERY;THYROID DISEASE;THYROIDITIS;ADALIMUMAB;AGE OF ONSET;ALKALINE PHOSPHATASE;ALLELE;AMPHOTERICIN B;ANDROGEN;AORTIC ROOT;AORTIC SINUS;AORTIC VALVE INSUFFICIENCY;AORTIC VALVE STENOSIS;ARTERIAL STIFFNESS;ASCENDING AORTA;ATELECTASIS;AUTOANTIBODY;AUTOIMMUNE DISEASE;BASILIC VEIN;BISPHOSPHONATE;BONE MINERAL;BORTEZOMIB;CALORIC INTAKE;CALORIMETER (PARTICLE PHYSICS);CARDIAC FUNCTION CURVE;CARDIOTOXICITY;CHAR;CLINICAL ONCOLOGY;COMMON CAROTID ARTERY;COMPLEMENT SYSTEM;CONVENTIONAL PCI;CORONARY ANGIOGRAPHY;CROHN'S DISEASE;CYTOTOXIC T CELL;CYTOTOXICITY;DENOSUMAB;DIFFUSION MRI;DNA SEQUENCING;DOXORUBICIN;EJECTION FRACTION;ELECTROLYTE DISORDER;ENDOSCOPIC MUCOSAL RESECTION;ENOPHTHALMOS;ESSENTIAL THROMBOCYTHEMIA;FACTOR V;FEMORAL NECK;FUKUSHIMA NUCLEAR ACCIDENT;GLOMERULONEPHRITIS;GLUTATHIONE;HAZARD RATIO;HYPERCAPNIA;HYPOGLYCEMIA;INFLIXIMAB;INNATE IMMUNE SYSTEM;INTERIM ANALYSIS;INTERLEUKIN;INTIMA-MEDIA THICKNESS;LATERAL GENICULATE NUCLEUS;LIPID PEROXIDATION;LUTEAL PHASE;MALONDIALDEHYDE;MENSTRUAL CYCLE;MOOD DISORDERS;MUTANT;MUTATION;MYELOFIBROSIS;NEUROENDOCRINE CARCINOMA;OBSTETRICS AND GYNAECOLOGY;OPTIC CHIASM;ORTHOPTIC;ORTHOPTICS;PARKINSON'S DISEASE;PERFORATION;PERIPROSTHETIC;PITUITARY GLAND;POLYPHENOL;POSITRON;PROTEINURIA;PSEUDOANEURYSM;PSORIATIC ARTHRITIS;RADIOACTIVE IODINE;REIMBURSEMENT;RENAL BIOPSY;RESPIRATORY DISEASE;SEPTIC ARTHRITIS;T CELL;THROMBOPHILIA;THYROID CANCER;THYROID FUNCTION;THYROID-STIMULATING HORMONE;ULCERATIVE COLITIS;VENOUS THROMBOSIS;VITAMIN D DEFICIENCY;WARFARIN;WHITE MATTER","5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MACE;BONE METASTASIS;ALTERNATIVE COMPLEMENT PATHWAY;ANDROGEN RECEPTOR;ANTHRACYCLINE;AUTOIMMUNE GASTRITIS;AUTOIMMUNE THYROIDITIS;BRONCHUS;CONE CALORIMETER;EPIRUBICIN;FACTOR V LEIDEN;FRACTIONAL ANISOTROPY;FREE THYROXINE;GLOMERULAR BASEMENT MEMBRANE;GLOMERULOPATHY;GLUTATHIONE DISULFIDE;GOLIMUMAB;INFLAMMATORY BOWEL DISEASES;INNATE LYMPHOID CELL;INTERLEUKIN 21;LYMPH NODE METASTASIS;MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;METHYLENETETRAHYDROFOLATE REDUCTASE;NATURAL KILLER CELL;OPTIC RADIATION;OSTEONECROSIS OF THE JAW;OSTEOPENIA;PAPILLARY THYROID CANCER;PROTEIN KINASE DOMAIN;RIVAROXABAN;SANGER SEQUENCING;SEX HORMONE-BINDING GLOBULIN;SOMATOTROPIC CELL;TRIPLE-NEGATIVE BREAST CANCER;ULNAR ARTERY;VEDOLIZUMAB","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;AGED;ITALY;MIDDLE AGED;PERCUTANEOUS CORONARY INTERVENTION;THYROXINE;ARTHRITIS, INFECTIOUS;GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE;TREATMENT OUTCOME;ADULT;ANEURYSM;ANEURYSM, FALSE;ANEURYSM, INFECTED;CANDIDIASIS;CAROTID ARTERY DISEASES;CAROTID ARTERY, INTERNAL;CORONARY DISEASE","42;15;11;11;7;7;7;7;7;5;5;5;4;4;4;4;4;4;4;4","THYROID DISEASE AND HORMONE REGULATION;DEVELOPMENT AND APPLICATIONS OF RADIOPHARMACEUTICALS;MANAGEMENT OF VALVULAR HEART DISEASE;VASCULAR ACCESS FOR CORONARY PROCEDURES AND TRAUMA MANAGEMENT;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;EPIDEMIOLOGY AND MANAGEMENT OF MAXILLOFACIAL TRAUMA;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;CARDIOTOXICITY OF CANCER TREATMENTS;CLINICAL CHARACTERISTICS OF DEEP NECK INFECTIONS;DIAGNOSIS AND MANAGEMENT OF ADRENAL INSUFFICIENCY;DIAGNOSIS AND MANAGEMENT OF FUNGAL INFECTIONS;DIAGNOSIS AND MANAGEMENT OF HYPONATREMIA;DIAGNOSIS AND TREATMENT OF CAROTID ARTERY DISEASE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;ECONOMICS OF PHARMACEUTICAL RESEARCH AND DEVELOPMENT;EFFECTS OF CAFFEINE ON HUMAN HEALTH;EFFICACY AND RESISTANCE IN CML TREATMENT","5;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","HYPOTHYROIDISM;HYPERTHYROIDISM;LEVOTHYROXINE;THYROID HORMONE;MACE;PROSTHETIC VALVES EVALUATION;ALPHA PARTICLE THERAPY;BICUSPID AORTIC VALVE;BIOSIMILAR;CLINICAL ENDPOINT;CONCOMITANT;CORONARY STENTS;FEMORAL ACCESS;FORMULARY;NK CELL ACTIVATION;NK CELL DEVELOPMENT;NK CELL RECOGNITION;RADIAL ACCESS;RADIUM-223;SORE THROAT","6;5;5;5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","AORTIC VALVE;PERCUTANEOUS CORONARY;ACCESS PROGRAM;ACUTE CORONARY;BICUSPID AORTIC;BREAST CANCER;CASTRATION-RESISTANT PROSTATE;CORONARY INTERVENTION;FEMORAL ACCESS;INFLAMMATORY BOWEL;INTRODUCTIVE ANALYSIS;METASTATIC CASTRATION-RESISTANT;NEWLY DIAGNOSED;ORAL LIQUID;PATIENTS TREATED;POPULATION-BASED STUDY;PROGRAM EAP;PROSTATE CANCER;SOUTHERN ITALY;AB PRECLINICAL;ACUTE EXACERBATION;ACUTE KIDNEY;ACUTE STENT;ALKALINE PHOSPHATASE;ALP DYNAMICS;AMERICAN THYROID;ANDROGEN RECEPTOR;ANEURYSM REPAIR;ANTIBIOTIC-LOADED CEMENT;AORTIC STRAIN","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","FEMORAL ACCESS;PTS TREATED;RADIAL ACCESS;ALP DECLINE;CD PATIENTS;CONCOMITANT BTA;TARGETED THERAPIES;BONE METASTASES;CONFIRMED ALP;NK CELLS;NON-BIOLOGICAL TARGETED;PAS- PATIENTS;PSA PATIENTS;REFRACTORY HYPOTHYROIDISM;RR CI;THYROID DISEASE;AUTOIMMUNE DISEASE;BREAST CANCER;GG POLYMORPHISM;LONGITUDINAL STRAIN;LUNG CANCER;PAI- GENE;PARKINSON DISEASE;PTS RECEIVED;RECEIVED RA-;RISK FACTORS;TABLET L-THYROXINE;TWELVE WEEKS;UC PATIENTS;WHITE MATTER","8;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,5.89,479.89,7.96,4,0.44,48.11,0,0,3,1,0,0,0,5,0,4,5,0,0,0,0,0,0,8,1,0,9,0,0,0,0,0,0,0,0,0,"Italy;United States;Denmark;Japan","7;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","9;6;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;MINORITY HEALTH;RARE DISEASES;BRAIN DISORDERS;PATIENT SAFETY;BEHAVIORAL AND SOCIAL SCIENCE;DEPRESSION;HEALTH DISPARITIES;HEMATOLOGY;MAJOR DEPRESSIVE DISORDER;MENTAL HEALTH;MENTAL ILLNESS;PREVENTION;SERIOUS MENTAL ILLNESS;AGING;ALS;ATHEROSCLEROSIS;CANCER;CARDIOVASCULAR","8;5;4;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1","MENTAL HEALTH;CANCER;CARDIOVASCULAR;INFECTION;MUSCULOSKELETAL;NEUROLOGICAL","2;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;7.1 INDIVIDUAL CARE NEEDS;8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)","7;2;1;1;1","LUNG CANCER;MYELOMA","1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"PUBLIC LIBRARY OF SCIENCE","7","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY;49 MATHEMATICAL SCIENCES;44 HUMAN SOCIETY;4905 STATISTICS","11;4;2;2;1;1","DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;HEPATITIS - C;INFECTIOUS DISEASES;LIVER DISEASE;CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;MINORITY HEALTH;WOMEN'S HEALTH","5;5;5;5;5;5;4;2;1;1","INFECTION;ORAL AND GASTROINTESTINAL","3;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","6;1","CLINICAL;BIOMEDICAL","3;2","CLINICAL MEDICINE AND SCIENCE","6","LIVER CANCER","4",NA,NA
"AOUSSN_GMARTINO",2018,88,17.4204545454545,2.09090909090909,0.284090909090909,0.272727272727273,0.25,1.4375,1.13636363636364,1.33333333333333,1.04761904761905,0.534090909090909,2,39,13,7,12,0.44,0.15,0.08,0.14,18.8,0.616077680980581,6.22185430463576,0.306818181818182,0.909090909090909,0.454,0.349,0.368,0.28,"SALVATORE BENVENGA;WALTER FRIES;MARCO VENTIMIGLIA;AMBROGIO ORLANDO;SEBASTIANO SIRINGO;SARA RENNA;L. AUDITORE;JOSEP M. CAMPISTOL;ROSALBA ORLANDO;FABIO SALVATORE MACALUSO;ANTONIO MAGNANO;MARIA CAPPELLO;MARIO COTTONE;PAOLO CALABRÒ;FILIPPO RUSSO;P. JAMES B. DYCK;BRADLEY MCEVOY;STEPHEN B. HEITNER;MORIE A. GERTZ;ROBERTO VITA","10;6;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4","SALVATORE BENVENGA;L. AUDITORE;LUCA LONGOBARDO;M GIOFFR�-FLORIO;SERGIO BALDARI;ERNESTO AMATO;A. ITALIANO;ROBERTO VITA;SALVATORE ARENA;M.C. ANGIOCCHI;SARAH PERELLI;GIOVANNI CAPODICASA;FRANCESCO CENTOFANTI;D ORTOLÀ;S MARCELLINO;DOMENICO FENGA;ROSA;GIUSEPPE ANGELICO;GIOVANNI TUCCARI;FRANCESCO ARENA","1.85;1.04;1;1;0.92;0.88;0.88;0.56;0.5;0.45;0.42;0.42;0.4;0.4;0.4;0.4;0.4;0.39;0.39;0.39","SALVATORE BENVENGA;WALTER FRIES;L. AUDITORE;GIUSEPPE VITA;SERGIO BALDARI;GIUSEPPE ANDÒ;CONCETTA FERRACANE;M.C. ANGIOCCHI;A. BROGNA;GIANLUCA TRIFIRÓ;IGNAZIO SALAMONE;DOMENICO CUCINOTTA;GIUSEPPE ANGELICO;SALVATORE CANNAVÒ;M SCOLARO;F. MIDILI;P. INFERRERA;ALBERTO NOTO;S. LANZAFAME;A. DI PASQUALE","10;6;5;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2","SALVATORE BENVENGA;L. AUDITORE;LUCA LONGOBARDO;M GIOFFR�-FLORIO;SERGIO BALDARI;M.C. ANGIOCCHI;D ORTOLÀ;S MARCELLINO;DOMENICO FENGA;ROSA;GIUSEPPE ANGELICO;GIOVANNI TUCCARI;FRANCESCO ARENA;ANTONIO IENI;AL SACCONE;H ALIFEROPULOS;C PICCIONE;SALVATORE CRIMI;IGNAZIO SALAMONE;EPIFANIO MONDELLO","1.85;1.04;1;1;0.92;0.45;0.4;0.4;0.4;0.4;0.39;0.39;0.39;0.39;0.33;0.33;0.33;0.31;0.29;0.29","ALESSANDRO LUPI;ANDREA SANTARELLI;ANTONIO ZINGARELLI;ARTURO AUSIELLO;BERNARDO CORTESE;ENRICO FRIGOLI;FILIPPO RUSSO;GENNARO SARDELLA;GIOVANNI ESPOSITO;GIUSEPPE ANDÒ;MARCO VALGIMIGLI;PAOLO CALABRÒ;PAOLO SGANZERLA;PASCAL VRANCKX;ROBERTO GARBO;SERGIO LEONARDI;SIMONE TRESOLDI;STEFANO GARDUCCI;STEPHAN WINDECKER;UGO LIMBRUNO","328;328;328;328;328;328;328;328;328;328;328;328;328;328;328;328;328;328;328;328","GIUSEPPE ANDÒ;GIOVANNI CONTI;SALVATORE BENVENGA;M GIOFFR�-FLORIO;WALTER FRIES;ALBERTO NOTO;P. MONDELLO;DOMENICO CUCINOTTA;GIUSEPPINA RUSSO;MARIA BUCCAFUSCA;ALFREDO CONTI;ANTONINO GERMANÒ;ANTONINO SCIBILIA;EGIDIO IMBALZANO;FELICE ESPOSITO;FILIPPO FLAVIO ANGILERI;FRANCESCO TOMASELLO;GIOVANNI RAFFA;SALVATORE CARDALI;SALVATORE CRIMI","328;275;135;103;92;91;71;67;67;57;45;45;45;45;45;45;45;45;45;42","SALVATORE BENVENGA;WALTER FRIES;L. AUDITORE;GIUSEPPE ANDÒ;GIUSEPPE VITA;SERGIO BALDARI;ANTONIO IENI;A. BROGNA;M.C. ANGIOCCHI;A. DI PASQUALE;ALBERTO NOTO;ANTONIO MICALI;C. SIRAGUSA;EGIDIO IMBALZANO;EPIFANIO MONDELLO;F. MIDILI;GIOVANNI CONTI;GIOVANNI TUCCARI;GIUSEPPE ANGELICO;I. IELO","10;6;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;CHEMISTRY;ENGINEERING;PSYCHOLOGY;ECONOMICS;MATERIALS SCIENCE;ENVIRONMENTAL SCIENCE;GEOLOGY;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY","86;21;12;8;8;7;7;4;3;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;GASTROENTEROLOGY;GENETICS;CARDIOLOGY;NUCLEAR MEDICINE;PATHOLOGY;PEDIATRICS;RADIOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;STATISTICS;BIOCHEMISTRY;FAMILY MEDICINE;MECHANICAL ENGINEERING;PHYSICAL THERAPY;ANESTHESIA;CLINICAL PSYCHOLOGY;EMERGENCY MEDICINE;MEDICAL PHYSICS;PSYCHIATRY;QUANTUM MECHANICS","65;17;15;12;11;11;11;10;10;9;8;6;6;6;5;5;5;5;4;4;4;4;4;4","DISEASE;COHORT;GENE;MYOCARDIAL INFARCTION;POPULATION;MONTE CARLO METHOD;THYROID;CANCER;STROKE (ENGINE);ADVERSE EFFECT;AMYLOIDOSIS;RANDOMIZED CONTROLLED TRIAL;TRANSTHYRETIN;ANTIBIOTICS;BACTERIA;BLOOD PRESSURE;CHEMOTHERAPY;CONFIDENCE INTERVAL;HEART FAILURE;HORMONE;ODDS RATIO;POLYNEUROPATHY;PROPENSITY SCORE MATCHING;RADIONUCLIDE","19;9;8;8;8;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","CROHN'S DISEASE;INFLAMMATORY BOWEL DISEASE;CLINICAL ENDPOINT;THYROIDITIS;ULCERATIVE COLITIS;ACUTE CORONARY SYNDROME;ADALIMUMAB;AGE OF ONSET;INFLIXIMAB;LEVOTHYROXINE;ABSORBED DOSE;AUTOANTIBODY;DIMETHYL FUMARATE;DOWNREGULATION AND UPREGULATION;FINGOLIMOD;GLATIRAMER ACETATE;HAZARD RATIO;PARKINSON'S DISEASE;PENUMBRA;PERCUTANEOUS CORONARY INTERVENTION;PSEUDOMONAS AERUGINOSA;REVASCULARIZATION;THYROID PEROXIDASE;TIGECYCLINE;TRIIODOTHYRONINE","5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","AMYLOID POLYNEUROPATHY;BIVALIRUDIN;POUCHITIS;TERIFLUNOMIDE;THYROXINE-BINDING GLOBULIN;VEDOLIZUMAB;ACINETOBACTER BAUMANNII;AMYLOID FIBRIL;ANTI-THYROID AUTOANTIBODIES;CELL CYCLE CHECKPOINT;COMPARATIVE GENOMIC HYBRIDIZATION;CONNECTIVE TISSUE DISEASE;COPY-NUMBER VARIATION;CYBERKNIFE;DEPERSONALIZATION;DIASTOLIC FUNCTION;DISEASE MANAGEMENT;FAMILY PLANNING;GOLIMUMAB;HEPACIVIRUS;INJURY SEVERITY SCORE;INSULIN RECEPTOR;MAMMOGRAPHY;OSTEONECROSIS OF THE JAW;OXALIPLATIN;PIRFENIDONE;POLYCYSTIC OVARY;RANIBIZUMAB;RIBONUCLEOPROTEIN;SANGER SEQUENCING;SOMATROPIN;SPLANCHNIC CIRCULATION;TAKOTSUBO SYNDROME;VANCOMYCIN","3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;ITALY;AGED;ACUTE CORONARY SYNDROME;PERCUTANEOUS CORONARY INTERVENTION;ADENOCARCINOMA;ANTINEOPLASTIC AGENTS;TREATMENT OUTCOME;HEMORRHAGE;ADOLESCENT;ANTICOAGULANTS;CROSS INFECTION;HEPARIN;HIRUDINS;PEPTIDE FRAGMENTS","54;32;26;25;19;16;16;14;13;10;9;9;8;7;6;6;6;6;6;6","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEALTH RISKS OF MEDICAL IMAGING RADIATION EXPOSURE;MOLECULAR MECHANISMS OF AMYLOIDOSIS;THYROID DISEASE AND HORMONE REGULATION;RADIOTHERAPY PHYSICS AND TECHNOLOGY;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF PROSTHETIC JOINT INFECTIONS;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEPATITIS C INFECTION AND TREATMENT;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;STANDARDISATION AND MANAGEMENT OF COPD;VASCULAR ACCESS FOR CORONARY PROCEDURES AND TRAUMA MANAGEMENT;;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;ATOPIC DERMATITIS AND SKIN MICROBIOME;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE","5;4;4;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","MONTE CARLO SIMULATIONS;STROKE (ENGINE);TREATMENT;CLINICAL ENDPOINT;HYPERTHYROIDISM;HYPOTHYROIDISM;THYROID HORMONE;TRANSTHYRETIN;AMYLOID POLYNEUROPATHY;BIVALIRUDIN;LEVOTHYROXINE;BIOSIMILAR;COPD;DIMETHYL FUMARATE;DISCONTINUATION;DRUG-INDUCED COLITIS;GLATIRAMER ACETATE;HEPATITIS C;IMAGE-GUIDED RADIOTHERAPY;IMAGING","6;5;5;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2","MONTE CARLO;HEREDITARY TRANSTHYRETIN;INFLAMMATORY BOWEL;TRANSTHYRETIN AMYLOIDOSIS;ACUTE CORONARY;BOWEL DISEASE;PHASE STUDY;STUDY NEURO-TTR;ANTERIOR CIRCULATION;CHRONIC OSTEOMYELITIS;CORONARY SYNDROMES;CROHNS DISEASE;CROSS-SECTIONAL SURVEY;DIMETHYL FUMARATE;FEMORAL ACCESS;INCREASED REQUIREMENT;INVASIVE MANAGEMENT;NON-NAÏVE PATIENTS;NUCLEAR MEDICINE;POSTPARTUM THYROIDITIS;PRELIMINARY RESULTS;PROPENSITY SCORE-MATCHED;RADIAL VERSUS;SCORE-MATCHED COMPARISON;SICILIAN NETWORK;THALASSEMIA MAJOR;UNDERGOING INVASIVE;UPPER LIMB;VERSUS FEMORAL;VESSEL OCCLUSIONS","6;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ICLT VE;COPD PATIENTS;INFLAMMATORY BOWEL;BOWEL DISEASE;SERUM TSH;SIGNIFICANT DIFFERENCES;ACCESS SITE;COMBINATION THERAPY;DISEASE ACTIVITY;INFUSION REACTIONS;NON-NAÏVE PATIENTS;PROPENSITY SCORE;ANTIBIOTIC RESISTANCE;CLINICAL BENEFIT;CLINICAL PRACTICE;IBD PATIENTS;IFX ADA;INCREASED L-T;INCREASED REQUIREMENT;INFLIXIMAB BIOSIMILARS;INTENSIVE CARE;ISOECHOIC NODULES;LATERAL INCISORS;MEDIAN FOLLOW-UP;PATIENTS TREATED;PRIMARY CARE;REGRESSION ANALYSIS;RETROSPECTIVE STUDY;SERUM CALCIUM;SERUM ESTRADIOL","11;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,3,363.17,4.8,3,0.5,75.5,0,0,0,0,4,0,0,2,0,5,1,0,0,0,0,0,0,6,0,0,6,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","6;3;2;2;2;2;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;RARE DISEASES;BRAIN DISORDERS;CYSTIC FIBROSIS;LUNG;MENTAL HEALTH;PEDIATRIC;AUTISM;AUTOIMMUNE DISEASE;BASIC BEHAVIORAL AND SOCIAL SCIENCE;BEHAVIORAL AND SOCIAL SCIENCE;CHRONIC LIVER DISEASE AND CIRRHOSIS;COMPARATIVE EFFECTIVENESS RESEARCH;CROHN'S DISEASE;DEPRESSION;HEMATOLOGY;HEPATITIS;HEPATITIS - B","4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CONGENITAL;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;ORAL AND GASTROINTESTINAL","2;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","4;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,"SCIELO JOURNALS;KARGER PUBLISHERS","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","6;3;1","CANCER;RARE DISEASES;CHRONIC LIVER DISEASE AND CIRRHOSIS;CLINICAL RESEARCH;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEPATITIS;HEPATITIS - C;INFECTIOUS DISEASES;LIVER DISEASE","2;2;1;1;1;1;1;1;1;1","INFECTION","1","2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;6.1 PHARMACEUTICALS","1;1",NA,NA,"CLINICAL MEDICINE AND SCIENCE","3","THYROID CANCER;LIVER CANCER","2;1",NA,NA
"AOUSSN_GMARTINO",2019,75,16.1066666666667,2.06666666666667,0.28,0.226666666666667,0.293333333333333,1.35964912280702,1.10526315789474,1.13333333333333,1,0.586666666666667,2,29,13,5,11,0.39,0.17,0.07,0.15,26.63,1.09498663976572,6.20172910662824,0.266666666666667,0.92,0.477,0.351,0.432,0.393,"SALVATORE BENVENGA;GIANLUCA TRIFIRÓ;YLENIA INGRASCIOTTA;ROBERTO VITA;DOMENICO SANTORO;SALVATORE CANNAVÒ;SALVATORE SCONDOTTO;SERGIO LUCIO VINCI;JANET SULTANA;VALENTINA IENTILE;PAOLO CALABRÒ;DANIELE UGO TARI;ANDREA ZINI;ANDREA SALETTI;GIUSEPPE REMUZZI;VALENTINA SAIA;ROBERTO GASPAROTTI;NARAYANA PIPITÒ;MARCO VALGIMIGLI;FILIPPO BENEDETTO","8;8;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","SALVATORE BENVENGA;ROBERTO CHIMENZ;ROBERTO VITA;GIANLUCA TRIFIRÓ;YLENIA INGRASCIOTTA;DAVID BARILLÀ;JANET SULTANA;SALVATORE CANNAVÒ;SALVATORE ARENA;FLAVIA DI BARI;FRANCESCO FERRAÙ;NARAYANA PIPITÒ;FILIPPO BENEDETTO;DOMENICO SPINELLI;FRANCESCO ZANCHETTA;LUCIANA RIGOLI;LUIGI TROISI;ERNESTO AMATO;MATTHEW BORG;VALERIA CERNARO","2.62;1.1;1.05;0.9;0.66;0.56;0.53;0.5;0.5;0.47;0.4;0.4;0.4;0.4;0.33;0.33;0.33;0.33;0.33;0.33","SALVATORE BENVENGA;GIANLUCA TRIFIRÓ;DOMENICO SANTORO;SALVATORE CANNAVÒ;SERGIO LUCIO VINCI;VALENTINA IENTILE;NARAYANA PIPITÒ;FILIPPO BENEDETTO;ROSARIO PAPA;AGOSTINO TESSITORE;FRANCESCO FERRAÙ;ANTONIO PITRONE;ANGELA ALIBRANDI;DAVID BARILLÀ;GIUSEPPE ANDÒ;DOMENICO SPINELLI;ROMINA GALLIZZI;WALTER FRIES;VANESSA INNAO;GUIDO FERLAZZO","8;8;5;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2","SALVATORE BENVENGA;ROBERTO CHIMENZ;GIANLUCA TRIFIRÓ;DAVID BARILLÀ;SALVATORE CANNAVÒ;FRANCESCO FERRAÙ;NARAYANA PIPITÒ;FILIPPO BENEDETTO;DOMENICO SPINELLI;FRANCESCO ZANCHETTA;LUCIANA RIGOLI;VALERIA CERNARO;GRAZIANA DERONE;VALENTINA IENTILE;DOMENICO SANTORO;ALFREDO BLANDINO;ALFREDO CAMPENNÌ;SERGIO BALDARI;STEFANO PERGOLIZZI;GIUSEPPE GIUFFRÈ","2.62;1.1;0.9;0.56;0.5;0.4;0.4;0.4;0.4;0.33;0.33;0.33;0.31;0.31;0.28;0.28;0.27;0.26;0.26;0.25","FABRIZIO DE BENEDETTI;FRANCESCO LA TORRE;MARCO CATTALINI;MARIA ALESSIO;MARIA CRISTINA MAGGIO;ROLANDO CIMAZ;ROMINA GALLIZZI;ALMA NUNZIA OLIVIERI;ANTONELLA INSALACO;CARLA GAGGIANO;CARLO SALVARANI;CLAUDIA BRACAGLIA;CLAUDIA FABIANI;DONATO RIGANTE;GIUSEPPE LOPALCO;JURGEN SOTA;LUCA CANTARINI;MANUELA PARDEO;PAOLO SFRISO;SALVATORE GROSSO","621;621;621;621;621;621;621;614;614;614;614;614;614;614;614;614;614;614;614;614","ROMINA GALLIZZI;ALESSANDRO DI GIORGIO;ANTONIO PITRONE;CARMELO RODOLICO;DOMENICO SANTORO;SERGIO LUCIO VINCI;SALVATORE BENVENGA;GIOVANNI EGITTO;GIUSEPPE CANNAVÒ;ERIKA MESSINA;FRANCESCA GRANATA;FRANCESCO FERRAÙ;FRANCESCO GRILLO;SERGIO BALDARI;AGOSTINO TESSITORE;GIANLUCA TRIFIRÓ;SALVATORE GIOVINAZZO;C. TUONO;SALVATORE CANNAVÒ;ALESSANDRO VENTO","621;296;110;108;106;87;80;76;76;72;72;72;71;68;61;57;57;53;52;50","SALVATORE BENVENGA;GIANLUCA TRIFIRÓ;ANTONIO PITRONE;SERGIO LUCIO VINCI;VALENTINA IENTILE;AGOSTINO TESSITORE;DOMENICO SANTORO;ERIKA MESSINA;FRANCESCA GRANATA;FRANCESCO FERRAÙ;FRANCESCO GIORGIANNI;FRANCESCO GRILLO;GIOVANNI EGITTO;GIUSEPPE ANDÒ;GIUSEPPE CANNAVÒ;GUIDO FERLAZZO;LUCIANA RIGOLI;ROBERTO CHIMENZ;ROMINA GALLIZZI;ROSARIO PAPA","7;5;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;ENGINEERING;ECONOMICS;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;SOCIOLOGY;CHEMISTRY;ART;BUSINESS;GEOGRAPHY;PHILOSOPHY","73;18;9;7;7;6;4;3;3;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GASTROENTEROLOGY;RADIOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PEDIATRICS;CARDIOLOGY;GENETICS;ONCOLOGY;ECONOMIC GROWTH;INTENSIVE CARE MEDICINE;ANESTHESIA;MECHANICAL ENGINEERING;PHARMACOLOGY;PHYSICAL THERAPY;FAMILY MEDICINE;PSYCHIATRY","56;18;13;11;10;9;9;9;9;8;8;8;6;6;5;5;5;5;4;4","COHORT;CONFIDENCE INTERVAL;MYOCARDIAL INFARCTION;ADVERSE EFFECT;POPULATION;RETROSPECTIVE COHORT STUDY;THYROID;RANDOMIZED CONTROLLED TRIAL;BIOSIMILAR;DISEASE;DRUG;HEALTH CARE;OBSERVATIONAL STUDY;STROKE (ENGINE);ANEMIA;CHEMOTHERAPY;LOGISTIC REGRESSION;MEDICAL PRESCRIPTION;ANEURYSM;ANTIBODY;CANCER;COHORT STUDY;GENE;ISCHEMIA;KIDNEY DISEASE;LUNG;LUNG CANCER;OCCLUSION;PROPORTIONAL HAZARDS MODEL;RADIATION THERAPY;STENT","13;8;8;7;7;7;7;6;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","HAZARD RATIO;THYROIDITIS;CLINICAL ENDPOINT;THROMBOLYSIS;ACUTE CORONARY SYNDROME;CONVENTIONAL PCI;CROHN'S DISEASE;ERYTHROPOIESIS;GRAVES' DISEASE;INFLAMMATORY BOWEL DISEASE;INFLIXIMAB;ISCHEMIC STROKE;LENALIDOMIDE;PERCUTANEOUS CORONARY INTERVENTION;PHARMACOEPIDEMIOLOGY;RADIOSURGERY;THYROID NODULES;TOCILIZUMAB;TOLERABILITY;ULCERATIVE COLITIS","4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BIVALIRUDIN;MODIFIED RANKIN SCALE;ACROMEGALY;ACTINOBACTERIA;ANTI-THYROID AUTOANTIBODIES;BACTEROIDETES;BRUCELLA MELITENSIS;CANAKINUMAB;CARFILZOMIB;CD11C;CRITICAL LIMB ISCHEMIA;DASATINIB;DIFFUSE ALVEOLAR DAMAGE;DIFFUSING CAPACITY;ECULIZUMAB;ENDOVASCULAR ANEURYSM REPAIR;FIRMICUTES;FRAMESHIFT MUTATION;GAMMAPROTEOBACTERIA;GLOMERULOPATHY;GLUTATHIONE PEROXIDASE;IMATINIB MESYLATE;INTERLEUKIN 12;INTRAVOXEL INCOHERENT MOTION;MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;NATURAL KILLER CELL;NILOTINIB;NIVOLUMAB;OLIGOARTHRITIS;OMALIZUMAB;PHYLOTYPE;PILON FRACTURE;POUCHITIS;PROLACTINOMA;PSEUDOALTEROMONAS;RUBELLA;SWORDFISH;THORACIC AORTIC ANEURYSM;TRAB;TYMPANOMETRY","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;ADULT;AGED;MIDDLE AGED;ITALY;STROKE;TREATMENT OUTCOME;NEOPLASMS;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;YOUNG ADULT;ANTIBODIES, MONOCLONAL, HUMANIZED;RENAL INSUFFICIENCY, CHRONIC;ACUTE CORONARY SYNDROME;ANEMIA;BONE MARROW;BRAIN ISCHEMIA","37;36;26;23;18;18;17;14;11;10;9;9;8;8;7;7;6;6;6;6","THYROID DISEASE AND HORMONE REGULATION;IMMUNOGENICITY OF BIOSIMILAR THERAPEUTICS IN DRUG DEVELOPMENT;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EFFICACY AND RESISTANCE IN CML TREATMENT;FACTORS AFFECTING VACCINE HESITANCY AND ACCEPTANCE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;ROLE OF ERYTHROPOIETIN IN DISEASE TREATMENT AND MANAGEMENT;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;AUTISM SPECTRUM DISORDERS;BREAST MAGNETIC RESONANCE IMAGING IN ONCOLOGY;BRUCELLOSIS: A RE-EMERGING ZOONOSIS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF FIBROMYALGIA SYNDROME;DIAGNOSIS AND MANAGEMENT OF HYPONATREMIA;DIAGNOSIS AND MANAGEMENT OF IGG4-RELATED DISEASE","6;5;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","HYPERTHYROIDISM;HYPOTHYROIDISM;BIOSIMILAR;STROKE (ENGINE);MEDICATION ADHERENCE;TREATMENT;CLINICAL ENDPOINT;THYROID HORMONE;BIVALIRUDIN;CROSS-SECTIONAL STUDY;DISCONTINUATION;ERYTHROPOIESIS-STIMULATING AGENTS;FIBROUS CAP;GROUP B;IMMUNIZATION COVERAGE;INFARCTION TREATMENT;INTERNATIONAL MYELOMA WORKING GROUP;INTERQUARTILE RANGE;IRON OVERLOAD;NEPHROLOGY","6;6;5;5;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2","SOUTHERN ITALY;COHORT STUDY;IDIOPATHIC ARTHRITIS;INFLAMMATORY BOWEL;JUVENILE IDIOPATHIC;OBSERVATIONAL STUDY;ACUTE CORONARY;BIVALIRUDIN INFUSION;BONE MARROW;BOWEL DISEASE;CHRONIC KIDNEY;CORONARY SYNDROME;ENDOVASCULAR TREATMENT;ERYTHROPOIESIS-STIMULATING AGENTS;KIDNEY DISEASE;LUNG CANCER;MYELOMA PATIENTS;PATIENTS TREATED;POPULATION-BASED STUDY;POSTPARTUM THYROIDITIS;PROSPECTIVE OBSERVATIONAL;STABLE CONSUMPTION;AB BIOMARKERS;AB EAR;ACCESS SITE;ACE CATHETERS;ACTIVATING RECEPTOR;ACUTE HYPOXEMIC;ACUTE STROKE;ADVANCED NON-SMALL","4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","PATIENTS TREATED;BIVALIRUDIN INFUSION;HR CI;MESSINA ITALY;HAZARD RATIO;MECHANICAL THROMBECTOMY;NK CELLS;EMICIZUMAB PROPHYLAXIS;ESA Α;INFLAMMATORY MYOFIBROBLASTIC;SPEAKERS BUREAU;CKD PATIENTS;HOMOZYGOUS ΒΒ;INTRAVENOUS THROMBOLYSIS;LUNG CANCER;MONTHS FU;OTSUKA PHARMACEUTICAL;BIOMEDICAL SCIENCES;COMORBID FMS;CONFIDENCE INTERVAL;ELDERLY PERSONS;ESA HYPORESPONSIVENESS;HOSPITAL MESSINA;JIA PATIENTS;LATE GADOLINIUM;MARTINO UNIVERSITY;MYOCARDIAL INFARCTION;MYOFIBROBLASTIC TUMOR;PRIMARY ENDPOINT;SOCIAL EXCLUSION","11;10;10;10;9;9;9;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,4.17,593.42,12,4,0.33,48.42,0,0,2,0,4,0,0,6,0,11,1,0,0,0,0,0,0,12,0,0,12,0,0,0,0,0,0,0,0,0,"United States;Italy;Japan","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;3213 PAEDIATRICS","12;6;3;3;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;PEDIATRIC;RARE DISEASES;BEHAVIORAL AND SOCIAL SCIENCE;CHRONIC LIVER DISEASE AND CIRRHOSIS;HEPATITIS;LIVER DISEASE;NEUROSCIENCES;NUTRITION;COMPLEMENTARY AND INTEGRATIVE HEALTH;HEPATITIS - B;INFECTIOUS DISEASES;WOMEN'S HEALTH;AUTISM;BRAIN DISORDERS;CANCER;CHRONIC PAIN;EYE DISEASE AND DISORDERS OF VISION","11;9;5;4;4;3;3;3;3;3;3;2;2;2;2;1;1;1;1;1","INFECTION;ORAL AND GASTROINTESTINAL;CANCER;MENTAL HEALTH","2;2;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","9;1;1;1;1","LIVER CANCER;ESOPHAGEAL / OESOPHAGEAL CANCER;MYELOMA;PANCREATIC CANCER;STOMACH CANCER","2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;6.2 SURVEILLANCE","3;2;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE","8;3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3213 PAEDIATRICS;46 INFORMATION AND COMPUTING SCIENCES;49 MATHEMATICAL SCIENCES;4904 PURE MATHEMATICS","18;8;2;1;1;1;1;1","PATIENT SAFETY;BRAIN DISORDERS;CLINICAL RESEARCH;HEADACHES;MIGRAINES;NEUROSCIENCES;PAIN RESEARCH;PEDIATRIC;GENETICS","5;3;3;3;3;3;3;3;2","NEUROLOGICAL","3","6.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION","5;3","CLINICAL","3","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","3;1","NOT SITE-SPECIFIC CANCER","5",NA,NA
"AOUSSN_GMARTINO",2020,89,17.4494382022472,2.64044943820225,0.202247191011236,0.303370786516854,0.359550561797753,1.59863945578231,0.947368421052632,1.58823529411765,1.14285714285714,0.595505617977528,1,40,21,7,9,0.45,0.24,0.08,0.1,13.91,0.5520199863943,6.70100502512563,0.224719101123595,0.921348314606742,0.44,0.278,0.397,0.31,"ANNA VIOLA;MARCO VENTIMIGLIA;WALTER FRIES;SERENA GARUFI;S. CAMILLERI;GIANLUCA TRIFIRÓ;FABIO SALVATORE MACALUSO;AMBROGIO ORLANDO;SARA RENNA;CARMELO BERTOLAMI;ROSALBA ORLANDO;GIULIA RIZZUTO;DOMENICO SANTORO;LUCIO CASTELLAN;MAURO BERGUI;MARIA CAPPELLO;R. MENOZZI;FILIPPO MOCCIARO;ANDREA ZINI;SALVATORE BENVENGA","9;8;8;8;8;8;8;7;7;7;7;7;6;6;6;6;6;5;5;5","SALVATORE BENVENGA;GIANLUCA TRIFIRÓ;GIUSEPPE PELLICANE;JANET SULTANA;CESARE DE GREGORIO;DOMENICO SANTORO;GAETANO CARAMORI;SERGIO BALDARI;GIUSEPPE FERRAZZO;SAVERIO LODDO;ROBERTO VITA;C. CACCAMO;GUIDO GEMBILLO;GIOVANNI SCAMBIA;ALFREDO ERCOLI;ALESSIA REMIGANTE;ANGELA MARINO;VINCENZO TRICHILO;ROSSANA MORABITO;RICCARDO LAUDICELLA","1.48;1.03;0.81;0.78;0.58;0.55;0.55;0.53;0.5;0.48;0.48;0.48;0.42;0.41;0.41;0.41;0.41;0.41;0.41;0.41","ANNA VIOLA;WALTER FRIES;GIANLUCA TRIFIRÓ;DOMENICO SANTORO;SALVATORE BENVENGA;GAETANO CARAMORI;VALENTINA IENTILE;SAVERIO LODDO;GUIDO GEMBILLO;SERGIO BALDARI;ALFREDO ERCOLI;GUIDO FERLAZZO;VINCENZO TRICHILO;IRENE COPPOLINO;RICCARDO LAUDICELLA;ALFIO PROIETTO;FEDERICA LO BELLO;ROSSELLA SILIGATO;GIUSEPPE PELLICANE;ANTONIO PONTORIERO","9;8;8;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3","SALVATORE BENVENGA;GIANLUCA TRIFIRÓ;GIUSEPPE PELLICANE;CESARE DE GREGORIO;DOMENICO SANTORO;GAETANO CARAMORI;SERGIO BALDARI;SAVERIO LODDO;GUIDO GEMBILLO;ALFREDO ERCOLI;VINCENZO TRICHILO;RICCARDO LAUDICELLA;ANNA VIOLA;WALTER FRIES;VALENTINA IENTILE;ROSSELLA SILIGATO;ROSARIA OTERI;OLIMPIA MUSUMECI;ANTÓNIO TOSCANO;GIOVANNI TUCCARI","1.48;1.03;0.81;0.58;0.55;0.55;0.53;0.48;0.42;0.41;0.41;0.41;0.41;0.37;0.37;0.34;0.33;0.33;0.33;0.3","GUIDO FERLAZZO;LUCIO CASTELLAN;MAURO BERGUI;R. MENOZZI;ANNA VIOLA;MARIA CAPPELLO;ANDREA ZINI;DANILO TONI;DOMENICO INZITARI;FABRIZIO SALLUSTIO;GIOVANNI PRACUCCI;GUIDO BIGLIARDI;MANUEL CAPPELLARI;MAURO MAGONI;PATRIZIA NENCINI;ROBERTO GASPAROTTI;ROSSANA TASSI;STEFANO VALLONE;VALENTINA SAIA;ALESSANDRO DE VITO","160;156;156;156;132;132;128;128;128;128;128;128;128;128;128;128;128;128;128;126","GUIDO FERLAZZO;ANNA VIOLA;WALTER FRIES;ANTONIO PITRONE;GIUSEPPE ANDÒ;GIUSEPPE MUSUMECI;GAETANA PEZZINO;SAVERIO LODDO;VINCENZO TRICHILO;FRANCESCO GRILLO;ROSA FORTUNATA MUSOLINO;SERGIO BALDARI;ISABELLA FRANCALANZA;FRANCESCO SAVERIO DE PONTE;ROSARIA MADDALENA RUGGERI;GIOVANNI CONTI;ROMINA GALLIZZI;ALBERTO NOTO;MARCELLO LONGO;GABRIELE CERVINO","160;132;121;89;85;84;77;70;70;61;61;61;56;52;51;48;48;47;47;44","ANNA VIOLA;GIANLUCA TRIFIRÓ;WALTER FRIES;ALFREDO ERCOLI;DOMENICO SANTORO;GAETANO CARAMORI;SERGIO BALDARI;GIUSEPPE PELLICANE;GUIDO FERLAZZO;SALVATORE BENVENGA;SAVERIO LODDO;VALENTINA IENTILE;VINCENZO TRICHILO;ALFIO PROIETTO;FEDERICA LO BELLO;GUIDO GEMBILLO;IRENE COPPOLINO;ROSSELLA SILIGATO;A CENTRITTO;A. BROGNA","9;8;8;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;ECONOMICS;MATHEMATICS;SOCIOLOGY;GEOLOGY;PSYCHOLOGY;BUSINESS;HISTORY;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE","82;24;10;10;7;6;4;4;3;2;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GASTROENTEROLOGY;GENETICS;ENVIRONMENTAL HEALTH;RADIOLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;PHYSICAL THERAPY;ENDOCRINOLOGY;PALEONTOLOGY;PEDIATRICS;PHARMACOLOGY;ARTIFICIAL INTELLIGENCE;CARDIOLOGY;BIOCHEMISTRY;FAMILY MEDICINE;NUCLEAR MEDICINE;ONCOLOGY;OPTICS","69;27;16;15;11;9;9;8;8;8;7;7;7;7;6;6;5;5;5;5;5","DISEASE;POPULATION;CONFIDENCE INTERVAL;ADVERSE EFFECT;ODDS RATIO;ALTERNATIVE MEDICINE;COHORT;KIDNEY;RANDOMIZED CONTROLLED TRIAL;CANCER;LUNG;MYOCARDIAL INFARCTION;RETROSPECTIVE COHORT STUDY;ANTIBODY;ASTHMA;CONTEXT (ARCHAEOLOGY);DIABETES MELLITUS;KIDNEY DISEASE;OBSERVATIONAL STUDY;PREGNANCY;PROPENSITY SCORE MATCHING;RADIATION THERAPY;STROKE (ENGINE);THYROID","26;9;8;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","ULCERATIVE COLITIS;ADALIMUMAB;INFLAMMATORY BOWEL DISEASE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);CROHN'S DISEASE;HAZARD RATIO;INFLIXIMAB;CLINICAL ENDPOINT;GLYCATION;PERCUTANEOUS CORONARY INTERVENTION;PLACEBO;PROTEINURIA;THYROIDITIS;CD8;CYTOTOXIC T CELL;ERYTHROCYTE MEMBRANE;EUTHYROID;INTERSTITIAL LUNG DISEASE;INTRACEREBRAL HEMORRHAGE;ISCHEMIC STROKE;LIPID PEROXIDATION;METASTASIS;NEURORADIOLOGY;PLAQUE PSORIASIS;PROGRESSIVE DISEASE;PSORIATIC ARTHRITIS;SUNITINIB;T CELL;THROMBOLYSIS;TYPE 2 DIABETES;UNIVARIATE ANALYSIS","7;6;6;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);VEDOLIZUMAB;GOLIMUMAB;BAND 3;MEMBRANOUS NEPHROPATHY;MODIFIED RANKIN SCALE;P2Y12;USTEKINUMAB;ABCIXIMAB;ACTIN CYTOSKELETON;AFLIBERCEPT;APOLIPOPROTEIN A1;ATYPICAL ANTIPSYCHOTIC;DEEP BRAIN STIMULATION;DIABETIC MACULAR EDEMA;ENDOTHELIAL PROGENITOR CELL;ENTHESITIS;FAMILY PLANNING;FORMOTEROL;GLOBUS PALLIDUS;GLUCOSE HOMEOSTASIS;GLYCATED HEMOGLOBIN;HONEYCOMBING;IN SITU HYBRIDIZATION;INDOLEAMINE 2,3-DIOXYGENASE;INTERLEUKIN 12;INTERLEUKIN 21;KYNURENINE;LYMPHOVASCULAR INVASION;MITOCHONDRIAL DISEASE;MONOCLONAL;NIVOLUMAB;OMALIZUMAB;PARATHYROIDECTOMY;PAZOPANIB;PRASUGREL;RANIBIZUMAB;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;STAR POLYMER;STEREOTACTIC RADIATION THERAPY;SWORDFISH;TBARS;TERIFLUNOMIDE;THIOBARBITURIC ACID;THORACIC AORTIC ANEURYSM;TICAGRELOR;TIROFIBAN;TRACTOGRAPHY","5;5;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;AGED;CROHN DISEASE;ITALY;ANTIBODIES, MONOCLONAL, HUMANIZED;STROKE;BRAIN ISCHEMIA;COLITIS, ULCERATIVE;GASTROINTESTINAL AGENTS;ANTIBODIES, MONOCLONAL;ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL;DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;INFLAMMATORY BOWEL DISEASES","54;35;26;23;19;13;13;12;11;11;11;10;10;9;8;7;6;6;6;6","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;IDIOPATHIC PULMONARY FIBROSIS: DIAGNOSIS AND MANAGEMENT;PELVIC FLOOR DISORDERS;RECIPROCAL DEVELOPMENT OF TH17 AND TREG CELLS;AGE-RELATED MACULAR DEGENERATION RESEARCH;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;ASTHMA;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;IMMUNOGENICITY OF BIOSIMILAR THERAPEUTICS IN DRUG DEVELOPMENT;MECHANOSENSITIVE ION CHANNELS IN PHYSIOLOGY AND DISEASE;MIGRAINE PATHOPHYSIOLOGY AND TREATMENT;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;POSITRON EMISSION TOMOGRAPHY IMAGING IN ONCOLOGY;THYROID DISEASE AND HORMONE REGULATION;ADVERSE DRUG REACTIONS AND PHARMACOVIGILANCE;BIOCHEMISTRY OF DIABETIC COMPLICATIONS;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES","6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","TREATMENT;INFARCTION TREATMENT;VEDOLIZUMAB;GOLIMUMAB;MEDICATION ADHERENCE;STROKE (ENGINE);BAND 3;BIOSIMILAR;CLINICAL ENDPOINT;CONCOMITANT;ERYTHROCYTE;INTERQUARTILE RANGE;PANDEMIC;PSORIASIS;ULCERATIVE COLITIS;CANCER THERAPY;CORONAVIRUS;DEEP VEIN THROMBOSIS;DISCONTINUATION;ENDORECTAL ADVANCEMENT FLAP","6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2","INFLAMMATORY BOWEL;BOWEL DISEASE;BAND PROTEIN;CROHNS DISEASE;HUMAN ERYTHROCYTES;PROPENSITY SCORE;SCORE WEIGHTED;SICILIAN NETWORK;ULCERATIVE COLITIS;WEIGHTED COMPARISON;ACUTE CORONARY;ACUTE ISCHEMIC;ANION EXCHANGE;BIOSIMILAR SB;BOWEL DISEASES;CARDIOVASCULAR RISK;CHRONIC KIDNEY;COHORT STUDY;DIRECT THROMBECTOMY;DISEASE SN-IBD;EXCHANGE CAPABILITY;HASHIMOTOS THYROIDITIS;INFLIXIMAB BIOSIMILAR;INTEGRATED BOOST;ISCHEMIC STROKE;KIDNEY DISEASE;MONTE CARLO;MULTIPLE SCLEROSIS;ORGAN PROLAPSE;PELVIC ORGAN","6;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PATIENTS TREATED;GA VERSUS;SPEAKERS BUREAU;AOR CI;CLINICAL RESPONSE;CV RISK;INFLUENZA VACCINATION;MODIFIED RANKIN;RANKIN SCALE;STATISTICALLY SIGNIFICANT;ULCERATIVE COLITIS;ADVISORY COMMITTEES;CLINICAL BENEFIT;ENTITYS BOARD;INFLAMMATORY BOWEL;MEDIAN FOLLOW-UP;SCALE SCORE;ADULT PATIENTS;ASPLENIC PATIENTS;BODY MASS;BODY RADIATION;CLINICAL PRACTICE;DIRECT MT;INTEGRATED BOOST;LU OXODOTREOTIDE;LUTETIUM LU;ODDS RATIO;SIGNIFICANT DIFFERENCES;STEREOTACTIC BODY;ANION EXCHANGE","20;11;11;10;9;9;9;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,3,212,4.2,2,0.33,31.83,0,0,1,0,0,0,0,5,0,3,3,0,0,0,0,0,0,5,1,0,6,0,0,0,0,0,0,0,0,0,"Italy","4","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3203 DENTISTRY;3212 OPHTHALMOLOGY AND OPTOMETRY;3215 REPRODUCTIVE MEDICINE;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","6;2;1;1;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;COLO-RECTAL CANCER;COMPARATIVE EFFECTIVENESS RESEARCH;CORONAVIRUSES;DENTAL/ORAL AND CRANIOFACIAL DISEASE;DIABETES;DIGESTIVE DISEASES;EYE DISEASE AND DISORDERS OF VISION;HEALTH SERVICES;HEMATOLOGY;LYMPHATIC RESEARCH;LYMPHOMA;MATERNAL HEALTH;PATIENT SAFETY;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PREGNANCY","5;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;METABOLIC AND ENDOCRINE;REPRODUCTIVE HEALTH AND CHILDBIRTH;SKIN","1;1;1;1","6.4 SURGERY","1","COLON AND RECTAL CANCER;NON-HODGKIN'S LYMPHOMA","1;1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;6.2 SURVEILLANCE","1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PUBLIC LIBRARY OF SCIENCE;MICROBIOLOGY SOCIETY","4;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;52 PSYCHOLOGY;31 BIOLOGICAL SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3105 GENETICS;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;4205 NURSING;46 INFORMATION AND COMPUTING SCIENCES;4608 HUMAN-CENTRED COMPUTING;5203 CLINICAL AND HEALTH PSYCHOLOGY","4;4;3;2;2;1;1;1;1;1;1;1;1","CANCER;BREAST CANCER;CLINICAL RESEARCH;WOMEN'S HEALTH;AGING;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY;BRAIN DISORDERS;CANCER GENOMICS;DEPRESSION;ESTROGEN;GENETICS;HUMAN GENOME;MENTAL HEALTH;MENTAL ILLNESS;OSTEOPOROSIS;PREVENTION;REHABILITATION","4;3;3;3;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;GENERIC HEALTH RELEVANCE;MENTAL HEALTH","3;1;1","5.1 PHARMACEUTICALS;6.6 PSYCHOLOGICAL AND BEHAVIOURAL","1;1","CLINICAL","3","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","3;1","BREAST CANCER","3",NA,NA
"AOUSSN_GMARTINO",2021,104,17.3269230769231,2.11538461538462,0.192307692307692,0.230769230769231,0.201923076923077,1.54929577464789,1.11111111111111,1.2,1.16666666666667,0.653846153846154,0,45,18,22,5,0.43,0.17,0.21,0.05,9.94,0.644737288322745,6.7353579175705,0.269230769230769,0.980769230769231,0.373,0.345,0.34,0.363,"WALTER FRIES;ANNA VIOLA;FABIO SALVATORE MACALUSO;AMBROGIO ORLANDO;ROCCO SALVATORE CALABRÒ;ANTONIO MAGNANO;CONCETTA FERRACANE;MARIA GRAZIA MAGGIO;MARCO VENTIMIGLIA;SALVATORE BENVENGA;LORENZO PISTELLI;SERENA GARUFI;MARIA CAPPELLO;ANGELO CASÀ;FRANCESCA PARISI;MARCO FRANZINO;ANTONINO CARLO PRIVITERA;GIUSEPPE VITA;SARA RENNA;GIOVANNI SCAMBIA","8;8;7;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4","ROCCO SALVATORE CALABRÒ;MARIA GRAZIA MAGGIO;SALVATORE BENVENGA;MARCO CICCIÙ;LUCA FIORILLO;WALTER FRIES;ANNA VIOLA;GIUSEPPE VITA;LORENZO PISTELLI;FRANCESCA PARISI;CONCETTA ZITO;CARMELO MAZZEO;FRANCESCA VISCOSI;GIORGIO BADESSI;EUGENIO CUCINOTTA;CARMELA CASELLA;GIUSEPPE DATTILO;GIOVANNI SCAMBIA;ALFREDO ERCOLI;ANTONINO NARO","0.72;0.72;0.64;0.5;0.5;0.5;0.5;0.48;0.47;0.47;0.45;0.45;0.45;0.45;0.45;0.41;0.36;0.35;0.35;0.35","WALTER FRIES;ANNA VIOLA;SALVATORE BENVENGA;LORENZO PISTELLI;FRANCESCA PARISI;GIUSEPPE VITA;GIUSEPPE COSTANTINO;FRANCESCO COSTA;GIOVANNI CONTI;ALFREDO ERCOLI;ROMINA GALLIZZI;SALVATORE CANNAVÒ;CLAUDIO ROMANO;GIUSEPPE DATTILO;DANIELE BRUSCHETTA;DOMENICO SANTORO;ANGELO ALITO;ANTONINO NARO;MARIA CRISTINA LUCANTO;ALFREDO MANULI","8;8;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","SALVATORE BENVENGA;MARCO CICCIÙ;LUCA FIORILLO;WALTER FRIES;ANNA VIOLA;GIUSEPPE VITA;LORENZO PISTELLI;FRANCESCA PARISI;CONCETTA ZITO;CARMELO MAZZEO;FRANCESCA VISCOSI;GIORGIO BADESSI;EUGENIO CUCINOTTA;CARMELA CASELLA;GIUSEPPE DATTILO;ALFREDO ERCOLI;ANTONINO NARO;SOCRATE PALLIO;DANIELE BRUSCHETTA;ANGELO ALITO","0.64;0.5;0.5;0.5;0.5;0.48;0.47;0.47;0.45;0.45;0.45;0.45;0.45;0.41;0.36;0.35;0.35;0.34;0.34;0.34","ALESSANDRA IURLO;DAVIDE RAPEZZI;FRANCESCA LUNGHI;MASSIMILIANO BONIFACIO;ALBERTO FERRARI;ALESSANDRA CAROBBIO;ALESSANDRA RICCO;ALESSANDRO M. VANNUCCHI;ALESSANDRO RAMBALDI;ANDREA PATRIARCA;ARIANNA GHIRARDI;ARIANNA MASCIULLI;BARBARA MORA;CARMELA MANNARELLI;CATERINA MUSOLINO;CRISTINA BUCELLI;ELENA ROSSI;ELISA RUMI;EMMA CACCIOLA;FABIO CICERI","116;116;116;116;93;93;93;93;93;93;93;93;93;93;93;93;93;93;93;93","CATERINA MUSOLINO;ANTONIO ARMANDO CARAGLIANO;SAVERIA SERENA FOTI;SERGIO LUCIO VINCI;GIOVANNI CONTI;ANNA VIOLA;WALTER FRIES;ANTONINO NARO;MARIA CRISTINA LUCANTO;MARIA BUCCAFUSCA;ALFREDO MANULI;ANTONINO CANNAVÒ;ANGELO ALITO;ANTONIO PONTORIERO;GIUSEPPE IATÌ;STEFANO PERGOLIZZI;MARIACARMELA SANTARPÍA;GIUSEPPE COSTANTINO;GIUSEPPE NAVARRA;LUCA SABA","93;80;65;62;51;49;49;47;46;45;44;44;43;42;42;42;39;37;36;34","ANNA VIOLA;WALTER FRIES;SALVATORE BENVENGA;GIOVANNI CONTI;GIUSEPPE COSTANTINO;GIUSEPPE ANDÒ;ALFREDO ERCOLI;ALFREDO MANULI;ANGELO ALITO;ANTONINO CANNAVÒ;ANTONIO ARMANDO CARAGLIANO;CARMELA CASELLA;MARCO MUSCIANISI;MARIA CRISTINA LUCANTO;OLIMPIA MUSUMECI;SAVERIA SERENA FOTI;SOCRATE PALLIO;ANTONINO NARO;GIUSEPPE VITA;ALFREDO CAMPENNÌ","7;7;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2","MEDICINE;BIOLOGY;ENGINEERING;PHYSICS;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;ECONOMICS;MATERIALS SCIENCE;MATHEMATICS;SOCIOLOGY;GEOGRAPHY;POLITICAL SCIENCE","102;18;10;9;8;8;6;6;2;2;2;1;1","INTERNAL MEDICINE;SURGERY;PSYCHIATRY;GASTROENTEROLOGY;PEDIATRICS;CARDIOLOGY;ENDOCRINOLOGY;GENETICS;IMMUNOLOGY;RADIOLOGY;PATHOLOGY;PHYSICAL THERAPY;MECHANICAL ENGINEERING;ONCOLOGY;BIOCHEMISTRY;CLINICAL PSYCHOLOGY;OPTICS;ENVIRONMENTAL HEALTH;ANATOMY;ANESTHESIA;NURSING;PHYSICAL MEDICINE AND REHABILITATION","84;36;19;14;13;12;12;11;11;11;10;9;8;8;7;6;6;5;4;4;4;4","DISEASE;COHORT;CANCER;MYOCARDIAL INFARCTION;PROSPECTIVE COHORT STUDY;RETROSPECTIVE COHORT STUDY;GENE;ADVERSE EFFECT;STROKE (ENGINE);THYROID;ANTIBODY;COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;CLINICAL TRIAL;MOOD;NEUROLOGY;POPULATION;REHABILITATION;COGNITION;HORMONE;INCIDENCE (GEOMETRY);INFLAMMATION;LESION;LUNG CANCER;OBSERVATIONAL STUDY;OCCLUSION;OUTBREAK;QUALITY OF LIFE (HEALTHCARE)","27;20;12;10;10;10;9;7;7;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","CLINICAL ENDPOINT;CROHN'S DISEASE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLAMMATORY BOWEL DISEASE;ACUTE CORONARY SYNDROME;ADALIMUMAB;COLORECTAL CANCER;THYROIDITIS;ULCERATIVE COLITIS;2019-20 CORONAVIRUS OUTBREAK;EJECTION FRACTION;MUTATION;NEUROREHABILITATION;PERCUTANEOUS CORONARY INTERVENTION;AUTOANTIBODY;COGNITIVE TRAINING;GENOTYPE;HEPATITIS B VIRUS;IMMUNOTHERAPY;INFLIXIMAB;ISCHEMIC STROKE;NEUROPSYCHOLOGY;NEURORADIOLOGY;OSTEOARTHRITIS;PLATELET-RICH PLASMA;RITUXIMAB;SEROLOGY;THYROID PEROXIDASE;TRANSCRIPTION FACTOR","8;8;8;7;6;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);COLONOSCOPY;VEDOLIZUMAB;USTEKINUMAB;HBSAG;MACE;ADENOSINE DEAMINASE DEFICIENCY;ANDROGEN DEFICIENCY;ANTI-THYROID AUTOANTIBODIES;AUTOIMMUNE THYROIDITIS;BIVALIRUDIN;BOMBESIN;BONE METASTASIS;BRAIN METASTASIS;CANAKINUMAB;CARBOPLATIN;CAREGIVER BURDEN;CCL2;CD117;CONFORMATIONAL EPITOPE;COPY-NUMBER VARIATION;CXCL10;DYSKINESIA;ERLOTINIB;GASTRIC BYPASS;GENE MUTATION;GERIATRIC DEPRESSION SCALE;GERMLINE MUTATION;GOLIMUMAB;HEREDITARY SPASTIC PARAPLEGIA;INFLAMMATORY BOWEL DISEASES;INNATE LYMPHOID CELL;INTRA ARTICULAR;LAFORA DISEASE;LAMIVUDINE;MEDULLARY CARCINOMA;MODIFIED RANKIN SCALE;MULTIFOCAL MOTOR NEUROPATHY;OCRELIZUMAB;OSTEONECROSIS OF THE JAW;PAX8;PEMBROLIZUMAB;PROBAND;PYRIN DOMAIN;REPRESSOR;RESPIRATORY RATE;RIGHT CORONARY ARTERY;SINGLE-NUCLEOTIDE POLYMORPHISM;SMN1;SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION;TARGET LESION;VATS LOBECTOMY;VESICOURETERAL REFLUX","8;4;4;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;COVID-19;RETROSPECTIVE STUDIES;ITALY;MALE;MIDDLE AGED;TREATMENT OUTCOME;SARS-COV-2;ADULT;AGED;PROSPECTIVE STUDIES;STROKE;TUMOR NECROSIS FACTOR INHIBITORS;ADOLESCENT;ANTIBODIES, MONOCLONAL, HUMANIZED;CARCINOMA, NON-SMALL-CELL LUNG;CYSTIC FIBROSIS;RECOMBINANT PROTEINS","62;42;18;16;14;13;13;10;10;9;7;6;6;6;6;5;5;5;5;5","GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;IMMUNOGENICITY OF BIOSIMILAR THERAPEUTICS IN DRUG DEVELOPMENT;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;THYROID DISEASE AND HORMONE REGULATION;APPLICATIONS OF PLATELET-RICH PLASMA IN REGENERATIVE MEDICINE;ATRIAL FIBRILLATION;CARDIAC REHABILITATION AND CARDIOVASCULAR HEALTH INTERVENTIONS;COLORECTAL CANCER RESEARCH AND TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;HEPATITIS B INFECTION AND TREATMENT;IMPACT OF COVID-19 ON MENTAL HEALTH;INTEROCEPTION AND SOMATIC SYMPTOMS;PELVIC FLOOR DISORDERS;ROLE OF PERIVASCULAR ADIPOSE TISSUE IN CARDIOVASCULAR HEALTH;ADVANCEMENTS IN LUNG CANCER RESEARCH;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;APPLICATIONS OF DEEP LEARNING IN MEDICAL IMAGING;BIOCHEMISTRY OF DIABETIC COMPLICATIONS","5;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","CLINICAL ENDPOINT;STROKE (ENGINE);PANDEMIC;TREATMENT;VEDOLIZUMAB;BIOSIMILAR;CARDIAC IMAGING;CYSTIC FIBROSIS;DEPRESSION (ECONOMICS);DISCONTINUATION;DRUG-INDUCED COLITIS;INFARCTION TREATMENT;INTERQUARTILE RANGE;NEUROREHABILITATION;THYROID ANTIBODIES;USTEKINUMAB;2019-20 CORONAVIRUS OUTBREAK;AFFECT (LINGUISTICS);ANXIETY;COGNITIVE TRAINING","8;7;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","INFLAMMATORY BOWEL;ACUTE CORONARY;CORONARY SYNDROME;BOWEL DISEASES;CROHNS DISEASE;CYSTIC FIBROSIS;LUNG CANCER;PLATELET-RICH PLASMA;BOWEL DISEASE;OBSERVATIONAL STUDY;PROSPECTIVE OBSERVATIONAL;PROSPECTIVE STUDY;REAL-WORLD DATA;RETROSPECTIVE STUDY;SARS-COV- INFECTION;SICILIAN NETWORK;ACID VERSUS;ADALIMUMAB BIOSIMILAR;BIOLOGICAL THERAPY;BIOSIMILAR ABP;BLUE LIGHT;CANCER PATIENTS;CAUSING RESISTANCE;CELL LUNG;CIRCULATION ENDOVASCULAR;CLINICAL CONSEQUENCES;CLINICAL PRACTICE;DISEASE TREATED;DISEASES SN-IBD;EFFECTIVE OPTION","7;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","DDR GENES;RISK FACTORS;RUTGEERTS SCORE;BIOLOGICAL DRUGS;CORONARY ARTERY;PANCREATIC IRON;PATIENTS UNDERGOING;ADVISORY BOARD;GLOBAL PANCREAS;IRON OVERLOAD;PATIENTS UNDERWENT;PERSONAL ADVISORY;SARS-COV- INFECTION;ARTERY DISEASE;COVID- PANDEMIC;HR CI;MYCOPHENOLIC ACID;NIRF IMAGING;PELVIC EXENTERATION;SIGNIFICANTLY LOWER;SOMATIC DDR;WALL MOTION;ABSTRACT AIMS;ACUTE CORONARY;ADVERSE EVENTS;ARTERY OCCLUSION;BIOLOGICAL DRUG;CORONARY SYNDROME;DISEASE PROGRESSION;DRUG USERS","12;9;9;8;8;8;8;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,2.62,809.25,6.02,2,0.25,20.75,0,0,1,0,2,0,0,5,0,4,4,0,0,0,0,0,0,7,1,0,8,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3107 MICROBIOLOGY;3207 MEDICAL MICROBIOLOGY;3209 NEUROSCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4202 EPIDEMIOLOGY;4203 HEALTH SERVICES AND SYSTEMS","7;3;3;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PREVENTION;PAIN RESEARCH;PATIENT SAFETY;RARE DISEASES;ATHEROSCLEROSIS;BEHAVIORAL AND SOCIAL SCIENCE;BREAST CANCER;CANCER;CARDIOVASCULAR;CHARCOT-MARIE-TOOTH DISEASE;CHRONIC PAIN;CYSTIC FIBROSIS;DIGESTIVE DISEASES;EYE DISEASE AND DISORDERS OF VISION;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;IMMUNIZATION;INFECTIOUS DISEASES","6;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;CONGENITAL;EYE;INFECTION;ORAL AND GASTROINTESTINAL","1;1;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;2.4 SURVEILLANCE AND DISTRIBUTION;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY","2;1;1;1;1;1","BREAST CANCER","1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,"PUBLIC LIBRARY OF SCIENCE;ZENODO;SPRINGER NATURE;KARGER PUBLISHERS","6;4;3;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;51 PHYSICAL SCIENCES;5107 PARTICLE AND HIGH ENERGY PHYSICS;3105 GENETICS;3107 MICROBIOLOGY;52 PSYCHOLOGY;5203 CLINICAL AND HEALTH PSYCHOLOGY","15;11;6;3;2;2;1;1;1;1","GENETICS;CLINICAL RESEARCH;AUTOIMMUNE DISEASE;BRAIN DISORDERS;CORONAVIRUSES;CYSTIC FIBROSIS;LUNG;PATIENT SAFETY;PSORIASIS;RARE DISEASES;EMERGING INFECTIOUS DISEASES;HEALTH DISPARITIES;INFECTIOUS DISEASES;MINORITY HEALTH","5;3;2;2;2;2;2;2;2;2;1;1;1;1","CONGENITAL;SKIN;INFECTION;METABOLIC AND ENDOCRINE","2;2;1;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION","2;2;1;1","CLINICAL;BIOMEDICAL","4;1","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","6;2",NA,NA,NA,NA
"AOUSSN_GMARTINO",2022,92,17.4565217391304,2.70652173913044,0.228260869565217,0.271739130434783,0.228260869565217,1.40677966101695,0.954545454545455,1.19047619047619,0.954545454545455,0.717391304347826,0,29,20,13,4,0.32,0.22,0.14,0.04,5.95,0.666044555234368,5.76446280991736,0.260869565217391,0.902173913043478,0.398,0.27,0.389,0.218,"ROCCO SALVATORE CALABRÒ;ANTONINO NARO;MARIA GRAZIA MAGGIO;DANIELA CARAMAZZA;GIOVANNI PANICO;ALFREDO MANULI;CONCETTA ZITO;LORENZO VACCA;ALFREDO ERCOLI;GAAFAR RAGAB;IBRAHIM ALMAGHLOUTH;BRUNO FREDIANI;GIUSEPPE LOPALCO;ROSALBA DE SARRO;VALERIA CAGGIANO;ANTONIO VITALE;GIOVANNI SCAMBIA;GIANLUCA DI BELLA;ABDURRAHMAN TUFAN;ALBERTO BALISTRERI","10;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4","ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALFREDO MANULI;MARIA GRAZIA MAGGIO;CONCETTA ZITO;DANIELA CARAMAZZA;GIOVANNI PANICO;LORENZO VACCA;ALFREDO ERCOLI;ROBERTO LICORDARI;ROSALBA DE SARRO;VELIO ASCENTI;DANIELE BRUSCHETTA;ANGELO ALITO;GIUSEPPE CAMPAGNA;LORIS PIGNOLO;GIOVANNI SCAMBIA;ANNA VIOLA;GIANLUCA DI BELLA;A. DI BENEDETTO","1.53;0.94;0.71;0.66;0.65;0.57;0.57;0.57;0.57;0.49;0.48;0.47;0.46;0.46;0.46;0.45;0.44;0.44;0.4;0.4","ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALFREDO MANULI;CONCETTA ZITO;ALFREDO ERCOLI;ROSALBA DE SARRO;GIANLUCA DI BELLA;GIOVANNI CONTI;ALBERTO CACCIOLA;ANNA VIOLA;MAURIZIO CUSMÀ-PICCIONE;WALTER FRIES;A. BROGNA;DANIELE BRUSCHETTA;FILIPPO BENEDETTO;A. DI BENEDETTO;EGIDIO IMBALZANO;ANGELO ALITO;ANTONIO PITRONE;SERGIO BALDARI","10;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","ROCCO SALVATORE CALABRÒ;ANTONINO NARO;ALFREDO MANULI;CONCETTA ZITO;ALFREDO ERCOLI;ROBERTO LICORDARI;ROSALBA DE SARRO;DANIELE BRUSCHETTA;ANGELO ALITO;ANNA VIOLA;GIANLUCA DI BELLA;A. DI BENEDETTO;EGIDIO IMBALZANO;SERGIO BALDARI;ROBERTA MANGANARO;G. DI BELLA;FILIPPO FLAVIO ANGILERI;FILIPPO BENEDETTO;ALBERTO CACCIOLA;FRANCESCA CUCINOTTA","1.53;0.94;0.71;0.65;0.57;0.49;0.48;0.46;0.46;0.44;0.4;0.4;0.35;0.34;0.32;0.32;0.31;0.3;0.29;0.29","SAŠA ŽIVKOVIĆ;MICHELE EMDIN;ROCCO SALVATORE CALABRÒ;ALBERTO CACCIOLA;FABIO MINUTOLI;SARA LILLO;A. BROGNA;GIANLUCA FERINI;SILVANA PARISI;STEFANO PERGOLIZZI;ANTONIO PONTORIERO;ANNA SANTACATERINA;ANNA VIOLA;GIACOMO FERRANTELLI;GIUSEPPE VITA;ALBERTA L. WARNER;AMIR DORI;ANGELA DISPENZIERI;ANNABEL WANG;ARNT V. KRISTEN","98;60;59;53;53;53;52;52;52;52;51;50;50;50;50;49;49;49;49;49","A. BROGNA;GIUSEPPE VITA;GIOVANNI CONTI;FILIPPO BENEDETTO;ANTONINO NARO;EGIDIO IMBALZANO;ALFREDO MANULI;WALTER FRIES;ARMANDO A CARAGLIANO;DANIELE BRUSCHETTA;SERGIO LUCIO VINCI;ANNA VIOLA;ARIANNA RICCIARDELLO;FRANCESCA CUCINOTTA;LAURA TURRIZIANI;STEFANO COSTA;GIUSEPPE NAVARRA;MARIA CRISTINA LUCANTO;SIMONA CRISTADORO;ALFREDO ABBRUZZESE","52;49;37;36;35;29;26;23;22;22;22;21;21;21;21;20;16;16;16;13","ALFREDO ERCOLI;ALFREDO MANULI;ANTONINO NARO;CONCETTA ZITO;GIOVANNI CONTI;ROSALBA DE SARRO;A. BROGNA;A. DI BENEDETTO;ANNA VIOLA;ANTONIO PITRONE;DANIELE BRUSCHETTA;EGIDIO IMBALZANO;GIANLUCA DI BELLA;GIUSEPPE ANDÒ;MAURIZIO CUSMÀ-PICCIONE;ROBERTA MANGANARO;G. DI BELLA;ROBERTO LICORDARI;WALTER FRIES;A MANCINELLI","5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2","MEDICINE;BIOLOGY;ENGINEERING;PHYSICS;PSYCHOLOGY;CHEMISTRY;MATHEMATICS;COMPUTER SCIENCE;ECONOMICS;POLITICAL SCIENCE;BUSINESS;MATERIALS SCIENCE;ENVIRONMENTAL SCIENCE;PHILOSOPHY;SOCIOLOGY","90;13;10;10;10;6;6;5;5;5;3;3;1;1;1","INTERNAL MEDICINE;SURGERY;RADIOLOGY;PSYCHIATRY;PATHOLOGY;CARDIOLOGY;ENVIRONMENTAL HEALTH;PEDIATRICS;GASTROENTEROLOGY;GENETICS;PHYSICAL THERAPY;NURSING;BIOCHEMISTRY;MECHANICAL ENGINEERING;NUCLEAR MEDICINE;OPTICS;PHYSICAL MEDICINE AND REHABILITATION;CLINICAL PSYCHOLOGY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;LAW;ONCOLOGY","68;26;18;17;16;14;11;9;8;8;8;7;6;6;6;6;6;5;5;5;5;5","DISEASE;POPULATION;CANCER;RANDOMIZED CONTROLLED TRIAL;HEART FAILURE;MAGNETIC RESONANCE IMAGING;PROSPECTIVE COHORT STUDY;RETROSPECTIVE COHORT STUDY;ADVERSE EFFECT;ANXIETY;GENE;INCIDENCE (GEOMETRY);MYOCARDIAL INFARCTION;OBSERVATIONAL STUDY;RADIATION THERAPY;REHABILITATION;ALTERNATIVE MEDICINE;BLOOD PRESSURE;CLINICAL TRIAL;CONFIDENCE INTERVAL;HEALTH CARE;ODDS RATIO;STROKE (ENGINE)","17;12;8;8;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4","INFECTIOUS DISEASE (MEDICAL SPECIALTY);ACUTE CORONARY SYNDROME;EJECTION FRACTION;ELECTRONIC DATA CAPTURE;INFLAMMATORY BOWEL DISEASE;ISCHEMIC STROKE;ADENOCARCINOMA;AGONIST;ARTERIAL STIFFNESS;AUTISM SPECTRUM DISORDER;BREAST CANCER;CARDIOMYOPATHY;CHEMORADIOTHERAPY;CLINICAL ENDPOINT;CONVENTIONAL PCI;CROHN'S DISEASE;DIASTOLE;DIFFUSION MRI;DISEASE REGISTRY;GESTATION;HAZARD RATIO;INTRACEREBRAL HEMORRHAGE;MUTANT;MUTATION;NEURODEVELOPMENTAL DISORDER;NEUROPSYCHOLOGY;NEURORADIOLOGY;PERCUTANEOUS CORONARY INTERVENTION;PLACEBO;PULSE PRESSURE;PULSE WAVE VELOCITY","7;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);MODIFIED RANKIN SCALE;GESTATIONAL DIABETES;MACE;OBETICHOLIC ACID;AFLIBERCEPT;APPLANATION TONOMETRY;ATYPICAL ANTIPSYCHOTIC;BREAST CARCINOMA;CANAKINUMAB;CAROTID STENTING;CD3;CENTRAL RETINAL VEIN OCCLUSION;CLINICAL GLOBAL IMPRESSION;COENZYME Q – CYTOCHROME C REDUCTASE;COMPOUND HETEROZYGOSITY;CYTOREDUCTIVE SURGERY;DOUBLE BLIND;EXTRAVERSION AND INTROVERSION;FOSSA OVALIS;GLUCOSE TOLERANCE TEST;HETEROLOGOUS EXPRESSION;INFORMATION GOVERNANCE;INTERATRIAL SEPTUM;INTRAPERITONEAL CHEMOTHERAPY;IVACAFTOR;KOUNIS SYNDROME;MUTAGENESIS;MYH7;PHENYLPYRUVIC ACID;PORTAL VENOUS PRESSURE;RANIBIZUMAB;ROS1;RUXOLITINIB;SPECKLE TRACKING ECHOCARDIOGRAPHY;SYSTEMIC THERAPY;TRACTOGRAPHY;USTEKINUMAB;VEDOLIZUMAB;VESICOURETERAL REFLUX","7;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;TREATMENT OUTCOME;COVID-19;RETROSPECTIVE STUDIES;MALE;BRAIN ISCHEMIA;FEMALE;CYSTIC FIBROSIS;STROKE;INTRACRANIAL ANEURYSM;PROSPECTIVE STUDIES;ACUTE CORONARY SYNDROME;AGED;CROHN DISEASE;ENDOVASCULAR PROCEDURES;HEMORRHAGE;RISK FACTORS;ACUTE KIDNEY INJURY;EMBOLIZATION, THERAPEUTIC","55;37;13;11;10;9;8;8;7;7;6;6;5;5;5;5;5;5;4;4","EPIDEMIOLOGY AND MANAGEMENT OF STROKE;PELVIC FLOOR DISORDERS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;CORONAVIRUS DISEASE 2019;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;IMPACT OF COVID-19 ON MENTAL HEALTH;IMPACT OF GESTATIONAL DIABETES MELLITUS ON PREGNANCY;MOLECULAR MECHANISMS OF AMYLOIDOSIS;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;PATHOPHYSIOLOGY AND MANAGEMENT OF CEREBRAL ANEURYSMS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;AUTISM SPECTRUM DISORDERS;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;CHOLESTEROL-LOWERING TREATMENT","3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","STROKE (ENGINE);DIAGNOSIS;ELECTRONIC DATA CAPTURE;LEFT VENTRICULAR FUNCTION;TREATMENT;CARDIAC AMYLOIDOSIS;CARDIAC IMAGING;CHEMORADIOTHERAPY;CLINICAL ENDPOINT;CYSTIC FIBROSIS;DELPHI METHOD;DEPRESSION (ECONOMICS);DIABETES;DISCONTINUATION;DISEASE REGISTRY;ECHOCARDIOGRAPHY;GESTATIONAL DIABETES MELLITUS;GOLD STANDARD (TEST);INFARCTION TREATMENT;MACE","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MAGNETIC RESONANCE;PROSPECTIVE STUDY;AIDA INTERNATIONAL;AUTOINFLAMMATORY DISEASES;BILIARY CHOLANGITIS;CIRRHOTIC PATIENTS;CLINICAL TRIAL;COVID- PANDEMIC;COVID- VACCINATION;CROHNS DISEASE;CYSTIC FIBROSIS;DIFFERENTIAL DIAGNOSIS;GESTATIONAL DIABETES;HEART FAILURE;INTERNATIONAL REGISTRY;IRON OVERLOAD;ISCHEMIC STROKE;LAPAROSCOPIC SACROCOLPOPEXY;MULTICENTER STUDY;MULTIPLE SCLEROSIS;NEURODEVELOPMENTAL DISORDERS;OBETICHOLIC ACID;PILOT STUDY;POP RECURRENCE;PRELIMINARY DATA;PRELIMINARY RESULTS;PRIMARY BILIARY;RANDOMIZED CLINICAL;REDO LAPAROSCOPIC;RESONANCE ENTEROGRAPHY","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","RA PATIENTS;MAJOR BLEEDING;HR CI;FIBRINOGEN DEPLETION;COVID- PANDEMIC;FUNDING SOURCES;HOMOZYGOUS Β;ΒΒ PATIENTS;ACUTE CORONARY;AUTISM SPECTRUM;LANGUAGE NETWORK;NURSING STUDENTS;PANCREATIC IRON;STILLS DISEASE;SYMPTOMATIC PATIENTS;ADVERSE CARDIOVASCULAR;BOWEL DISEASE;CARDIOVASCULAR EVENTS;CORONARY SYNDROME;ELDERLY RA;GLUCOSE METABOLISM;IADPSG CRITERIA;INFLAMMATORY BOWEL;INTELLECTUAL DISABILITY;INTERNATIONAL REGISTRY;MAGNETIC RESONANCE;NORMAL VALUES;NTMS-BASED MAPPING;P-VALUE AMPLT;RISK FACTORS","22;10;9;8;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,2.33,189,3.51,1,0.17,55,0,0,1,0,2,0,0,3,0,4,2,0,0,0,0,0,0,6,0,0,6,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","5;2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;COMPLEMENTARY AND INTEGRATIVE HEALTH;CYSTIC FIBROSIS;LUNG;NUTRITION;ORPHAN DRUG;AGING;CHRONIC LIVER DISEASE AND CIRRHOSIS;DIETARY SUPPLEMENTS;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEMATOLOGY;INFECTIOUS DISEASES;LIVER DISEASE;MINORITY HEALTH;PEDIATRIC;PREVENTION","4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CONGENITAL;INFECTION;ORAL AND GASTROINTESTINAL","2;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","4;1","LEUKEMIA / LEUKAEMIA;LIVER CANCER","1;1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"FRONTIERS;ZENODO","4;2","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;46 INFORMATION AND COMPUTING SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","6;2;2;2;2;2;1;1","BRAIN DISORDERS;CANCER;NEUROSCIENCES;BIOENGINEERING;BIOMEDICAL IMAGING;BRAIN CANCER;CARDIOVASCULAR;CLINICAL RESEARCH;GENETICS;HEART DISEASE;MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE;NETWORKING AND INFORMATION TECHNOLOGY R&D (NITRD);RARE DISEASES;WOMEN'S HEALTH;AUTOIMMUNE DISEASE;LUNG;LUNG CANCER;MULTIPLE SCLEROSIS;NEURODEGENERATIVE;PATIENT SAFETY","3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","CARDIOVASCULAR","2","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS","2;2","CLINICAL","2",NA,NA,"PITUITARY TUMOR;LUNG CANCER","2;1",NA,NA
"AOUSSN_GMARTINO",2023,112,22.3392857142857,2.44642857142857,0.196428571428571,0.214285714285714,0.258928571428571,1.52222222222222,1.1,1.04347826086957,1.16,0.732142857142857,0,41,25,5,7,0.37,0.22,0.04,0.06,3.02,0.688522830856645,4.99274047186933,0.375,0.9375,0.403,0.316,0.306,0.357,"GIOVANNI CONTI;BRUNO FREDIANI;GIUSEPPE LOPALCO;VALERIA CAGGIANO;ANTONIO VITALE;ALBERTO BALISTRERI;LUCA CANTARINI;ALFREDO ERCOLI;MARIA CRISTINA MAGGIO;JURGEN SOTA;CARLA GAGGIANO;CLAUDIA FABIANI;PETROS P. SFIKAKIS;IBRAHIM ALMAGHLOUTH;FLORENZO IANNONE;ABDURRAHMAN TUFAN;KATERINA LASKARI;MARIA TARSIA;EWA WIĘSIK–SZEWCZYK;FRANCESCO LA TORRE","9;8;8;8;8;8;8;8;8;8;8;8;7;7;7;7;7;7;7;7","ALFREDO ERCOLI;ROCCO SALVATORE CALABRÒ;GIOVANNI SCAMBIA;GIANLUCA DI BELLA;AMELIA RIZZO;ALDO SITIBONDO;DANIELA CARAMAZZA;SARA MASTROVITO;GIOVANNI PANICO;LORENZO VACCA;GIUSEPPE CAMPAGNA;SCIPIONE CARERJ;GIANCARLO TRIMARCHI;ANGELO ALITO;ADRIANA TISANO;ANDREA LOMBISANI;CONCETTA ZITO;COSIMO GALLETTI;DANIELE BRUSCHETTA;FRANCESCO MARCELLO ARICÒ","0.93;0.89;0.66;0.64;0.6;0.6;0.59;0.59;0.59;0.59;0.59;0.59;0.52;0.5;0.5;0.45;0.44;0.43;0.35;0.34","GIOVANNI CONTI;ALFREDO ERCOLI;GIOVANNI SCAMBIA;GIANLUCA DI BELLA;SARA MASTROVITO;SCIPIONE CARERJ;GIOVANNI PANICO;GIUSEPPE ANDÒ;GIUSEPPE CAMPAGNA;WALTER FRIES;ANGELO ALITO;CONCETTA ZITO;ANTONIO PONTORIERO;ADRIANA TISANO;GIANCARLO TRIMARCHI;ANTONIO ARMANDO CARAGLIANO;SABINA RUSSO;ANNA VIOLA;ROBERTA GRANESE;SALVATORE CANNAVÒ","9;8;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3","ALFREDO ERCOLI;GIOVANNI SCAMBIA;GIANLUCA DI BELLA;ALDO SITIBONDO;SARA MASTROVITO;GIOVANNI PANICO;GIUSEPPE CAMPAGNA;SCIPIONE CARERJ;GIANCARLO TRIMARCHI;ANGELO ALITO;ADRIANA TISANO;CONCETTA ZITO;DANIELE BRUSCHETTA;FRANCESCO MARCELLO ARICÒ;EGIDIO IMBALZANO;ROBERTA GRANESE;CESARE DE GREGORIO;DANIELE PORTELLI;ANTONINO NARO;GIUSEPPE ANDÒ","0.93;0.66;0.64;0.6;0.59;0.59;0.59;0.59;0.52;0.5;0.5;0.44;0.35;0.34;0.34;0.33;0.33;0.33;0.33;0.32","GIOVANNI MONTINI;AGNIESZKA SZMIGIELSKA;ALBERTO CALDAS AFONSO;ALEKSANDRA ŻUROWSKA;ANDREA PASINI;ANGELA LA MANNA;ANNA KRANZ;AUGUSTINA JANKAUSKIENĖ;CLAUDIO LA SCOLA;DARIO GUIDO MINOLI;DIEGO DE PALMA;DJALILA MEKAHLI;DONATAS VAJAUSKAS;DOROTA DROŻDŻ;DOVILĖ RUZGIENĖ;EGIDIO BARBI;ESRA BASKIN;FATOŞ YALÇINKAYA;FRANCESCA BECHERUCCI;FRANZ SCHAEFER","44;43;43;43;43;43;43;43;43;43;43;43;43;43;43;43;43;43;43;43","ROBERTO CHIMENZ;GIOVANNI CONTI;CATERINA MUSOLINO;ALFREDO ERCOLI;SALVATORE CANNAVÒ;GIOVANNI PANICO;GIOVANNI SCAMBIA;GIUSEPPE CAMPAGNA;SARA MASTROVITO;ANNA VIOLA;GIUSEPPE ANDÒ;MARTA RAGONESE;OANA RUXANDRA COTTA;SERGIO LUCIO VINCI;WALTER FRIES;YLENIA ALESSI;ANTONINO NARO;AGOSTINO TESSITORE;ALFREDO MANULI;ANTONIO MACRÌ","43;34;31;18;16;15;15;15;15;13;13;13;13;13;13;13;12;11;10;10","GIOVANNI CONTI;GIANLUCA DI BELLA;GIUSEPPE ANDÒ;ALFREDO ERCOLI;ANNA VIOLA;ANTONIO ARMANDO CARAGLIANO;GIANCARLO TRIMARCHI;SABINA RUSSO;WALTER FRIES;AGOSTINO TESSITORE;CATERINA MUSOLINO;FRANCESCO MARCELLO ARICÒ;SALVATORE CANNAVÒ;SERGIO LUCIO VINCI;SOCRATE PALLIO;ALDO SITIBONDO;ALFREDO MANULI;ANTONINO CANNAVÒ;ANTONIO PARLAVECCHIO;ANTONIO PONTORIERO","9;5;5;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;ECONOMICS;ENGINEERING;MATHEMATICS;PSYCHOLOGY;CHEMISTRY;POLITICAL SCIENCE;MATERIALS SCIENCE;SOCIOLOGY","111;24;13;13;8;8;7;6;4;4;3;2","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;PATHOLOGY;RADIOLOGY;PEDIATRICS;GASTROENTEROLOGY;PALEONTOLOGY;ENDOCRINOLOGY;GENETICS;PSYCHIATRY;ENVIRONMENTAL HEALTH;OPTICS;PHYSICAL THERAPY;NURSING;MECHANICAL ENGINEERING;NUCLEAR MEDICINE;ONCOLOGY;CLINICAL PSYCHOLOGY;INTENSIVE CARE MEDICINE","81;40;17;16;14;13;12;11;10;10;10;9;9;9;8;7;7;7;6;5","DISEASE;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;CANCER;CONFIDENCE INTERVAL;MYOCARDIAL INFARCTION;POPULATION;COHORT;DIABETES MELLITUS;DISCONTINUATION;QUALITY OF LIFE (HEALTHCARE);CONTEXT (ARCHAEOLOGY);INCIDENCE (GEOMETRY);ISCHEMIA;REHABILITATION;STROKE (ENGINE);ALTERNATIVE MEDICINE;CHEMOTHERAPY;CONCOMITANT;GENE;GOLD STANDARD (TEST);HEART FAILURE;OCCLUSION","34;16;10;10;10;10;9;8;8;7;7;6;6;6;6;6;5;5;5;5;5;5;5","CLINICAL ENDPOINT;COLORECTAL CANCER;INFECTIOUS DISEASE (MEDICAL SPECIALTY);ISCHEMIC STROKE;PERCUTANEOUS CORONARY INTERVENTION;TOLERABILITY;ACUTE CORONARY SYNDROME;CONVENTIONAL PCI;HAZARD RATIO;INFLAMMATORY BOWEL DISEASE;OVARIAN CANCER;GROWTH HORMONE;IMATINIB;INFLIXIMAB;PARKINSON'S DISEASE;RANDOMIZATION;ULCERATIVE COLITIS;2019-20 CORONAVIRUS OUTBREAK;ADULT-ONSET STILL'S DISEASE;ANAKINRA;ARGON PLASMA COAGULATION;BEHCET'S DISEASE;BONE MINERAL;BREAST CANCER;CARDIOMYOPATHY;CROHN'S DISEASE;EJECTION FRACTION;FETUS;HEART RATE;MUSCLE BIOPSY;MUTATION;NEUROREHABILITATION;PLACEBO;PROTEINURIA;REFLUX;THROMBOCYTOSIS;TOFACITINIB","11;7;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CORONAVIRUS DISEASE 2019 (COVID-19);COLONOSCOPY;CYTOREDUCTIVE SURGERY;MODIFIED RANKIN SCALE;MACE;ACROMEGALY;CANAKINUMAB;DASATINIB;IMATINIB MESYLATE;INTRAPERITONEAL CHEMOTHERAPY;NILOTINIB;USTEKINUMAB;ALPORT SYNDROME;APOLIPOPROTEIN A1;BETA DEFENSIN;CALCITONIN GENE-RELATED PEPTIDE;CALCIUM ATPASE;CD117;DEBULKING;DEPERSONALIZATION;DISEASE MANAGEMENT;DRUG-ELUTING STENT;DUAL ENERGY;DYSKINESIA;ESOPHAGITIS;EXOME SEQUENCING;GLOMERULAR BASEMENT MEMBRANE;GLUCOSE TOLERANCE TEST;GRAVES' OPHTHALMOPATHY;GROWTH RESTRICTION;IDIOPATHIC NEPHROTIC SYNDROME;IMPAIRED GLUCOSE TOLERANCE;INTRAUTERINE GROWTH RESTRICTION;IVACAFTOR;KARYOTYPE;KOUNIS SYNDROME;LDL RECEPTOR;MICROHEMATURIA;MULTICENTER TRIAL;NEOADJUVANT THERAPY;NOISE-INDUCED HEARING LOSS;PALIPERIDONE;PALIPERIDONE PALMITATE;PATHERGY;PDGFRA;PERITONEAL CARCINOMATOSIS;PULSE WAVE ANALYSIS;QUANTITATIVE COMPUTED TOMOGRAPHY;SABR VOLATILITY MODEL;SANGER SEQUENCING;SERCA;TOTAL MESORECTAL EXCISION;UMBILICAL ARTERY;VESICOURETERAL REFLUX;WOMAC","5;4;4;4;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;ADULT;COVID-19;STILL'S DISEASE, ADULT-ONSET;ACUTE CORONARY SYNDROME;BEHCET SYNDROME;MALE;FEMALE;ITALY;RETROSPECTIVE STUDIES;PERCUTANEOUS CORONARY INTERVENTION;ACROMEGALY;QUALITY OF LIFE;SINUS THROMBOSIS, INTRACRANIAL;STROKE;TREATMENT OUTCOME;CHILD;CORONARY ARTERY DISEASE;CROSS-SECTIONAL STUDIES","70;41;10;9;9;8;8;8;7;7;7;6;5;5;5;5;5;4;4;4","EFFICACY AND RESISTANCE IN CML TREATMENT;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;PELVIC FLOOR DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF STROKE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;MANAGEMENT OF PERITONEAL CARCINOMATOSIS FROM DIGESTIVE TRACT;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS;IMPACT OF COVID-19 ON MENTAL HEALTH;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ADAPTATION OF TENDON AND SKELETAL MUSCLE TO MECHANICAL LOADING;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANALYSIS OF ELECTROMYOGRAPHY SIGNAL PROCESSING;APPLICATIONS OF ELECTROPORATION IN BIOTECHNOLOGY AND FOOD PROCESSING;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;ATOPIC DERMATITIS AND SKIN MICROBIOME;ATRIAL FIBRILLATION","5;5;5;5;4;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1","CLINICAL ENDPOINT;CARDIAC IMAGING;DISCONTINUATION;STROKE (ENGINE);CONCOMITANT;GOLD STANDARD (TEST);TOLERABILITY;CARDIOVASCULAR RISK ASSESSMENT;ULCERATIVE COLITIS;CYTOREDUCTIVE SURGERY;DEEP VEIN THROMBOSIS;HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY;INFARCTION TREATMENT;INTRAPERITONEAL CHEMOTHERAPY;MACE;PELVIC ORGAN PROLAPSE;PERITONEAL METASTASES;PHLEBOTOMY;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;TREATMENT DISCONTINUATION","11;7;7;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3","STILLS DISEASE;AIDA NETWORK;MULTICENTER STUDY;INTERNATIONAL AIDA;DISEASE REGISTRY;PERITONEAL METASTASES;POLYETHYLENE GLYCOL;RAS SYSTEM;ATRIAL STRAIN;CHEMOTHERAPY HIPEC;CHRONIC MYELOID;CLINICAL TRIAL;HUGO RAS;HYPERTHERMIC INTRAPERITONEAL;INTRAPERITONEAL CHEMOTHERAPY;LEFT ATRIAL;MYELOID LEUKEMIA;ORGAN PROLAPSE;PATIENTS TREATED;PELVIC ORGAN;REAL-LIFE DATA;RETROSPECTIVE MULTICENTER;ROBOTIC SACROCOLPOPEXY;ACUTE CORONARY;ARTERY DISEASE;ARTIFICIAL INTELLIGENCE;ASCORBATE VERSUS;BEHÇETS DISEASE;BEHÇETS SYNDROME;CEREBRAL VENOUS","8;7;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","STILLS DISEASE;PEAK DOSE;LEFT ATRIAL;MD CI;MEDIAN IQR;MOLECULAR RESPONSE;PATIENTS TREATED;PRESSURE ULCERS;SPEAKERS BUREAU;BIOLOGIC AGENT;MEDIAN AGE;SENSITIVITY CI;SPECIFICITY CI;ADVERSE EVENTS;ARTHRITIS PATIENTS;AUTOINFLAMMATORY DISEASE;CLINICAL FEATURES;DISEASE ONSET;GOLD STANDARD;HUGO RAS;IPI IPI;MEDIAN FOLLOW-UP;MOTION ABNORMALITIES;PATIENTS AFFECTED;PROGRESSIVE ARM;RUTGEERTS SCORE;SIGNIFICANT DIFFERENCES;SKIN INVOLVEMENT;STATISTICALLY SIGNIFICANT;TKI DISCONTINUATION","26;11;9;9;8;8;8;8;8;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6;6;6;6;6",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,2,269.71,3.98,1,0.14,6.71,0,0,0,0,1,0,0,6,0,4,3,0,0,0,0,0,0,6,1,0,7,0,0,0,0,0,0,0,0,0,"Italy","7","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3209 NEUROSCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;42 HEALTH SCIENCES","7;3;1;1;1;1;1","CLINICAL RESEARCH;NEUROSCIENCES;BRAIN DISORDERS;CARDIOVASCULAR;CHRONIC PAIN;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;NEURODEGENERATIVE;PAIN RESEARCH;PHYSICAL ACTIVITY;PREVENTION;WOMEN'S HEALTH;AGING;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;BIOMEDICAL IMAGING;BIOTECHNOLOGY;CANCER;COMPLEMENTARY AND INTEGRATIVE HEALTH","7;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","CARDIOVASCULAR;CANCER;MENTAL HEALTH;METABOLIC AND ENDOCRINE;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","2;1;1;1;1;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS","2;2;2;2;1;1","BREAST CANCER","1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"FRONTIERS;ZENODO","2;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY","8;3;2;1;1","BIOENGINEERING;BIOMEDICAL IMAGING;CARDIOVASCULAR;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE;MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE;CLINICAL RESEARCH;PREVENTION","2;2;2;2;2;2;1;1","CARDIOVASCULAR","2","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS","2;1","CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","3",NA,NA,"3 GOOD HEALTH AND WELL BEING","1"
"AOUSSN_GMARTINO",2024,94,27.1489361702128,2.0531914893617,0.170212765957447,0.159574468085106,0.180851063829787,1.45112781954887,1.14285714285714,1.07142857142857,1.21428571428571,0.595744680851064,0,40,17,6,6,0.43,0.18,0.06,0.06,0.96,1.00182303072233,4.28598130841122,0.404255319148936,0.98936170212766,0.409,0.387,0.303,0.387,"GIOVANNI CONTI;FRANCESCO LA TORRE;PETROS P. SFIKAKIS;GAAFAR RAGAB;ANDREA HINOJOSA‐AZAOLA;VALERIA CAGGIANO;ANTONIO VITALE;R. C. KARDAŞ;ABDURRAHMAN TUFAN;SAMAR THARWAT;GIUSEPPE ANDÒ;ΑΝΑΣΤΆΣΙΟΣ ΚΑΡΑΜΑΝΆΚΟΣ;GIUSEPPE LOPALCO;TOMMASO D’ANGELO;JOSÉ HERNÁNDEZ‐RODRÍGUEZ;LUCA CANTARINI;GIACOMO EMMI;JURGEN SOTA;CARLA GAGGIANO;EZGI DENIZ BATU","8;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5","GIUSEPPE ANDÒ;ALFREDO MANULI;ROCCO SALVATORE CALABRÒ;ANTONINO MICARI;LAURA PISANU;ANTONELLA GAGLIANO;VINCENZO FICARRA;MARIA GRAZIA MAGGIO;ANGELO QUARTARONE;TOMMASO D’ANGELO;ANGELO ALITO;MIRJAM BONANNO;DEMETRIO MILARDI;ROSSELLA TALOTTA;MAŁGORZATA WAŚNIEWSKA;FRANCESCA BANDITELLI;DOMENICO CORICA;GIORGIA PEPE;ALESSANDRA LI POMI;AMELIA RIZZO","0.7;0.59;0.59;0.56;0.48;0.48;0.46;0.45;0.43;0.43;0.4;0.39;0.38;0.37;0.36;0.33;0.31;0.31;0.31;0.28","GIOVANNI CONTI;GIUSEPPE ANDÒ;TOMMASO D’ANGELO;MAŁGORZATA WAŚNIEWSKA;ANTONINO MICARI;VINCENZO FICARRA;PASQUALE CREA;STEFANO COSTA;DOMENICO CORICA;GIORGIA PEPE;ALFREDO MANULI;SILVIO MAZZIOTTI;GIUSEPPE NAVARRA;LUDOVICA R. M. LANZAFAME;GIUSEPPE M. BUCOLO;TOMMASO AVERSA;GIAMPIERO VIZZARI;SALVATORE CANNAVÒ;GABRIELLA DI ROSA;SALVATORE BENVENGA","8;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2","GIUSEPPE ANDÒ;ALFREDO MANULI;ANTONINO MICARI;ANTONELLA GAGLIANO;VINCENZO FICARRA;TOMMASO D’ANGELO;ROSSELLA TALOTTA;MAŁGORZATA WAŚNIEWSKA;DOMENICO CORICA;GIORGIA PEPE;GABRIELE SORCE;STEFANO COSTA;GIAMPIERO VIZZARI;TOMMASO AVERSA;GIUSEPPE M. BUCOLO;SILVIO MAZZIOTTI;LUDOVICA R. M. LANZAFAME;DONATELLA SANGARI;ANGELO DIMARTINO;G. MICELI","0.7;0.59;0.56;0.48;0.46;0.43;0.37;0.36;0.31;0.31;0.25;0.24;0.23;0.22;0.22;0.21;0.21;0.2;0.2;0.2","ALBERTO BARENGO;ALESSANDRO FASOLINO;ALESSANDRO LUPI;ALESSIA CURRAO;ANGELO AURICCHIO;ANTONIO SANZO;ANTÓNIO TOSCANO;ARIANNA MORENA;CAROL GRAVINESE;CLAUDIA CARASSIA;CLAUDIA COLOMBO;CLAUDIA SCUDU;DOMENICO ZAGARI;EDOARDO GANDOLFI;ENRICO BALDI;FEDERICA DE VECCHI;FILIPPO ANGELINI;FILIPPO MARIA CAUTI;FRANCESCA ROMANA GENTILE;FRANCESCO DE SENSI","21;21;21;21;21;21;21;21;21;21;21;21;21;21;21;21;21;21;21;21","PASQUALE CREA;SONIA MESSINA;GIOVANNI CONTI;GIUSEPPE ANDÒ;ALFREDO MANULI;ANTONIO GENNARO NICOTERA;TOMMASO AVERSA;AMBRA BUTERA;ANNA GAIA ATTARDI;ANTONIO BRUNO;ARIANNA MANCINI;DOMENICO CORICA;ELISA GIUSEPPA LO RE;GIORGIA PEPE;GIOVANNI GENOVESE;LETTERIA ANNA MORABITO;MARIA ROSARIA ANNA MUSCATELLO;MAŁGORZATA WAŚNIEWSKA;NUNZIA CALABRÒ;P. DI BELLA","21;16;10;9;6;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","GIOVANNI CONTI;GIUSEPPE ANDÒ;VINCENZO FICARRA;ANTONINO MICARI;PASQUALE CREA;ALFREDO MANULI;MAŁGORZATA WAŚNIEWSKA;TOMMASO AVERSA;STEFANO COSTA;AGOSTINO TESSITORE;ANTONELLA GAGLIANO;ANTONIO ARMANDO CARAGLIANO;ANTONIO GENNARO NICOTERA;CONCETTA ZITO;DOMENICO CORICA;FRANCESCO FERRAÙ;GIORGIA PEPE;LETTERIA ANNA MORABITO;SALVATORE BENVENGA;SALVATORE CANNAVÒ","8;6;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;ENGINEERING;PHYSICS;CHEMISTRY;PHILOSOPHY;SOCIOLOGY;MATERIALS SCIENCE;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;ENVIRONMENTAL SCIENCE;GEOGRAPHY;GEOLOGY","90;13;12;11;8;7;6;4;4;3;2;2;2;1;1;1","INTERNAL MEDICINE;SURGERY;CARDIOLOGY;PSYCHIATRY;PATHOLOGY;PHYSICAL THERAPY;INTENSIVE CARE MEDICINE;PEDIATRICS;RADIOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;PHYSICAL MEDICINE AND REHABILITATION;ENDOCRINOLOGY;GENETICS;MECHANICAL ENGINEERING;NEUROSCIENCE;NURSING;ENVIRONMENTAL HEALTH;ONCOLOGY;BIOCHEMISTRY;NUCLEAR MEDICINE","68;16;14;14;12;12;10;9;9;7;7;7;6;6;6;6;6;5;5;4;4","DISEASE;CANCER;MYOCARDIAL INFARCTION;COHORT;COGNITION;ISCHEMIA;RANDOMIZED CONTROLLED TRIAL;ALTERNATIVE MEDICINE;GENE;QUALITY OF LIFE (HEALTHCARE);STROKE (ENGINE);LOGISTIC REGRESSION;POPULATION;RECEIVER OPERATING CHARACTERISTIC;RECEPTOR;ANXIETY;AREA UNDER THE CURVE;ASTHMA;CONFIDENCE INTERVAL;CYSTIC FIBROSIS;DIABETES MELLITUS;KIDNEY;MULTIDISCIPLINARY APPROACH;NEUROLOGY;OBESITY;OBSERVATIONAL STUDY;OCCLUSION;PATHOLOGICAL;PSYCHOLOGICAL INTERVENTION;REHABILITATION;RETROSPECTIVE COHORT STUDY","15;10;9;7;6;6;6;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","ISCHEMIC STROKE;PERCUTANEOUS CORONARY INTERVENTION;PROSTATE;AGONIST;BEHCET'S DISEASE;CONVENTIONAL PCI;CORONARY ANGIOGRAPHY;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;MULTICENTER STUDY;PROSTATE CANCER;VASCULITIS;BASAL (MEDICINE);BECK DEPRESSION INVENTORY;BREAST CANCER;CULPRIT;NEURORADIOLOGY;PLACEBO;PRIMARY PREVENTION;REVASCULARIZATION;SLEEP DISORDER","4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","IVACAFTOR;OBETICHOLIC ACID;PROSTATE-SPECIFIC ANTIGEN;RETINAL VASCULITIS;BACILLUS LICHENIFORMIS;BIORESORBABLE SCAFFOLD;BOND STRENGTH;BRONCHIAL HYPERRESPONSIVENESS;CD15;CETUXIMAB;CHILDHOOD OBESITY;CONTRAST-TO-NOISE RATIO;CROHN DISEASE;DENTAL CEMENT;DIRECT BILIRUBIN;DOUBLE BLIND;ENTHESITIS;FIBROBLAST GROWTH FACTOR 23;FOLLICLE-STIMULATING HORMONE;IMMUNOGLOBULIN A;INFLAMMATORY BOWEL DISEASES;LOSS FUNCTION;LOWER URINARY TRACT SYMPTOMS;MASTECTOMY;MODIFIED RANKIN SCALE;MULTIPARAMETRIC MRI;MYELOID-DERIVED SUPPRESSOR CELL;P2Y12;PCA3;PRASUGREL;PROSTATE BIOPSY;PUSTULOSIS;RIGHT CORONARY ARTERY;RIVAROXABAN;SEROTONERGIC;SLEEP MEDICINE;TICAGRELOR;TIGIT;TRIPLE-NEGATIVE BREAST CANCER","3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;MALE;FEMALE;ITALY;AGED;MIDDLE AGED;TREATMENT OUTCOME;ADULT;CHILD;AGED, 80 AND OVER;REGISTRIES;RETROSPECTIVE STUDIES;PROSPECTIVE STUDIES;RISK FACTORS;ADOLESCENT;COHORT STUDIES;HEMORRHAGE;ISCHEMIC STROKE;MYOCARDIAL INFARCTION","59;35;26;23;16;15;15;11;10;9;8;6;6;5;5;4;4;3;3;3","EPIDEMIOLOGY AND MANAGEMENT OF STROKE;ASTHMA;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;DUAL-ENERGY COMPUTED TOMOGRAPHY;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;AUTISM SPECTRUM DISORDERS;CANCER SURVIVORSHIP AND QUALITY OF LIFE;DIAGNOSIS AND MANAGEMENT OF LIVER DISEASES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GLOBAL TRENDS IN OBESITY AND OVERWEIGHT RESEARCH;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;MANAGEMENT OF VALVULAR HEART DISEASE;PROSTATE CANCER RESEARCH AND TREATMENT;SLEEP'S ROLE IN MEMORY CONSOLIDATION AND REGULATION;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ATRIAL FIBRILLATION;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION","5;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1","STROKE (ENGINE);TREATMENT;DUAL-ENERGY CT;INFARCTION TREATMENT;MULTI-ENERGY CT;ASTHMA;OBETICHOLIC ACID;PRIMARY SCLEROSING CHOLANGITIS;PROSTATE CANCER;BASAL (MEDICINE);CANCER IMAGING;CARDIAC IMAGING;CFTR;CLINICAL OUTCOMES;CLINICAL SIGNIFICANCE;CONSTRAINT-INDUCED THERAPY;CROSS-SECTIONAL STUDY;CULPRIT;CYSTIC FIBROSIS;DIAGNOSIS","5;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","AIDA NETWORK;ITALIAN SOCIETY;PATIENTS IMPLANTED;AORTIC VALVE;BEHÇETS DISEASE;BILIARY CHOLANGITIS;CYSTIC FIBROSIS;DISEASE REGISTRY;INTERNATIONAL AIDA;ISCHEMIC STROKE;MYOCARDIAL INFARCTION;PRIMARY BILIARY;PROSTATE CANCER;ARREST COMPARED;ATRIAL FIBRILLATION;CANCER PATIENTS;CARDIAC ARREST;CHILDHOOD OBESITY;CLINICAL PRACTICE;COHORT STUDY;DISEASE DATA;DOUBLE-BLIND PLACEBO-CONTROLLED;EVENT-FREE SURVIVAL;GANGLION BLOCK;ICD INTERVENTION;ITALIAN MULTICENTRIC;MECHANICAL THROMBECTOMY;MONOENERGETIC IMAGING;NETWORK REGISTRIES;OBETICHOLIC ACID","5;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SEVERE ASTHMA;BEHÇETS DISEASE;FEMALE PATIENTS;PROSTATE CANCER;VMI RECONSTRUCTIONS;Β CI;CAROTID ARTERY;ERABS PROTOCOLS;FMF PATIENTS;IMAGE QUALITY;NURSING STUDENTS;PALLIATIVE CARE;ADJ-OR CI;BASAL LH;DIAGNOSTIC ASSESSABILITY;DIAGNOSTIC WORKUP;DISEASE PATIENTS;ENDODONTIC POSTS;INTERQUARTILE RANGE;KEV VMI;NERVOUS SYSTEM;NON-TREATED PATIENTS;QUALITY VASCULAR;STANDARD KV;TSHAMPGT ΜIUML;VASCULAR CONTRAST;BOND STRENGTH;BREAST CANCER;CANCER DEVELOPMENT;CHILDHOOD OBESITY","8;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,179.5,1.55,0,0,10,0,0,1,0,0,0,0,1,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;3213 PAEDIATRICS","2;1;1","CLINICAL RESEARCH;ASTHMA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EYE DISEASE AND DISORDERS OF VISION;GENETICS;LUNG;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PRETERM, LOW BIRTH WEIGHT AND HEALTH OF THE NEWBORN;PREVENTION;WOMEN'S HEALTH","2;1;1;1;1;1;1;1;1;1;1","EYE;REPRODUCTIVE HEALTH AND CHILDBIRTH;RESPIRATORY","1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES","1;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"FRONTIERS","7","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5204 COGNITIVE AND COMPUTATIONAL PSYCHOLOGY","10;5;4;2","BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CLINICAL RESEARCH;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MENTAL HEALTH;PEDIATRIC;BIOENGINEERING;NEURODEGENERATIVE;NEUROSCIENCES;PHYSICAL ACTIVITY;RARE DISEASES;RETT SYNDROME;SLEEP RESEARCH;AUTISM","7;7;7;7;7;7;5;5;5;5;5;5;5;2",NA,NA,NA,NA,"CLINICAL","7","CLINICAL MEDICINE AND SCIENCE","7",NA,NA,NA,NA
